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ABSTRACT
Matt Halvorsen: Disease associated mutations and functional
variants that significantly disrupt RNA structure
(Under the direction of Alain Laederach)
Genome-Wide Association Studies (GWAS) have revealed a great deal of trait and disease-
associated Single Nucleotide Polymorphisms (SNPs) that fall in noncoding or intergenic
regions of the human genome. This is congruent with the current understanding that many of
these regions are actively transcribed, and that many transcripts and transcript regions that
do not code for protein have important roles in the cell. In carrying out many transcripts’
functions, RNA structure plays a critical role. We hypothesized that a subset of noncoding
disease associated SNPs significantly change RNA structure. We developed a program called
SNPfold to identify SNPs that cause significant RNA structural rearrangement and utilized
it on a set of 514 disease-associated SNPs in 350 unique noncoding regions of the human
transcriptome. We identified six disease-states (Hyperferritinemia Cataract Syndrome, β-
Thalassemia, Cartilage-Hair Hypoplasia, Retinoblastoma, Chronic Obstructive Pulmonary
Disease, and Hypertension) where multiple SNPs significantly alter RNA structural ensembles.
We then conducted Selective 2’ OH Acylation and Primer Extension (SHAPE) in order
to confirm predicted structure change caused by SNPs associated with Hyperferritinemia
Catraract Syndrome (U22G and A56U in the FTL 5’ UTR). Both mutations are shown to
disrupt the formation of an Iron Response Element stemloop that is critical to translational
regulation of the mRNA. We identified compensatory mutations that were able to restore
these mutant structures to that of wildtype FTL 5’ UTR. We then identified from human
haplotype data several regions where SNP pairs inherited together conserve structure. Lastly,
we explored the functional effect of common SNPs associated with change in RNA expression
level by calculating the enrichment of their overlap with experimentally derived binding
sites for 14 different RNA-binding proteins. Consistent with a subset of these SNPs altering
iii
structure in functionally important sites of mRNA transcripts, we identified several proteins
where SNPs are enriched for proximal overlap. These results in their entirety indicate that
both rare disease-associated and common SNPs that significantly change RNA structure are
present in human populations, and that such a functional effect may account for a subset of
phenotypic differences and complex disease propensities among individuals.
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CHAPTER 1
Introduction
In humankind’s body of work in science and medicine, there has been a long standing
focus on trying to understand the root of what makes us what we are, what makes us
different from one another, and why we get sick. Many answers to this question have been
hypothesized throughout history, but it is only recently that we have been able to formulate
a hypothesis that has withstood scientific rigor. We now know that we are a product of the
biochemical interactions that take part within every cell in our body, and that ultimately we
represent a finely tuned balance between organic and biomolecule synthesis and breakdown.
We also know that the instructions required for the synthesis of known biomolecules that do
work within our cells, as well as that of any other known cellular organism can be found
within DNA, and that ultimately, our phenotypes are determined by our DNA sequence.
Our ability to read the sequence of DNA quickly and accurately has undergone a dramatic
improvement over the last few decades, and not only have we been able to sequence and
analyze the genomes of humans and compare them to other species, but we’ve also been
able to compare our sequence content to one another. We have additionally developed
technologies that allow us to measure more indirect things that are informative of gene
activity. The data from the human genetic variation we have collected, combined with the
gene expression data that has been accumulated in various large-scale projects, provided a
message which was counter-intuitive to the commonly held central dogma of biology, where
the order of information and control travels linearly from DNA to RNA to protein.
1.1 Unexpected results from GWAS and transcriptome profiling challenge be-
liefs on the function of RNA
The completion of the first draft of the human genome in 2001 made it possible to explore
human sequence variation on a massive scale [1]. With a scaffold to compare sequenced
read fragments against, it was now possible to not only quickly and efficiently identify single
nucleotide polymorphisms (SNPs) on a large scale, but also to determine the distribution of
these variant positions in the genome [2, 3]. The new genome-scale map of human variation
was a very exciting development for geneticists who were interested in the etiology of complex
phenotypes and diseases. Older techniques for analyzing the etiology of genetic diseases and
particular phenotypes, such as pedigree analysis, enzymatic assays and sequencing analysis
of a particular gene region, have been much more suited to situations where the phenotype
in question is known to be directly associated with the alternative expression of a single
gene [4–7]. As an alternative, geneticists had in the past utilized analyses where SNPs are
used as tags for a particular locus in the genome, and that their presence in a particular
phenotype means that they are in linkage with some causative mutation in that same locus
[8]. These analyses were limited by the low-throughput manner in which genotyping could
be conducted. With the introduction of genotyping arrays, the presence of many SNPs
could be tested all at once, and large-scale association tests between the presence of tagging
SNPs across the genome and a particular phenotype could be conducted in Genome-Wide
Association Studies (GWAS). These allowed for the analysis of particularly complex diseases
because no prior knowledge of causative loci is required [9]. As of December 2013, there have
been over 1,700 individual Genome-Wide Association studies done in order to identify loci
tied with some phenotype or genetic disease [10]. An analysis of significant trait-associated
SNPs derived from these GWAS studies has shown that around 88% of the SNPs map to
intronic or intergenic regions of the genome, with many intergenic SNPs being found far
from any annotated gene region [10]. While the most obvious means of altering a gene’s
activity through mutation involves the alteration of the triplet codons that encode the amino
acid sequence for the resultant protein, there exist additional functional mutations that are
alter gene activity and expression, and do not fall within a protein coding region of a gene.
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At around the same time, the functional status of these intergenic regions was coming under
question due to large-scale tiling arrays being carried out in order to determine just how
much of the human genome was being transcribed. Initial estimates from the pilot phase of
the ENCODE project using tiling arrays showed that upwards of 93% of the genome was
in some way, shape or form transcriptionally active [11, 12]. Due to the shortcomings of
utilizing tiling arrays, such as the significant distances in the genome between probe-covered
sites and the inability to ascertain the abundances of transcripts, these initial results were
subject to scrutiny and debate [13]. In the follow-up phase to the ENCODE project, concerns
over the accuracy of the conclusions reached from tiling arrays were addressed by utilizing
RNA-seq instead to determine both transcription coverage and transcript sequence. Results
from this study dropped the percentage of the genome reported to be transcriptionally active
down to 74.7% [14]. Technology now exists to specifically target transcripts produced from
the so-called intergenic regions, and has been used to uncover low abundance transcripts
that show evidence of undergoing processing [15]. From these results it is clear that much
more of the genome is transcriptionally active than once thought. Given the number of trait
or disease-associated SNPs found in untranslated or intergenic loci in the human genome,
combined with the strong evidence that the majority of the human genome is passed on to
an RNA transcript, it seems reasonable to assert that a number of functional SNPs being
tagged in genome studies (including those that fall in supposedly gene-bare areas) are in
regions that are transcribed but not translated, and that they exert their effect by altering
RNA transcript functionality or regulation.
1.2 Our initial understanding of RNA’s biological function
While the integral part in the production of proteins on the part of RNA was not yet
understood, the general concept that genes are responsible for the production of protein
products dates back to the beginning of the 20th century. At that time, a general hypothesis
developed that a single gene controlled the development of a single enzyme. Archibald
Garrod, through his analyses of familial genetic diseases such as Alkaptonuria, hypothesized
that inheritance of a defective gene led to the genetic diseases characterized by defective
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proteins; Beadle and Tatum, through mutational analyses of Neurospora crassa, found
mutant strains that required particular vitamins for growth, and that the enzymes normally
responsible for the production of these vitamins had acquired a genetic defect [16]. Later
work done after the discovery of DNA cemented RNA’s important role in protein production.
Crick et al. discovered through mutational studies of genes in T4 virus that the insertion
or deletion of a single nucleotide can completely abolish could lead to a complete loss of
protein function. In further experimentation they found that exposing these mutant strains
to an additional round of mutagenesis could restore the function, and that the locations of
compensatory mutations were usually very close to that of the original insertion/deletion
mutation [17]. In the early 1960s, Nirenberg et al. not only deciphered the triplet genetic
code alluded to by Crick, but also confirmed RNA’s essential as the intermediate carrier of
the information required for protein synthesis. To do this, Niremberg and his colleagues
took advantage of cellular extract from bacteria, known to still be able to synthesize protein
even after cell lysis. They applied DNase, which degrades any DNA present, and then added
synthetic RNA of known sequence content to the extract. Not only did they observe that
protein product now occurred, but also, by controlling the nucleotide content of poly(GU)
input RNA so that GGG was the most likely triplet they were able to confirm that in RNA,
a triplet sequence codes for an amino acids. Through the application of this method using
RNA polymers and labeled amino acids in the extract, the specific amino acid produced by
each triplet codon was deduced [18]. Other important roles of RNA in this process, known
as translation, were being discovered at the same time : Chapeville et al. discovered that
tRNAs with sequence complementarity to each triplet carry the corresponding amino acid,
and multiple scientists identified the large RNAs that formed the scaffold for the prokaryotic
and eukaryotic ribosomes [19, 20].
All of the described body of work during this time period of research into RNA biology
seemed to illustrate that the primary function of RNA in the cell was to aid in protein
production by either facilitating the transfer of information from genes in DNA, or by taking
part in translation of protein-coding RNA transcripts to polypeptides. This initial work
built up the central dogma of molecular biology, where genes are transcribed to RNA, which
is then translated to proteins that conduct almost all of the catalytic and regulatory activity
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within the cell. later work, however, would reveal that the diversity of functions of RNA
had been underestimated.
1.3 RNA’s full range of functionality begins to be understood
Research on the function of RNA in the years since the cracking of the codon code and
the deduction of RNA’s role in protein production has revealed that RNA is not merely the
carrier of blueprints for proteins. Like DNA and proteins, it can be modified in ways that
affect its function. And like proteins it can catalyze reactions and respond to the presence
of small molecules. Over time RNA has proven to be a multifunctional biomolecule whose
activity has proven essential for multiple forms of gene regulation in the cell.
Splicing was first discovered in the late 1970s by the labs of Richard Roberts and Phillip
Sharpe in their studies on RNA transcripts from Adenovirus. Here, they experimentally
showed that a single Hexon mRNA produced by Adenovirus consisted of sequence correspond-
ing to four discontiguous regions of the Adenovirus genome, providing electron microscopy
images of a DNA fragment from the Adenovirus genome hydrogen-bonded via small stretches
of sequence to the Hexon mRNA, separated by large loops [21, 22]. Further research into the
transcripts produced by Adenovirus showed that several different transcript isoforms can be
mapped to these transcribed regions of the Adenovirus genome, indicating that a so-called
gene region in the DNA of an organism can produce via alternative splicing multiple distinct
transcripts. This phenomenon has been shown to be extremely common in eukaryotes,
especially those that are higher-order organisms where the presence of multiple tissue types
dictates that it is important to have tight control over gene regulation: vertebrates have been
shown to have a considerably higher portion of transcripts that where alternative splicing
occurs than invertebrates [23, 24].
RNA is also subject to chemical modification that can affect its biological function. The 5’
ends of many RNAs have a 7-Methylguanosine attached, protecting from 5’ exonucleases that
could degrade the transcript [25, 26]. The 3’ ends many eukaryotic RNAs have a stretch of
Adenine nucleotides attached which serve the purpose of recruiting additional proteins to offer
protection of the transcript from degradation [27–29]. Individual nucleotides in transcripts
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are often subject to direct chemical alteration or modification as well. There are currently on
record from the RNA Modification database (mods.rna.albany.edu/) 109 distinct distinct
modified nucleosides that have been detected in some RNA. The class of RNA with the
largest number of these modified nucleotides is tRNA, with 95 of these modification events
being detected at some point (a statistic taken from mods.rna.albany.edu), and an average
of eight nucleotides being found in each tRNA molecule [30]. These many modifications serve
various roles, including the promotion of proper codon-anticodon interactions, increasing
stability by lowering the free energy of the tRNA structure, and acting as a form of
identification for particular tRNAs in the cell [31–36]. Other RNAs that are well known as
targets of nucleotide modification are rRNA and snRNA, with both undergoing modifications
serving the purpose of enhancing functionality either through an increase of structural
stability or the promoting of particular hydrogen bond interactions with other biomolecules
[37]. There have also been multiple modification events detected in eukaryotic mRNAs, the
most famous and well known being a C-to-U editing event in the gene APOB which leads to
a premature stop codon, altering the final protein product produced by the APOB mRNA
[38]. Both C-to-U and A-to-I editing events have been observed in eukaryotic mRNAs. The
A-to-I events are far more common, and are believed to serve multiple functions, including
the modification of anti-codon wobbles (where the Inosine gets misread as a Guanosine) and
the modification of miRNA functionality [31, 39]. These particular modifications have also
been shown to preferentially occur in structured double-stranded RNA elements typical of
transcribed retrotransposons and foreign RNA [40]. It is believed that this editing event
plays a particularly important role in brain tissue, where significantly higher rates of A to I
editing have been reported than in other assayed tissues [41–43].
In approaching the current understanding of RNA’s role in biological function, perhaps
the most surprising discovery of the last few decades was that like proteins, RNA is capable
in certain scenarios of catalyzing reactions. This discovery was jointly made in separate
work from Cech and collegues on an intron in the organism Tetrahymena thermophilia,
as well as Altman and colleagues on the transcript RNase P. Cech and collegues were
studying a suspected intronic region within the gene coding for an rRNA in Tetrahymena,
and determined that this region catalyzed its own splicing, independent of assistance from
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any other cellular enzyme or RNP [44]. Altman and colleagues, in their work with the
RNP known as RNase P, showed that under in vitro conditions the RNA component of
RNase P is capable of catalytically processing tRNA precursor transcript in the absence of
its protein partner, leading to the conclusion that the RNA component of this RNP was
the component responsible for its catalytic activity [45]. Since these discoveries multiple
additional enzymatically active RNAs, now known as ribozymes, have been made. Many
more examples of independently functioning self-splicing introns like that within the rRNA
of Tetrahymena have been found in transcripts from other organisms, leading to this form of
intron being given its own classification, the group I self-splicing intron. Another class of
catalytic intron, known as the group II intron, displays a similarity to RNase P activity in
that it is able to catalyze its splicing reaction alone in particular conditions in vitro. Both
group I and group II introns can be found across multiple kingdoms of life. There are other
examples of ribozymes, including the hammerhead ribozyme, which consists of a structural
motif that catalyzes a single nucleotide backbone cleavage event in itself, and the Hepatitis
D virus ribozyme [46, 47].
Figure 1.1: An example of a theoretical riboswitch. The region in green is the aptamer, or the part of the riboswitch
that binds some small molecule, while the region in red is an expression platform, or some important functional
sequence. When the small molecule is introduced (or more realistically, when it reaches a certain physiological concen-
tration) the riboswitch undergoes a conformational change such that the expression platform is rendered inaccessible,
altering gene regulation and expression. Structures generated using VARNA [48].
A final discovery made that revealed the full extent to which the biochemical functionality
of RNA had been underestimated was that there exists a class of RNAs that are able to
bind small molecules, undergoing an oftentimes functional conformational change as a
result. These RNAs, known as riboswitches, represent a means by which modulation of gene
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expression can quickly occur in response to a change in physiological state (represented by a
change in small molecule concentration). Given that the first riboswitch was only discovered
in 2002, the number discovered since, combined with the wide variety of mechanisms through
which they operate, is quite remarkable. Riboswitches were discovered by Breaker and
colleagues, who reported the presence of several different moieties of riboswitches in the
5’ UTRs of bacterial transcripts [49–51]. The protein product encoded by the mRNAs
containing these identified riboswitches is often involved in the metabolism or transport
of the small molecule (or some downstream metabolite) in question (Figure 1.1). Most
riboswitches have two primary components: a ligand-binding aptamer region, and an
expression platform where the alteration of gene expression can occur. Scientists had known
since the early 1990s that RNAs can function as aptamers for binding ligands, as methods
such as SELEX had been devised to select for RNAs that have strong binding preference for
particular small molecules [52]. In a riboswitch ligand binding to this aptamer site leads to a
conformational change in the expression platform region where some critically important site
to gene expression, such as the Shine-Delgarno sequence in bacteria for recruiting and binding
the small subunit of the ribosome [53, 54]. A wide diversity of riboswitches have been found,
with a broad range of ligands and biochemical responses to activation of the aptamer. Many
more ’traditional’ riboswitches have been found that regulate gene expression by binding a
wide range of ligands, ranging from amino acids to charged ions such as Magnesium and
Flouride [55–57]. While many of these riboswitches change gene regulation in the presence
of ligand through conformational reshuﬄing of the exression platform leading to either the
halting of transcription or the blocking of translation, there are several known riboswitches
that exert change their expression platform through different means. These include the glmS
riboswitch, which utilizes its dual function as a riboswitch and ribozyme to cleave itself
and trigger its own transcript’s degradation in the presence of glucosamine-6-phosphate,
and the SreA/SreB moieties of the SAM riboswitch in Listeria monocytogenes, which are
able to terminate transcription of an mRNA from a separate gene [58, 59]. Of particular
interest to us in this work is the existance of purine riboswitches, named for their ability to
bind and respond to purine nucleotides in their aptamer domain [60]. The ability of a single
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nucleotide to rearrange the structure of an RNA is a central focus of this work, and this
riboswitch will be a point of reference in later chapters.
The work described in the last few decades has led to a general paradigm shift in the
genetics and Molecular Biology community, with respect to how they view the role of RNA
in the cell, from that of a general carrier of protein-coding information to a multifunctional
biomolecule capable of being highly regulated, catalyzing reactions and reacting to changes
in physiological state within the cell. These findings, as well as additional findings from the
past decade, lead to our current understanding of the extent of the roles that RNA plays
within the cell.
1.4 The many different classes and functions of RNA in the cell
Many of the types of functional RNA that were initially found in the cell were directly
involved in protein synthesis. Over time, however, a broad variety of RNAs across different
kingdoms of life have been discovered that play important roles in all sorts of known cellular
processes, including post-transcriptional gene regulation, splicing, immune response and
ribonucleoprotein assembly (Table 1.1).
1.4.1 Classes of RNA involved in protein synthesis
It is, of course, important to cover the most obvious classes of RNA, those which aid in
the transferring and translation of protein-coding message from information coded within
genes in DNA. The first class of RNA identified, mRNA, carries with it a sequence of
nucleotides that code for a particular sequence of amino acids that fold into protein. As
mentioned before, it is subject to multiple modification events that serve different purposes.
Some, such as the 5’ and 3’ end modification of mRNAs, stabilizes the transcript so that it
has a longer half-life when it is out in the cell cytosol, and thus can be utilized for more
rounds of translation. Others, such as splicing and RNA editing, act as a mechanism for
producing a wider range of alternative protein product for a given gene region. For complex,
multicellular organisms, gene regulatory networks are larger, and thus require more distinct
nodes in order to maintain control over the network. It is a much faster process to evolve
9
new alternative ways of processing information in existing genes than it is to inherit entirely
new genes over time. This class of RNA is essentially ubiquitous across all organisms, since
all known forms of life need to be able to be able to synthesize protein using ribosomes
and transfer instructions for production of protein to progeny. The second class of RNA
discovered is ribosomal RNA (rRNA), which forms part of both small and large ribosomal
subunits across the kingdoms of life. Ribosomal RNA acts as the primary determinant
of the folded structure of the ribosome, acting as a scaffold to which multiple proteins
bind to during its assembly. In fact, the majority of the final structure is taken up rRNA;
the ribosome is stabilized by tertiary interactions between its rRNAs’ secondary structure
domains, as well as the binding of multiple proteins to the both the rRNA surface and
exposed pockets [61]. The third discovered class of RNA discovered is tRNA, which brings
the amino acid corresponding to a particular codon to the growing nascent polypeptide chain
during translation so that it can be added. As mentioned before, a tRNA molecule that
is meant for a particular codon has base complementarity to that codon in the anticodon
loop of its folded structure, and often contains many modification that serve the purpose of
promoting stability, as well as allowing other cellular machinery to identify the tRNA. While
these classes of RNA are well studied and essential to every organism one way or another,
they only scratch the surface of the many types of RNA that can be found within cells.
1.4.2 RNAs that guide post-transcriptional modification events
From all the RNAs discovered so far, one broad category of RNAs can be defined whose
members serve the general purpose of modifying other biomolecules. One such member
that serves this function is small nuclear RNA (snRNA), which is best known for forming
part of spliceosomal RNP complexes in eukaryotes. Multiple specific snRNAs, including
snRNA components of the snRNPs U1, U2, U4, U5 and U6, make up the spliceosomal RNP
complex [16]. Association of the disruption of spliceosome activity with several diseases (in
particular, neuromuscular-wasting diseases, such as Duchene’s Muscular Atrophy) is well
established, though there are only a small subset mutations in spliceosomal machinery linked
to these diseases (likely due to the requirement of normal function of this machinery for
general organism survival) [62, 63]. These RNAs are also subject to several modification
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RNA class RNA name General function
protein synthesizing mRNA carry protein coding sequence to ribosomes in
cytosol for translation
rRNA scaffold for ribosome assembly
tRNA bring amino acids to sites of translation, match
to proper codon
modifying snRNA form snRNPs that conduct pre-mRNA splicing
snoRNA form snoRNPs that guide nucleotide modifica-
tion of select RNAs
scaRNA form RNPs that guide modifications of snR-
NAs
small regulatory miRNA downregulate gene expression via targeting
mRNAs for RNAi pathway
siRNA Downregulate gene expression via RNAi path-
way pathway (explicit basepair complementar-
ity)
piRNA Deactivate foreign gene expression via RNAi
pathway
large regulatory lncRNA Chromatin remodeling, post-transcriptional
regulation
Table 1.1: Known classes of Eukaryotic RNAs separated by their function.
events in their maturation prior to taking part in the spliceosome. These modifications
are brought about by another class of RNA, the small nucleolar RNA (snoRNA). These
RNAs are particularly interesting because their primary purpose is to bring about nucleotide
modifications on other classes of RNA. They are responsible for many of the modification
events in RNA that were alluded to earlier. Their targets include not only snRNA, but also
rRNA and tRNA. Two common types of snoRNAs (named for their clusters of consensus
sequence elements that each contains) are C/D box and H/ACA box snoRNAs [64]. Both
are used as scaffolds for RNA assembly; the C/D box snoRNPs primarily work to methylate
2’ OH sites in target RNAs, while H/ACA box snoRNPs conduct pseudouridinylation
modifications that are commonly found in tRNA and rRNA [65]. While there are many
well-cataloged examples of snoRNAs that are conserved across eukaryotes, recent work
utilizing contemporary protein/RNA complexing techniques has provided evidence of several
more less conserved, uncharacterized snoRNAs produced in eukaryotic cells [66]. A subclass
of snoRNA that is sometimes classified as being distinct is small cajal associated RNA, or
scaRNA. This type of snoRNA is unique in that it can guide both pseudouridinylation and 2’
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OH methylation events, primarily acting on snRNAs and localizing to an snRNP processing-
focused compartment in the nucleolus known as the cajal body [67]. There are additional
RNAs involved with transcript modification that are difficult to place into a particular
class. RNase P, previously referenced as one of the first ribozymes discovered, makes up
part of an RNP that splices pre-tRNA transcripts into tRNAs. The RNA component of
telomerase helps prime the extension of telomeres, elements at the end of chromosomes that
protect from DNA decay via free radicals, via a mechanism dependent on the RNA’s tertiary
structure [68, 69]. RNase MRP makes up part of an RNP, and has multiple roles, including
the priming of mitochondrial DNA during transcription and involvement in the production
of siRNA [70, 71]. This particular RNA will be of interest to us in later chapters when we
analyze the structural basis of mutations in it that are associated with the genetic disorder
cartiliage-hair Hypoplasia [72, 73].
1.4.3 Gene regulatory RNAs
An additional broad set of identified RNAs serve the function of regulating gene expres-
sion. Here, there is a particularly wide variety of different RNAs with different transcript
characteristics and mechanisms of function. It would be simplest here to separate these gene
regulatory transcripts into two groups: small RNAs and larger RNAs.
1.4.3.1 Small regulatory RNAs
Perhaps the most talked-about classes of RNA over the last decade that regulate gene
expression are small RNAs, including small interfering RNA (siRNA), micro RNA (miRNA)
and piwi-interacting RNA (piRNA). The discovery of siRNA spawned from plant genetics
research, where attempts to alter plant phenotype via gene copy inserts led to an opposite
effect likely caused by in increase in downregulation of the gene in question [74]. Additionally,
plants with RNAs complementary to viral transcripts were shown to be protected against
infection [75]. From this work biologists were inspired to find analogous regulation events in
other organisms. This led to the first discovery of siRNAs, found in C. elegans to trigger
strong knockdown of gene expression upon introduction into the cell [76]. The siRNAs
are typically 22-24 nucleotides in length, and must be introduced in double stranded form.
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Given their strong impact on gene expression even in scenarios where provided dosage was
extremely low, it was suspected that there was an underlying pathway that the dsRNA
triggered which may be primarily responsible for the gene knockdown. The pathway, known
as RNA interference, is now understood to be a mechanism of regulating gene expression
that is shared across eukaryotes. The machinery that the pathway consists of utilizes siRNA
as a guide to target genes. It can also use another type of RNA class, known as microRNA
(miRNA) to guide this targeting. The primary differences between siRNA and miRNA
are their sources and expected target affinity. While miRNAs must be cellular in origin,
siRNAs can either be cellular or artificially introduced into the cell. With respect to target
affinity, siRNAs interact with their target transcript via perfect basepairing, while miRNA
can utilize more imperfect pairing [77]. Additionally, siRNA are typically transcribed from
repeat regions in the genome, whereas miRNA are transcribed from full genes [78]. For
our discussion, miRNAs will become particularly pertinent due to the involvement of their
dysregulation or improper targeting to various forms of cancers in humans, with publicly
available databases listing the activity of 236 miRNAs being associated with development of
78 different forms of cancer [79]. While miRNA and siRNA are comparable in many respects,
piRNA differs in both transcript characteristics and target. The piRNA are typically larger
than miRNA and siRNA, and so far appear to have far less sequence conservation. The genes
encoding piRNAs are often clustered, and tend to overlap and run antisense to transposon
regions, indicating that their primary purpose is to protect against the activity of foreign
transcripts [80]. Like miRNA and siRNA, piRNA are loaded onto protein and used as guides
to target RNA to degrade. The protein that piRNA interacts with, piwi, is of the same
argonaute family of proteins that the RNAi pathway is reliant on, and though the processing
steps that piRNA goes through before being being loaded onto piwi is not understood, it is
known that the piwi protein shares the same piwi domain that argonaute proteins that take
part in RNAi use to process siRNA and miRNA [81]. Interestingly, piRNAs are primarily
expressed in gamete (sperm and egg) cells, and in Drosophilia, their disruption or absence
has been associated with a loss of fertility [82].
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1.4.3.2 Large regulatory RNAs
Large noncoding RNAs (commonly known as lncRNAs) are only now starting to be
appreciated for their roles in controlling gene expression through multiple mechanisms.
Initially, lncRNAs were not thought of as being particularly common in eukaryotic genomes.
Before the turn of the century, the number of lncRNAs that had been identified was quite
modest. The two most well known lncRNAs that had been discovered by that time were
H19 and XIST. H19, the first lncRNA characterized in mammalian cells, is reported to
regulate a network of genes known as the imprinted gene network (IGN) that are important
to development, while XIST is responsible for the control and sustaining of X chromosome
inactivation in female mammals [83, 84]. It was only when the aforementioned transcriptome
tiling array technologies were developed at the turn of the century that it became obvious
there were additional non-coding transcripts being produced that weren’t annotated. Initial
tiling arrays were aimed at transcriptional profiling of chromosome 22, with separate studies
finding evidence of abundant noncoding transcripts containing hallmark signs of functionality
(promoter regions within the transcription start of the gene, evolutionary conservation across
species) [11, 85]. However, additional evidence was needed to classify these lncRNAs as
being functional, and not mere transcriptional noise. A key feature of functional gene regions
was discovered in the ENCODE project, where it was found that particular chromatin
characteristics (including H3K4 methylation status and DNase hypersensitivity) around a
site were highly predictive of whether or not the site was a gene with regulated transcriptional
activity [12]. Using this knowledge as a guide, over 1,000 lncRNA gene regions within discrete
transcriptional units, as evidenced by the overlaying chromatin state, were identified in a
mouse model [86]. These gene regions showed positive evolutionary selection across species
(more than intronic and intergenic sequence), were subject to transcription factor binding
that regulated transcriptional activity, and were linked to several biological functions [86].
As of October 2013 there are 14,353 distinct lincRNA transcripts (which, when mapped to
distinct transcriptional units, correspond to 8,130 regions of the genome) listed as part of
the broad institute lncRNA catalogue [87]. There are several means through which different
lncRNAs are able to control gene expression. One of the most common means is through the
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modulation of chromatin state in order to control transcription. A well known lncRNA that
uses this mechanism is HOTAIR, which is able to silence transcriptionally active sites in the
genome by recruitment of an RNP known as the Polycomb Repressive Complex (PRC) at
sites in chromatin, where it conducts H3K27 trimethylation in order to promote a closed
chromatin state [88, 89]. In general, lncRNAs exert control over chromatin state by either
altering the activity of chromatin-regulating proteins in a promoting or repressive manner.
Many examples of known functional lncRNAs that regulate gene activity via chromatin
modification exist [88, 90, 91]. There is also evidence of some lncRNAs controlling the
recruitment of transcription initiation factors to promoter regions [92, 93]. Additionally,
examples exist of lncRNAs regulating gene expression post-transcriptionally through various
means, including altering splicing, being processed into endogenous siRNA, and the control
of translational efficiency [94–96].
1.5 The chemistry of RNA
While the wide diversity of functions that RNA is involved in should now be clear,
it is also very important to discuss reasons for which RNA is able to take on so many
role in the molecular biology of organisms. The chemical properties of RNA enable fast,
direction-specific, energy-efficient synthesis via polymerization, as well as the ability contain
a variety of function-specific information within its sequence made primarily of an alphabet
of 4 characters. The chemistry of RNA also allows it to form structures that can make it
possible for the RNA to interact with other molecules both small, and in some cases enable
the formation of an active site in the RNA that can catalyze reactions. Ultimately, it is the
chemistry of RNA that determines its function.
1.5.1 General chemistry of biopolymers
To understand RNA, it is important to understand that ultimately RNA is a nucleic
acid, and is a naturally occurring polymer. Nucleic acid is one of the three main biologically
derived polymers found in organisms, alongside proteins and polysaccharides. In general,
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a polymer consists of monomer compounds that are covalently bonded together to form
repeating units.
In many cases of biopolymers, the chemical composition of each monomer is identical.
This is the case with polysaccharides, where the monomer is an aldehyde or ketone with
at least two hydroxyl groups (and thus at least 3 carbons forming its backbone). Simple
polymers can have a structure supporting role (chitin, cellulose) or an energy storing role
(starch, glycogen) in the cell [16]. The structure-supporting polysaccharides involve long
linear chains of monomer units (with cellulose and chitin the monomers are glucose-derived
units covalently linked via β 1,4 glycosidic linkages). The energy storing polysaccharides
can come in linear or branched form. The amylose portion of starch is linear, linked via
α 1,4 linkages, whereas glyocogen and the amylopectin portion of starch contain both α
1,4 and α 1,6 linkages) [97]. Synthetic polymers also usually consist of simple homogenous
monomers, as this lends itself to predictable, stable polymer chemistry. However, for the
transfer of information and reaction catalysis that is necessary for the sustaining of life, it is
insufficient. For this, there needs to be an increased level of complexity in the monomeric
units that make up biopolymers.
In order to take on high level structure and more diverse functionality, other proteins
like polypeptides and nucleic acids have side groups that are part of each monomeric unit.
In proteins, the monomeric unit, the amino acid, is a simple organic compound, consisting of
a positively charged amino group and a negatively charged carboxyl group joined together
via an α carbon at the center. It is the R-group side chains that are also attached to the
α carbon that give proteins their wide array of functionality. There are 20 different side
groups found within the amino acids that make up most proteins. Several of these groups
are uncharged nonpolar side groups, leading to them being of low reactivity in solution.
However, other groups have chemical properties that make them functionally important to
peptide polymer. These include side groups with polar charges (more subject to modification
events), groups with the potential to form particularly stable bonding interactions (Cysteine
being the key example) and charged groups that are often found at catalytic sites in proteins
[97]. In nucleic acids, the monomeric unit, the nucleotide, consists of nucleotide units linked
together via phosphodiester linkages. The monomers of a typical nucleic acid (such DNA
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or RNA) are identical, save for the ”side group” nitrogenous base. The alphabet of ”side
group” bases in nucleic acid polymers is much smaller than in proteins, as well as far less
reactive. Because of this nucleic acids are significantly less catalytically active. An additional
important distinction to make between proteins and nucleic acids is that the synthesis of
nucleic acids is far less energetically expensive than proteins [97]. Taking these factors into
consideration it seems logical that in organisms nucleic acids are more likely to be carriers
of information, while proteins are more likely to be involved in enzymatic activity necessary
for biological function. As nucleic acid biochemists and RNA biologists have found out,
however, the truth is not so black and white.
1.5.2 The chemistry and primary structure characteristics of DNA and RNA
DNA, the classical nucleic acid polymer, has several features that make it particularly
well suited for information transfer. Its 2’ Carbon in its central ribose ring lacks a hydroxyl
group that is typically found in a ribose sugar. This protects the phosphate backbone from
being nucleophilically attacked by the 2’ hydroxyl group, a common spontaneous occurrence
in nucleic acid polymers with this group on their ribose sugar. More importantly, DNA
comes double-stranded, with strands running antiparallel and reverse complementary to
one another. This strand complementarity allows for polymer-wide canonical Watson-Crick
basepairing between nucleotides on opposite strands (3 hyrdogen bonds between Guanine
and Cytosine bases, 2 hyrdogen bonds between Adenine and Thymine nucleotides) [98]. This
double-strandedness provides increased protection from degradation, and also makes the
process of replicating DNA particularly effective, with two double-stranded DNAs (each
containing a parent strand of DNA) being produced from an individual double-stranded
DNA replication event. The fact that each daughter dsDNA has a single parent strand is
advantageous for detecting replication errors or spontaneously altered bases, as this can
result in basepair mismatches in the dsDNA that can be detected and repaired by DNA
repair enzymes [16]. DNA is well adapted to the role of carrying gene information and
passing it on to daughter cells via its replication.
RNA shares much of the chemical properties of DNA, though some characteristics make
it less suited for information transfer and more suited for binding with other molecules
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Figure 1.2: Chemical structure of RNA and its nitrogenous bases. A) A schematic figure representing the backbone
of a nucleic acid biopolymer. This particular nucleic acid is RNA, since it has at every ribose 2’ position a Hydroxyl
(OH) group, whereas in DNA this group is not found at this position. B) The general hydrogen bonding between
bases seen in nucleic acids. Guanine and Cytosine (seen in both DNA and RNA) bond via three hydrogen bonds,
whereas Adenine and Thymine (found in DNA) form two basepairs. C) In RNA that has been transcribed from DNA,
Uracil replaces Thymine. Uracil forms two hydrogen bonds with Adenine, and can also interact via two hydrogen
bonds with Guanine. Adapted from [16]
and in some cases catalytic activity (Figure 1.2). Like DNA it is a nucleic acid polymer
consisting of nucleotide monomers, covalently linked via phosphodiester bonds. It shares
3 of its four common nitrogenous bases with DNA, and its functionality and stability are
dependent on basepairing interactions between these bases as well. However there are several
key differences. One key differing feature is that the ribose sugar in each nucleotide unit
found in RNA has a 2’ Hydroxyl group, something that each DNA nucleotide lacks. Also,
RNA is typically single-stranded. These two features (or lack thereof) make RNA a much
less stable molecule than DNA, and yet it’s single strandedness allows it to form higher
order structure than DNA that can often be functional. With respect to the selection of
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nitrogenous bases found in RNA, the Thymine typically found in RNA is replaced with
Uracil in RNA. A possible explanation for why DNA might use Thymine as a base instead
of Uracil is that Cytosine deamination is a common mutagenic event that requires repair,
and that a Cytosine, when deaminated, becomes a Uracil. DNA repair mechanisms, when
searching for these Cytosine deamination events likely would have a large amount of difficulty
telling the difference between natural Uracils and deaminated Cytosines, and for this reason
Thymine, chemically equivalent to 5-methyluracil, or a Uracil base with a methyl group
added at the fifth position of the base’s aromatic ring, is used instead.
In spite of the fact that these characteristics that seem to do little more than confer
instability, the fact that RNA typically is single-stranded allows it take on higher order
structure that DNA is too structurally constrained to form. This structure plays a key role
in RNA’s ultimate set of functions in nature.
1.5.3 Higher-order structure
Like other polymers with differential compositions of monomers (the best examples
being the aforementioned DNA and protein) RNA is governed by thermodynamic laws that
cause it, from its linear, unfolded state, to seek a lower free energy status by folding into a
more energetically stable conformation. While this issue does not concern DNA, due to its
high stability through maximized basepairing with a complementary strand, RNA sequences,
like protein, are under thermodynamic pressure to fold in a way that minimizes their free
energy.
1.5.3.1 A comparison of folding in proteins versus RNA
The dynamics of folding of RNA is comparable to that of proteins in some ways, and
different in others. In proteins, much of the thermodynamic pressure to form a low energy
conformation comes from the diverse chemistry of the side groups. One of the key drivers
for polymer folding (again, fueled by thermodynamics) is the need to keep parts of the
polymer that are nonpolar and hydrophobic away from the surface of the folded structure,
which is in contact with water molecules. Because of this the structure of proteins is heavily
influenced by the burying of these hydrophobic residues to the center of the structure, where
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protection from polar water molecules can be found. Analogously, a large driver of RNA
folding is the thermodynamic pressure to lower the free energy of the polymer by burying
hydrophobic nitrogenous bases in basepairs. With respect to secondary structure formation,
both proteins and RNA rely on hydrogen bonding interactions. However, proteins rely on
interactions between parts of their monomeric units, not even involving their side chain
groups, which are more involved in tertiary structure formation. The motifs formed in
proteins are rather ubiquitous, involving interactions between Amino and Carboxyl groups
of amino acids to form well defined secondary motifs such as the α helix or the β pleated
sheet [97]. In RNA, the secondary structure primarily consists of canonical Watson-Crick
pairing between nitrogenous base ”side groups”. With respect to tertiary structure, both
protein and RNA contain common motifs amongst themselves. In protein, the side groups
are the primary determinant of tertiary structure, whereas in RNA, the secondary structures
formed are key determinants of the tertiary structure (often formed as a result of their
interactions). While the formation of protein secondary structure and tertiary structure are
not thought to be particularly independent of one another, it is known that a majority of an
RNA structure’s stability comes from the basepairing inherent to its secondary structure
[99, 100].
1.5.3.2 RNA secondary structure
The secondary structure of an RNA often involves a series of hyrodgen bonding between
canonical basepairs within the RNA sequence. The number of hydrogen bonds per canonical
pair remains equivalent here to that in DNA : three bonds in a GC pairing, and two
bonds in an AU pairing. In RNA, GU basepairing (initially detected as a wobble base in
codon/anti-codon matching, and formed by two hydrogen bonds) also contributes to the
formation of secondary structure [31, 101]. In addition to these basepairing rules there are
particular caveats that must be taken into account when ascertaining the stability of a
structure. One of the most important key rules to keep in mind is that a set of basepairings
that are stacked on top of one another in a stem conformation are given a stability bonus due
to the added stacking energy that constrains each nucleotide in the stem. This particular
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paradigm becomes more relevant once energy parameters from experimentation are brought
into RNA secondary structure prediction.
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Figure 1.3: Simple structural motifs that are common components of full secondary structures of RNAs. A)
Structural motifs that utilize non-overlapping basepairing, where given ij and hk basepairing, h < i < j < k. In
present secondary structure prediction methodologies, thermodynamic parameters for these motifs (in particular,
ones including the stem motif, where consecutive basepairs add additional stability) have been defined via physical
chemistry experimentation. B) Structural motifs where the h < i < j < k does not hold. While these motifs are
known to be relatively common in structured RNA, the computational complexity involved in their prediction has
made it difficult to integrate their detection into structure prediction algorithms. Adapted from [16]
In RNA secondary structures, there are a variety of common ”motifs” that are commonly
found (Figure 1.3). Each of these motifs has particular measurable free energies that are
dependent on their inherent sequence content. Figuring out how these separate measured
energies can be factored together was a key in developing efficient RNA secondary structure
prediction.
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1.5.3.3 RNA tertiary structure
While often RNA is depicted as only folding on a two-dimensional plane, there is an
additional dimension of folding that takes place, compacting a transcript further into its
folded structure. The tertiary structure of an RNA will often involve a mixture of canonical
Watson-Crick and noncanonical base interactions between secondary structural elements
formed. Just as the secret to stable secondary structure in RNA lies in the stacking of
consecutive basepairings to form stems, in tertiary structure, stacking of stem regions of
folded RNA provides a great deal of additional stability, and has been found to be common
in tertiary structures of structurally conserved RNAs, with a perfect example being the
stacking of the stem regions in tRNA [16]. There are also particular motifs in tertiary
structures that confer additional stability. The pseudoknot and kissing loop motifs can be
considered tertiary interactions since they do not really operate on a two-dimensional plane
(Figure 1.3B). Another motif, the tetraloop, is found in loop regions in secondary structures,
and involves interactions between the four nucleotides that involve a non-planar structural
representation [102]. Such a motif is actually regularly incorporated into the calculation of
energies for secondary structure prediction programs [103]. Additionally, a motif known as a
G-quadruplex uses non-canonical interactions between four consecutive Guanine residues to
provide stability, and has been found to be biologically functional in different scenarios at
both the DNA and RNA level [104]. Algorithms now exist that allow for its detection in
RNA structure prediction, and interestingly their presence is observed to be enriched in 5’
UTRs of mRNAs [105].
Tertiary structure prediction of RNA has proven to be difficult for several reasons. First,
it is highly dependent on knowledge of the correct RNA secondary structure [106]. Given
that our ability to correctly predict secondary structure still needs work, this dependency is a
severe handicap [107]. Additionally, known tertiary structures consist of many non-canonical
basepairings, making it difficult to produce a way of determining optimal structures in an
efficient manner as is done in secondary structure prediction. For these reasons, much of
focus here will be on RNA secondary structure and its prediction.
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1.6 RNA Secondary structure prediction
The accurate prediction of secondary structure of RNAs has been a popular research
topic in computational biology for several decades. Because of the large number of described
basepairs that are possible for a given sequence, there are a myriad number of possible
secondary structures that a transcript can adapt, with an estimate of 1.8N possible secondary
structures, given a sequence N nucleotides in length [108]. While for some small RNAs it is
possible to make an accurate guess at the most stable RNA secondary structure that can
be formed, it is typically impossible to determine without the use of some sort of scoring
which structure of the many that are possible for a sequence is the most likely to be found
in solution. The history of research into answering this question will now be reviewed.
1.6.1 The Nussinov algorithm
One of earliest attempts at predicting the secondary structure for an RNA given its
primary sequence came from Nussinov and colleagues in the late 1970s [109]. Attempts
had been made before to create means of predicting the optimal structure for a given
sequence, but they involved algorithmic approaches that were somewhat inefficient and took
an unreasonable amount of time to run [110]. The Nussinov algorithm seeks to find the
most likely structure in a more efficient manner through the use of dynamic programming.
Dynamic programming is a method that can be used to solve a complex problem in a time
efficient manner. It does this by breaking down a given problem into the smallest possible
subproblems, building off of the answers to these subproblems to eventually arrive at the
optimal solution to the overall problem in question. Here, the explicit problem that the
Nussinov algorithm seeks to answer is to identify the secondary structure s from a collection
of possible secondary structures S with the maximum number of basepairings b. To put this
in more mathematical terms, the goal of the algorithm is to find :
{s(bmax) : bmax = max(b); b = f(s); s ∈ S}
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Figure 1.4: The setup and execution of the Nussinov algorithm. A) The possibilities for basepairing in the structure
S given nucleotides i and j. B) A walkthrough of the filling in of the dynamic programming array used in the Nussinov
algorithm. The array is first initialized by setting every position in the matrix where i = j or i − 1 = j to 0. The
matrix is then filled along the diagonal, inputting in each space a value for b consistent with which of the four types
of possibilities from A would produce the maximum b value. The final array depicts the traceback step, where the ij
indeces are sent back through filled in values in order to yield the path consistent with a structure or structures for
the input sequence that have the number of basepairings bmax. C) The single structure emitted by the input sequence
with the number of bases bmax, obtained from traceback. Structures generated using VARNA [48].
Assuming that the ensemble of possible structures S is generated from a sequence X,
where X is N characters in length and X = (x1, x2, ..., xN ), the Nussinov algorithm calls
for the creation of a dynamic programming array of size [N,N ], referred to from here-on
as γ. All values in γ stored along the i, i diagonal, as well as the i, i− 1 diagonal, are first
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initialized to 0. In the filling of this matrix, we consider four possible scenarios: a direct
ij basepairing, an unpaired i, an unpaired j and a bifurcation loop where i and j are the
outermost nucleotides (Figure 1.4A). From here, γ is filled using the following recursion:
for i = 2 to N do
for j = i to N do
w =

1 X[i] and X[j] are canonical bases
0 otherwise
γ[i, j] = max

γ[i+ 1, j]
γ[i, j − 1]
γ[i+ 1, j − 1] + w
maxi<k<j(γ[i, k] + γ[k + 1, j])
end for
end for
At the final position in γ that is filled (γ[1, N ]), the value stored is equal to the maximum
number of possible basepairs bmax for any of the possible structures in S. From this position
in the matrix, it is now necessary to conduct a traceback in order to determine the structure
that is compatible with bmax. To do this, the following recursion back through the matrix
applies:
i = 1; j = N ;
while i < N and j > 1 do
if γ[i+ 1, j] = γ[i, j] then
i = i+ 1
else if γ[i, j − 1] = γ[i, j] then
j = j − 1
else if γ[i+ 1, j − 1] + w = γ[i, j] then
Store basepairing in X between i,j
i = i+ 1
j = j − 1
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else
for k = i+ 1 to j − 1 do
if γ[i, k] + γ[k + 1, j] = γ[i, j] then
i = k + 1
j = k
end if
end for
end if
end while
After running this traceback through γ, A series of basepairings are generated, creating
a secondary structure whose number of basepairings is equal to bmax. An illustration of
this algorithm being utilized on an RNA sequence GGGGAAACCCC has been provided
(Figure 1.4B). In this example we see that the traceback yields a bmax of 4, and an s(bmax)
consisting of a stemloop with four basepairs and a loop region of three nucleotides (Figure
1.4C). The filling of γ is O(N3) in runtime and O(N2) in required memory, whereas the
traceback operation is O(N) in runtime and required memory [109].
While this algorithm was a pioneer with respect to setting up a method of predicting
RNA secondary structure in an efficient manner, there were also several disadvantages to
its approach, mainly centering around the incongruity between its approach and the actual
thermodynamics of RNA structure. Perhaps the largest issue with the Nussinov algorithm
is that the assumption that the structure with the maximal amount of basepairs is the most
stable structure in the RNA is flawed. As alluded to before, while it is true that lower
free energy structures are more likely to have a large amount of basepairs, the orientation
of these basepairs is critically important, due to the additive stabilizing effect on dsRNA
regions that consecutive basepairs offer [111]. Because of this, just because a structure s
has a number of possible basepairs bmax, doesn’t mean that it has the lowest possible free
energy structure in the ensemble of possible structures S. Another flaw that can make itself
evident in the traceback step is that there are sequences that emit from S more than one s
that have a number of basepairs equal to bmax. Because of this the Nussinov algorithm more
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accurately represents a method to access a set of structures {s1, ..., sn : s ∈ S; b(s) = bmax}.
This method allows for a decent guess at the lowest energy structure within S, particularly
in RNAs that are where there is a strong predominant structure such as in tRNAs. However,
a more accurate identification of the lowest free energy structure within the ensemble of
possible structures S requires the use of specific thermodynamic parameters as guidance,
rather than the number of basepairings b.
1.6.2 Thermodynamic parameters of RNA secondary structure obtained through
experimentation
When finding the lowest free energy structure s in the structural ensemble S of a sequence
X, the value used as a measurement of this energy is commonly known as Gibb’s Free
Energy. For a given state, the Gibb’s Free Energy is defined as the difference between the
Enthalpy of the state in question and its temperature-adjusted entropy. Or, put differently,
G = H − TS
Where G is the Gibb’s Free Energy, H is the Enthalpy and S is the entropy (not to be
confused with the S being utilized before the represent an ensemble of structures). Here, we
wish to look at the change in Gibb’s Energy when a particular structure forms, under the
conditions of a constant internal environment (constant volume and pressure). Therefore we
use the equation
H = U + PV
where U is the internal energy of the system and V is the volume, to modify the equation to
dG = dU + PdV + V dP − SdT − TdS
Where T is the temperature within the system. We can then use the equation
dU = dqrev + dwrev = TdS − PdV
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To substitute in for dU , in order to get
dG = V dP − SdT
To estimate the change in Gibb’s Free Energy that occurs when an RNA folds, the
general strategy utilized is to calculate the energetic contributions of RNA/RNA duplex
formations that make up a structure that make up a particular structure s. To facilitate
understanding we will consider the following example, where GG and CC dinucleotides are
”reactants”, and a GG/CC duplex is the ”product” (though there is no actual modification
of any of the reactants’ chemistry). In a situation where GG and CC basepair:
GGss + CCss 
 GG/CCds
We wish to find some way to calculate the dG for such a reaction. To approach this problem
we alter our equation for Gibbs Energy by adding additional terms µCC ,µGG and µCC/GG
representing the chemical potential inherent to a reactant or product, or the following:
µi =
(
∂G
∂ni
)
T,P,n¬i
Where the term ni is the molar quantity of item i, and n¬i refers to the molar quantities of
any item that is not i. Given these added terms, a non-constant ni, and constant T and P ,
our new equation is
dG = µGG ∗ dnCC + µGG ∗ dnGG + µCC/GG ∗ dnCC/GG
Given that the change in the amount of reactant is represented by dnCC and dnGG, and the
amount of product is represented by dnCC/GG, we introduce a new term dξ that is equal
to the change in the ”progress” of the reaction (set at 1 when there is all reactant and no
product, and set at 0 when there is all product and no reactant). Assuming a negative
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nreactant and positive nproduct,
dξ = −dnreactants = dnproducts
We substitute this equation into our terms for dG to get
dG = (µproducts − µreactants) dξ =
(
µCC/GG − (µCC + µGG)
)
dξ
and
∂G
∂ξ T,P
= µproducts − µreactants = µCC/GG − (µCC + µGG)
From here we can apply ideal gas laws to each µi, such that
µi = µ0i +RTln(Pi/1atm)
to get
(
∂G
∂ξ
)
T,P
=
[
µ0products +RTln (Pproducts/1atm)
]
−
[
µ0reactants +RTln (Preactants/1atm)
]
or simplified,
(
∂G
∂ξ
)
T,P
= dG0 +RTln Pproducts
Preactants
= dG0 +RTln
PCC/GG
PCCPGG
Since we are dealing with oligonucleotides in solution we can deal with molar concentrations,
rather than P for each item. Also, if we look at dG0 when −µreactants = µproducts, we are
looking at the equilibrium state where subsequently
(
∂G
∂ξ
)
T,P
= 0. Thus,
dG0 = −RTln [CC/GG][CC][GG] = −RTlnKp
Where Kp is the equilibrium constant of the reaction in question. Lastly, we can take an
equation known as the Gibbs-Helmholtz equation, where we relate change in temperature
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and Gibbs Energy to change in Enthalpy,
[
∂ dGT
∂T
]
P
= −dH
0
T 2
and moving some additional terms, as well as differentiating our equation for Gibbs Energy
with respect to T, allows us to get the equation
(
∂lnKP
∂T
)
P
= dH
0
RT 2
which is known as the Van’t Hoff equation [112]. A linear model where the dependent
measurement is T of duplex melting, and the indepdendent measurement is lnKP can
be produced via duplex melting in optical melting curve experiments, and the slope and
y-intercept parameters extracted from linear least squares regression will be equal to
(
R
dH0
)
and
(
dS0
dH0
)
, respectively. From these calculated parameters, dG0 for the duplex can be
calculated.
The parameters derived for multiple possible dinucleotide duplexes have been derived
from multiple independent experiments and serve as the foundation on which RNA secondary
structure predictions meant to find the lowest free energy structure are built [113–115]. A
popular model for the estimation of RNA duplex energy is known as the nearest neighbor
model, where the free energy of a given basepair is directly effected by the pairing energy
of its nearest neighbors in the RNA. A known caveat to this model was that the initiating
basepair in a duplex does not have any stacking energy that contributes to its stability [115].
The thermodynamic contributions of altering base composition in RNA duplex stacks, as
well as at the initiation basepairs, were investigated in additional sets of thermodynamics
experiments where the parameters of different RNA duplex sequences were calculated using
similar optical melting curve methodologies [116]. Free Energy parameters for full secondary
structure motifs, including terminal mismatches, hairpins, bulges, and additional motifs
such as internal and multibranch loops, are also available and have been incorporated into
several well known secondary structure prediction programs [117]. With these free energy
measurements, the total estimated Gibbs Free Energy can be calculated as a sum of the
30
additive nearest neighbor energies for common motifs found within the predicted structure.
Given that the parameters for estimating the Gibbs Free Energy of a structure are accessible,
what is the most efficient means of finding the structure s in the ensemble of structures S
with the lowest Gibbs Free Energy dG0?
1.6.3 The Zuker algorithm
The Zuker algorithm (made popular through distribution of the well-known secondary
structure prediction software package Mfold) serves the purpose of finding the lowest Energy
structure s in the ensemble of structures S emitted from an RNA sequence X. The Gibbs
Energies are found by combining the energies of substructures that make up a predicted
structure, which is possible through the utilization of thermodynamic parameters derived
from the previously described optical melting curve experiments. It is analogous to the
Nussinov algorithm in that it uses dynamic programming techniques to efficiently select
from the ensemble of structures S for a sequence X the structure s, only here the criteria
for this particular structure or structures is different. Like the Nussinov algorithm, there
are two general steps in this process: a fill step of scores (in this case minimal energies for
subsequences), and a traceback step in order to identify the structure s consistent with the
minimal calculated energy.
Before the selection of an optimal structure s with minimal energy, it is first necessary to
arrive at the Gibbs Energy ”score” that belongs to the s in question. To do this a dynamic
programming approach significantly more complex than that of the Nussinov algorithm is
necessary. The algorithm has seen many reproductions under other names, but was originally
produced by Zuker and colleagues [118]. The notations and recursions describe come from
the implementation of the Zuker algorithm for RNAfold, part of the popular Vienna suite
of RNA secondary structure prediction programs [103]. In this implementation there are
four dynamic programming matrices, each of dimensions N x N (where N is the length
of sequence X). The first, F , stores the lowest energy of each substructure between i and
j. The second, C, stores the lowest energy of each substructure between i and j under
the constraint that i and j are basepaired. The third, M , stores the minimal energy for
a substructure between i and j under the constraint that between i and j there exists a
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multi-loop that contains at least one enclosing basepair. Finally, the fourth matrix, M1,
contains the minimal energy for the substructure between i and j such that i is basepaired
to a position h within the multi-loop region, where i < h ≤ j. Pseudocode for filling in these
arrays and then taking the structure of minimal energy is as follows :
for i = 1 to N do F [i, i] = 0 C[i, i] = M [i, i] = M1[i, i] = +∞
end for
for d = 4 to N do
for i = 1 to d do
j = i + d
C[i, j] = min

H[i, j]
mini<k<l<j Ckl + I(i, j; k, l)
mini<µ<jMi+1,µ +M1µ+1,j−1 + a
F [i, j] = min

Fi+1,j
mini<k≤j Cik + Fk+1,j
[M [i, j] = min

mini<u<j(u− i+ 1)c+ Cu+1,j + b
mini<µ<jMi,µ + Cµ+1,j + b
Mi,j−1 + c
M1[i, j] = min

M1[i, j − 1] + c
C[i, j] + b
end for
end for
MFE = F [1, N ]
A figure representing these recursions has been included (Figure 1.5). As indicated
at the end of the pseudocode, the optimum ”score” can be found at the 1,N position, in
the F matrix. Traceback to get the structure corresponding to the minimum calculated
energy is analogous to the Nussinov algorithm traceback described previously. In fact, in
spite of the obvious increase in complexity of the dynamic programming approach utilized,
the basic strategy is the same : build up minimum energy values for small subsets of the
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Figure 1.5: Feynman diagram representation of the recursions utilized in the consideration of possible substructures
emitted by an RNA sequence S. We see that many substructures are subsets of one another. For example, given that
F represents the energy of the minimum energy structure for the subsequence between i and j in X, the energies
of optimal substructures from C,M and M1 all represent necessary recursions in building up a solution, and these
optimal substructures must be determined in building up the matrix F . Adapted from [119].
sequence, and then use these values to progressively build up to an optimal solution for
the entire sequence. In its current listed form this algorithm takes up O(N2) memory
and O(N4) runtime. However, a significant improvement in runtime can be made if, for
mini<k<l<j Ckl + I(i, j; k, l), we place a constraint such that the size of an interior loop for
I can be no greater than 30. Put another way, for this term, (j − l − 1) + (k − i− 1) ≤ 30.
This brings our runtime down to O(N3) [118].
Minimum Free Energy methods for deriving the most likely structure a sequence emits
from its ensemble of possible structures have been utilized with some success, particularly on
more highly structured RNAs [118, 120, 121]. When the entropy of an RNA’s thermodynamic
landscape is very low and there is a singular optimal structure that the RNA adapts, the
Zuker algorithm is capable of accurately predicting the RNA’s structure. It is quite common,
however, that for a given sequence of RNA, there are multiple structures that are extremely
close in energy to that of the Minimum Free Energy structure called from the Zuker
algorithm [121]. In some cases, these suboptimal structures are also functional [122]. The
Zuker algorithm delivers little information regarding the ensemble of possible structures
emitted by an RNA sequence, as well as the confidence you can have in a particular base being
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paired in any RNA of a particular sequence when found in solution. In order to efficiently
retrieve this information, a method for predicting, storing and backtracking through the
structural ensemble of a sequence needed to be developed. The mathematics required for
such a method can be found in statistical mechanics, where mathematical representations of
entropy in a system are well defined.
1.6.4 A statistical interpretation of RNA structure
In order to develop a more accurate representation of a population of RNA molecules in
solution, and the full ensemble of structures S that are found within, we fit the ensemble
and the subsequent probability of each s to a Boltzmann distribution. The Boltzmann
distribution is a fundamental concept in statistical mechanics and thermodynamics, and is
used to described the probability of a particle being in a state ni, given that there are N total
possible states that the particle can exist in. The Boltzmann distribution specifically weights
each possible state in an ensemble of states by its energy, such that more thermodynamically
likely states have a higher weighted probability of being observed. To derive the equation
that is used to represent the probability of the state ni within N , we begin with Boltzmann’s
equation that describes entropy (S) as a function of the number of microstates present in a
particular state (W ), multiplied by Boltzmann’s proportionality constant k:
S = klnW
We can think of W in a combinatoric sense as the total possible combinations of possible
states that the total collection of items N can be found in. Therefore:
S = kln
(
N !
n0!n1!...ni!...
)
We can modify this equation so that the change in entropy upon changing the state of a
molecule from n0 to ni:
dS = kln
(
N !
(n0 − 1)!n1!...(ni + 1)!...
)
− kln
(
N !
n0!n1!...ni!...
)
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Upon expanding and eliminating multiple terms:
dS = −kln
(
ni + 1
n0
)
≈ −kln
(
ni
n0
)
Taking an additional definition of dS derived under conditions of zero change in system
energy:
dS = dU
T
We can combine these two terms, resulting in:
dU
T
= i
T
= −kln
(
ni
n0
)
and thus
ni
n0
= e−i/kT
To transform this value into a true probability of the state ni in N , we must divide nin0 by a
normalizing factor Z, which we call the partition function. This is equal to the sum of the
relative probability of all possible states in N :
Z = N
n0
=
∑
e−i/kT
We take Z and use it to normalize nin0 in order to get our final equation for the probability
of ni in the ensemble of states N :
e−i/kT
Z
= ni
N
= p(ni)
To quickly relate this to RNA secondary structure, we replace ni with s, and N with S,
representative of a single structure for a sequence X and the full ensemble of structures that
X can emit, respectively:
p(s) = e
−E(s)/kT
Z
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Where we set E(s) as the Gibbs Energy calculated for the structure s. Now that we are
able to present a normalized probability for any structure s in the ensemble S, how can we
translate this into the probability of i being basepaired to j in the ensemble?
1.6.5 The MacCaskill algorithm
The goal of the MacCaskill algorithm is to traverse the total possible structures s
within the ensemble of possible structures S for a sequence X, and then from the results
derive the probability of any nucleotide i being bound to any nucleotide j in S, given that
1 ≤ i < j ≤ N . The probabilities are weighted by the their frequency in lower free energy
structures, and thus high probability basepairs are more likely to be seen in the MFE and
suboptimal structures than low probability basepairs. This algorithm uses as the described
fitting of the ensemble S to the Boltzmann ensemble to derive all pairing probabilities. But
how can the probabilities of each structure be efficiently navigated and then backtracked to
deliver individual pairing probabilities?
Here, the key is remembering that Z[1, N ] represents the total energy of all structures
that fall between 1 and N (where N is the sequence length) in sequence X. Suppose that for
an ensemble energy Z we wish to find the probability of a particular substructure C (located
between k and l, such that 1 < i < j < N) in the ensemble Z, where C is flanked on its left
by two possible structures A and B, and flanked on the right by D and E. The ensemble
energy Z[1, i− 1] would contain A and B, while Z[i, j] would contain C, and Z[j + 1, N ]
would contain D and E. We would represent Z as follows:
Z = e−E(C)/RT ∗ (e−E(A)/RT ∗ e−E(D)/RT + e−E(A)/RT ∗ e−E(E)/RT
+e−E(B)/RT ∗ e−E(D)/RT + e−E(B)/RT ∗ e−E(E)/RT )
Calculating the energetic contribution of each set of possible combination of substructure in
the entire sequence S can be computationally expensive, so instead, we observe that there
36
are multiple repeated terms and adjust accordingly:
Z = e−E(C)/RT ∗
(
e−E(A)/RT ∗
(
e−E(D)/RT + e−E(E)/RT
))
+e−E(C)/RT ∗
(
e−E(B)/RT ∗
(
e−E(D)/RT + e−E(E)/RT
))
Z = e−E(C)/RT ∗
(
e−E(A)/RT + e−E(B)/RT
)
∗
(
e−E(D)/RT + e−E(E)/RT
)
Z = Z[1, i− 1] ∗ e−E(C)/RT ∗ Z[j + 1, N ]
In a manner similar to how we store minimal energies for all subsequences of S, we can
store total ensemble energies for all subsequences of S, building up to a total solution for
the entirety of S. We can relate the listed example to finding the probability of i and j
basepairing in the total ensemble by substituting the energy contribution of C with the total
energy contribution of all structures between i and j where nucleotide i is basepaired with
nucleotide j:
Z = Z[1, i− 1] ∗
∑
(e−E(SC [i,j])/RT ) ∗ Z[j + 1, N ]
Z = Z[1, i− 1] ∗ ZC [i, j] ∗ Z[j + 1, N ]
p(i, j) =
Z[1, i− 1] ∗ ZC [i, j] ∗ Z[i+ 1, N ]
Z
The initial steps for the MacCaskill algorithm are very similar to that of the Zuker
algorithm. Four matrices of dimensions N by N , referred to here as Z,ZB,ZM and ZM1.
These represent the total partition function Z, Z subject to a constraint that the outermost
bases i and j are basepaired, Z subject to the constraint that a multiloop exists between i
and j, and Z subject to a multi-loop constraint between i and j such that i is basepaired to a
position h within the multi-loop region (i < h ≤ j), respectively. Represented in pseudocode:
for i = 1 to N do Z[i, i] = 1 ZB[i, i] = ZM [i, i] = ZM1[i, i] = 0
end for
for d = 4 to N do
for i = 1 to d do
j = i + d
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Z[i, j] = Z[i+ 1, j] +
∑
ZB[i, k]Z[k + 1, j]
ZB[i, j] = eH[i,j]/RT +
∑
i<k<l<j
ZB[k, l]eI(i,j:k,l)/RT+
∑
i<µ<j
ZM [i+ 1, µ]ZM1[µ+ 1, j − 1]e−a/RT
ZM [i, j] =
∑
i<µ<j
ec(µ−i+1)/RTZM [µ+ 1, j]+
∑
i<µ<j
ZM [i, µ]ZB[µ+ 1, j]e−b/RTZM [i, j − 1]ec/RT
ZM1[i, j] = ZM1[i, j − 1]ec/RT + ZB[i, j]eb/RT
end for
end for
Z = F [1, N ]
Once the full partition function Z for structures found within the sequence S ha been
calculated, a traceback through the filled matrices can be done. Given that the contribution
of structures where basepairing between i and j to the partition function is equal to∑
e−E(S[i,j]/RT (where S[i, j] equals the total energy of structures containing an ij basepair),
the normalized probability of i and j being found basepaired in the ensemble is
p[i, j] =
∑
e−E(S[i,j]/RT
Z
p(i, j] = Z[i, j]
Z
In order to conduct this backtrack step, it is necessary to find a way to take into consideration
all structures within the ensemble that contain the basepair kl, where i < k < l < j. For
this there are multiple scenarios that contain an kl basepair that must be taken into account.
They are treated as distinct so that recursion steps can be utilized in the consideration of
their energetically weighted contribution to the ensemble. These distinct cases include the
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formation of a kl external basepair, kl being a member of some stack, bulge or interior loop
enclosed by an ij basepair, and kl being a member of a multiloop enclosed by an ij basepair.
Cases where kl is the external basepair are the easiest to take into consideration, as the
contribution of structures containing kl to the partition function Z via:
pE [k, l] = Z[1, k − 1]Z
b[k, l]Z[l + 1, N ]
Z[1, N ]
This value is easily recoverable from the built up dynamic programming matrices and doesn’t
require recursion. For the second case, where kl is internal to an ij basepair in a series of
basepairings, recursion is necessary, as we need to take into account the contribution of
all structures containing an ij basepair exterior to kl. The recursion is summarized in the
following equation:
pSBI [k, l] =
∑
pSBI [k, l]i<k<l<j(i, j)
pSBI [k, l] =
∑
i<k<l<j
p[i, j]e
SBI(i,j,k,l)/RTZB[k, l]
ZB[i, j]
The case where kl is part of a loop enclosed by ij is the most complex recursion that is
necessary to calculate. Here, we split the instances of ij basepairings into three different
scenarios, where the kl basepairing is on the 5’ end, where it is in the middle (not the very 5’
or 3’ end), and where kl is on the very 3’ end of the ij-enclosed multiloop. We summarize
these scenarios in the order that they are listed as follows:
pM [k, l]|p[i, j] = p[i, j] ∗ [
ZB[k, l]ZM [l + 1, j − 1]e(a+b+(k−i−1)c)/RT
+ ZM [i+ 1, k − 1]ZB[k, l]ZM [l + 1, j − 1]e(a+b)/RT
+ ZM [i+ 1, k − 1]ZB[k, l]e(a+b+(j−l−1)c)/RT
]/Z[i, j]
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For the total probability of kl basepairing occurring interior of a multiloop closed by all ij,
the contributions to the ensemble from all exterior ij basepairs is summed:
pM [k, l] =
∑
i<k<l<j
pM [k, l](i, j)
In considering each of the cases we have covered in the total ensemble of structures in S
where there is a kl basepair, we arrive at the final equation for calculating the probability of
a kl basepair in the total ensemble of structures:
p[k, l] = pE [k, l] +
∑
i<k<l<j
pSBI [k, l](i, j) +
∑
i<k<l<j
pM [k, l](i, j)
The probability of all ij basepairs that are part of the structural ensemble S can be recursively
calculated by starting from the outermost possible basepairings in S and working inward,
in a directionality that is opposite from that of building up the total partition function Z,
where the total solution was built up from the smallest possible substructures in S.
The baseline memory and runtime requirements for the partition function calculation
are similar to that of the baseline Zuker algorithm (O(N4) and O(N4), respectively). Also,
just like the Zuker algorithm, a constraint is placed on the size of internal loops allowed,
resulting in a change in runtime to (O(N3)).
The MacCaskill algorithm offers up several advantages over the Nussinov and Zuker
algorithms. The most obvious advantage is that it offers structural information on the full
Boltzmann ensemble of structures emitted by a sequence X, whereas the Nussinov and
Zuker algorithms report a single structure from the ensemble that is maximally scoring.
In the process of reporting only one optimal structure from the ensemble, a great deal of
information regarding the predicted basepairing interactivities of each position in X is lost.
Given an optimal structure, without the information derived from the MacCaskill algorithm,
there is no available measurement of certainty that a particular predicted basepair occurs in
the ensemble. Basepairings with high probability in the ensemble have been observed to have
a higher positive predictive value when chemical mapping has been performed to deduce
their structure in vitro, and if a particular predicted structure is to be used as a model,
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then the partition function can tell you the amount of confidence you can have in particular
basepairs within the structure [123]. The distribution of probabilities at each nucleotide
position in the resultant basepairing probability matrix can be summed to report a total
probability of basepairing per nucleotide (a simple transformation used by our program
SNPfold, as described in the next chapter) [124]. The full set of pairing probabilities inherent
to S can be used to determine the entropy (or in this case, to put it differently, structural
disorder) inherent to the ensemble [125]. The Ensemble representation of RNA structure is
additionally useful for measuring the distance in structure between two different sequences of
the same length [124]. Much of the work described in later chapters relies on the MacCaskill
algorithm in the prediction of RNA structural ensembles and their disruption via mutation.
1.6.6 General weaknesses shared by the described algorithms
While the weaknesses inherent to the Nussinov and Zuker algorithms individually
have been covered, the weaknesses inherent to the recursive methodology shared by these
algorithms (as well as the MacCaskill algorithm) hav not. In general, the nature of these
algorithms makes it so that for the sake of reasonable runtime and memory usage, there are
only certain types of basepairing interactions and motifs that are allowed. The Nussinov
algorithm is the worst offender, with only canonical AU and GC basepairings being allowed,
and no favor given to basepair stacks. The Zuker and MacCaskill algorithms are more
versatile with respect to the types of basepairing interactions that are allowed, with GU
basepairs and tetraloop interactions being factored into the recursions [120]. Of course,
these algorithms, using thermodynamically derived parameters, also give more accurate
weight to the stabilizing effect that base stacking can have on RNA secondary structure.
However, there are several motifs that any of these algorithms cannot explicitly account for,
due to their recursive nature. The main motif worth discussing that falls into this category
is that of the pseudoknot. A pseudoknot involves a set of basepairings ik and hj in as
single structure s such that h < i < j < k (Figure 1.3). All algorithms described so far
will only consider basepairings hk and ij, under the same constraints. In other words, the
dynamic programming strategy dictates that basepairings may only be interior or exterior
of one another, and that they may not cross. Because of this, none of these algorithms, as
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they have been presented here, can explicitly identify pseudoknots. An advantage that the
MacCaskill algorithm has, however, is that it allows for the inference of pseudoknots. The
reason for this is that in the consideration of all possible structures within the ensemble,
assuming the existence of some ik/hj pseudoknot in the true structure, if there is sufficient
stacking adjacent to ik and hj, then there will be separate sets of structures recursed
through that contain ik or hj, and never a combination of the two. Still, there are many
basepairing interactions that are noncanonical (at least 46 total basepairing types have been
observed according to Nagaswamy et al.), and are not taken into account with the current
set of thermodynamic parameters that have been derived for RNA [126]. Additionally, the
presence of modified nucleotides within many structured RNAs, combined with an incomplete
understanding of their effect on structure, means that that the alphabet of four characters
typically used in RNA secondary structure prediction is likely too small for particular cases
[30, 37].
Perhaps the most significant problem with the RNA structure prediction algorithms
that are described is that they are particularly poor in predicting structure in large RNAs,
and in particular accurately predicting long range basepair interactions. In understanding
the contribution of RNA structure to biological function, it will be important to be able to
identify with high confidence both local and long range secondary structure interactions in an
RNA. A role where these long range interactions are involved that is particularly pertinent
to this discussion is that of alternative splicing, where long range interactions have been
shown to play a role in how splicing is conducted during transcription [127, 128]. It is known
that the algorithms described do not lend themselves well to long range interactions. In
comparison of the structure obtained via the Zuker algorithm with the true known structures
for 5S and 16S rRNA, Zuker algorithm prediction accuracies of 71% and 41% have been
reported [107]. Additionally, the prediction accuracy for 16s rRNA is reported to drop
exponentially with increasing predicted base pair distance [107]. Further work done has
shown that given the current thermodynamics parameters, the accuracy of base pairing
predictions made with the MacCaskill algorithm is optimal at around a maximum allowed
span of 150 nucleotides, and a total window size of 200 nucleotides, and that beyond this
cutoff, the accuracy goes down [129]. The idea that there simply are a significant amount of
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stable long range basepair interactions that form is counter to an analysis of basepairing
distances from crystal and NMR structures that reports a greater than expected amount
of observed long range interactions [130]. Therefore, the fact that these algorithms cannot
accurate predict these interactions is a large problem.
Lastly, structure prediction algorithms such as these can give you predicted information
about diversity of a structural ensemble, as well as what the single most stable structure is,
but they cannot tell you whether these structures serve a particular functional purpose in
the molecular biology of an organism. In order to determine whether a particular sequence
region or structure in RNA is functional, it is necessary to compare the sequences and
structures of multiple homologous RNAs, since a functional region is more likely to have
conserved sequence or structure across species.
1.6.7 Alternate algorithms for single sequence structure prediction
Beyond the three algorithms that we have covered in depth (all of which take as input a
single sequence) there are a myriad number of additional single sequence algorithms that
have been developed. Not many of these algorithms reinvent the wheel, so to speak, but
rather add additional steps or place particular constraints on the Zuker or MacCaskill
algorithm in manner meant to either improve its accuracy or specialize it for a particular
use. We will cover some of these algorithms in a manner that highlights what they are most
useful for, and place emphasis on ones that have been used in the work described in later
chapters.
1.6.7.1 An algorithm for the sampling of structures from the ensemble
One particularly popular type of algorithm that has been developed as an offshoot of
the MacCaskill algorithm takes the partition function calculated and samples from it any
user-defined number of structures in a manner that can be completely random or weighted
by each structure’s energy. A method of the type described was first created in order to
explore the structure space of suboptimal structures only, and thus had poor performance
in cases of large sampling [131]. A different method of sampling was first implemented in
the program Sfold [132]. In general, the algorithm involves the generation of the partition
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function for a sequence X using the described forward algorithm utilized in the MacCaskill
algorithm. Like the MacCaskill algorithm, the second step utilizes a backward algorithm,
but here it is used to determine the sampling probabilities for particular substructures and
motifs that are encompassed within the partition function Z. This type of sampling allows
for the extraction of multiple suboptimal structures within the ensemble, and is extremely
useful when the structural diversity of the most likely structures to be found in the ensemble
are to be analyzed.
1.6.7.2 A modification of the Zuker and MacCaskill algorithms to allow for
pseudoknot detection
While the initial Zuker and MacCaskill algorithms are limited to the detection of nested
basepairs, and thus cannot explicitly detect Pseudoknots, modifications to these algorithms
allow for their (computationally expensive) detection. The first RNA structure prediction
algorithm that incorporated pseudoknots was developed by Rivas and colleagues [133]. In
general, the methodology for the prediction of optimal RNA structure with consideration of
pseudoknots involved the detection of structural elements enclosing a single ”gap” (loop),
and then recursing through possible overlapping ”gapped” elements in order to find the
optimal structure. This approach allowed for the detection of more exotic types of crossed
basepairing motifs, such as kissing loops, but is also very computationally expensive (O(N4)
space, O(N6) runtime). Additionally, a method of calculating the partition function that
allows for explicit detection of pseudoknots has been created (O(N4) space, O(N5) runtime)
[134]. A heavily restricted approach has been published more recently that only allows for
overlap between two stem regions, taking its recursion into account as a modification of
the Zuker algorithm, resulting in O(N2) space and O(N4) runtime [135]. Most recently, a
method to detect pseudoknots in a structural ensemble for sequence X has been developed
that combines RNA secondary structure predictions without pseudoknots with data from
high-resolution chemical mapping in order to call putative pseudoknots in the RNA [136].
While pseudoknots are important structural elements and have been tied with functionality
in different RNAs their prediction is not a focus of the work that is covered here [137].
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1.6.8 Algorithms for RNA structure prediction that use multiple sequences as
input
As was alluded to earlier, often times single sequence RNA structure prediction is error
prone, due to our still insufficient parameters for describing the energetic contributions of
different possible substructures that can form within a given ensemble. Because of this,
scientists often use multiple sequence alignment data for a given region of RNA that is
suspected to be structured search across the alignment for evidence of any structure being
conserved across the alignment. This has proven to be a reliable method for detecting
regions of RNA that are not only conserved in structure, but also functional, as evidenced by
their conservation across species [138–140]. Common metrics used when looking at structure
across aligned sequences, as well as commonly used algorithms for finding structures in
multiple sequence alignments, will now be covered.
1.6.8.1 Mutual information and covariation as evidence of conserved RNA
structure
While conservation in sites such as transcription factor binding sites, codon regions and
other sequence motifs is modeled in a way that the conservation of each position can be
quite independent of one another, rules of conservation in noncoding regions of RNA operate
very differently. Here, there may be a mixture of sequence motifs, which may operate along
similar rules of conservation to that which is commonly understood, and structure motifs,
where the conservation of sequence is secondary to the conservation of structure. For the
detection of regions in a sequence alignment where there is sequence variation that conserves
structure, we introduce the concepts of Mutual Information (MI) and Covariance. The
motivation here is that we can detect evidence of structural conservation in an alignment
by searching for nucleotide position pairs that display consistent Watson Crick basepair
compatibility in spite of sequence variation that may occur across the alignment for both
positions. For a simple example, consider a single sequence that folds into a stemloop with
an ij basepair in the stem where i is a G, and j is a C (Figure 1.6). If this stemloop is
conserved and found across multiple organisms, then we may see evidence of this through
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the existence of sequence variants of this RNA where i is an A and j is a U. In spite of
the fact that two positions have been altered in sequence content, the conserved RNA
structure persists. We can quantify the amount of these Watson-Crick-consistent nucleotide
changes in an alignment by calculating the Mutual Information present, or we can use the
alignment to build a covariance model that takes the conserved basepairings into account
[122, 138, 139, 141].
Figure 1.6: Example of two different RNA structures with divergent sequence content but conserved structure.
The sequence variation between these two structures does not alter basepairing, but rather maintains it. When such
structure conservation is observed across sequences in multiple species for a particular transcript region, it is indicative
that there exists functional structure that has been evolutionarily conserved. Structures generated using VARNA [48].
We will now briefly cover the general mutual information equation. In a sequence
alignment A with an alignment length L and number of sequences n we define the general
equation for the mutual information score between columns i and j in the alignment as
X,Y ∈ A,U,G,C,−
MI[i, j] =
∑
p(i, j)[X ∗ Y ]log2 p(i, j)[X ∗ Y ]
p(i)[X]p(j)[Y ]
In layman’s terms, the equation calculates the amount of difference there is between the
joint distribution X ∗ Y (such that X and Y are basepair complementary) and the marginal
distributions for X and Y between i and j. This equation can be modified such that it is
subsetted on basepairing nucleotide pairs. If there is a basepair between i and j, where both
i and j have variable sequence identity across the alignment, is conserved, then we expect to
see a joint distribution of nucleotides at i and j that preserve basepairing.
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1.7 Chemical mapping of folded RNA structure
The probing of folded RNA with structure-sensitive enzymes and chemical reagents has
been essential to the determination of true folded RNA structures, as well as the evaluation
of the accuracy of RNA structure prediction algorithms. While these experiments may
not deliver quite as much structural detail as X-ray crystallography or Nuclear Magnetic
Resonance (NMR) spectroscopy, they provide details important to an accurate deduction of
the correct secondary and tertiary structure a transcript will fold into. Figure 1.7 depicts an
outline of a general RNA chemical mapping protocol, where folded RNA would be exposed
to a chemical or enzymatic probe, revealing structural details about the molecules in solution.
Here we will concentrate on RNA chemical mapping using the SHAPE (Selective 2’ OH
Acylation followed by Primer Extension) protocol [142].
1.7.1 SHAPE analysis of folded RNA
While many chemical reagents and enzymes have been used to modify RNA in a
structure-dependent manner, the chemistry involved in SHAPE analysis is particularly useful
in comparison due to its lack of distinct nucleotide bias [142, 143]. The compounds utilized,
either N-methylisatoic anhydride (NMIA) or 1-methyl-7-nitroisatoic anhydride (1M7) modify
nucleotides at the 2’ OH group of ribose groups in nucleotides, leaving a bulky organic
adduct. The modification happens in a structurally dependent manner: the occurrence
of the modification at a particular nucleotide position is most highly correlated with the
flexibility of that position in the folded structure [142]. SHAPE also has an advantage of
being more able to label nucleotides that are more ’buried’ in tertiary structures, due to the
chemical’s small size. This is an advantage that a large probe (in particular, an enzyme)
would not have. All structure probing contained within this work utilizes a SHAPE protocol.
The general strategy that is followed in chemical mapping of RNA structure is relatively
simple. A folded RNA is exposed to some chemical or enzyme that modifies its structure,
ideally in a single-hit kinetics fashion. Modified transcripts are then reverse-transcribed,
using a primer that is reverse complementary to the 3’ end of the transcript of interest.
During the reverse transcription step, nucleotides that have been modified (or sites that
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Figure 1.7: General workflow for a chemical mapping experiment utilizing a capillary electrophoresis machine. Folded
RNA in solution is first exposed to some chemical or enzyme that modifies transcripts in a structure-dependent fashion.
Then, reverse transcription is carried out on these modified transcripts using fluorescently labeled primers, resulting in
a population of cDNAs whose lengths correspond to the location in the original RNA that the reverse transcriptase fell
off, due to modification. When run alongside fluorescently labeled ladder sequence in capillary electrophoresis machine,
it is possible to obtain single nucleotide resolution chemical modification data, which correlates to the structural state
at each nucleotide. Adapted from [144].
have been cleaved, if it is a digestion enzyme being used) cause the reverse transcriptase
to fall off, leading to a cDNA fragment that corresponds to the modification site in the
original RNA. This reverse transcription step leads to a wide diversity of cDNA fragments.
Using a standardized nucleic acid ladder, the lengths of these cDNA fragments can be
determined. The amount of cDNA fragment of a particular length, when lined back up
to a particular position of the original RNA transcript, will provide information on how
modified that position was (thus providing detail on the structure at that particular position).
While it is common to run chemical mapping of nucleic acid structure out on a larger gel
against a standardized ladder, a more accurate solution is to use a method such as capillary
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electrophoresis to get cDNA fragment length concentrations at single nucleotide resolution
[144].
1.8 Both RNA sequence and structure content contribute to its proper func-
tion
In functional RNA it often the case that there are important sequence and higher order
structural features that contribute to overall transcript function. As evidenced by Table 1.2,
this line of logic extends to most major classes of eukaryotic RNAs. Specific examples of
functional sequence and structure within these classes of RNA will now be provided.
RNA name Sequence Functionality Structure Functionality
rRNA Peptidyl Transferase acitivity Ribosome assembly
tRNA Anticodon loop compatibility ’cloverleaf’ structure for inter-
action with ribosome
mRNA Conserved Coding region binding motifs and accessible
sites for proteins, small RNAs
snRNA localization of Sm protein pen-
tamer around Sm site sequence
RNP assembly
snoRNA sense/antisense binding of tar-
get RNA next to site to modify
snoRNP assembly
miRNA Sequence complementarity
with target site
pre-miRNA processing, target
site binding efficiency
piRNA sequence specific targetting of
virally derived RNA
Unknown
lncRNA Polypurine tracts found in mul-
tiple transcripts [145]
Act in multiple cases as scaffold
for formation of RNP
Table 1.2: Example uses of functional sequence and structure in known classes of Eukaryotic RNAs.
1.8.1 Examples of sequence content contributing to function across multiple
classes of RNA
It has been long-understood that RNAs contain particular conserved sequence that
contribute heavily to their function. Examples of conserved sequence can be found in all
described classes of RNA from Table 1.1.
Numerous examples of functional sequence content exist across RNAs that are involved in
the production of protein. Ribosomal RNAs, which are likely the most important, conserved
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transcripts across both eukaryotes and prokaryotes, are highly relient on conserved sequence
for both their proper processing, localization and activity as a scaffold for ribosome assembly
and function. For processing, pre-rRNAs contain a UCCCGA sequence element which
through binding of the protein nucleolin promotes pre-rRNA maturation [146]. While less
dependent in eukaryotes than in prokaryotes on conserved sequence content for the initiation
of translation, a link between sequence content in the 3’ end of the 18s rRNA and efficient
translation termination in eukaryotes has been identified [147]. The most obvious role of
sequence content in rRNA is to promote binding between rRNA and ribosomal proteins
in ribosome assembly. Transfer RNA has a particularly obvious dependence on sequence
content in the form of its anticodon loop, whose conservation determines whether or not a
particular amino acid will be brought matched up with the proper codon in mRNA coding
regions. Another critical example of functional sequence content in tRNA is the CCA
sequence found at the 3’ end of tRNA (either part of the primary transcript or added during
processing), which acts as site of linkage between the tRNA and the corresponding amino
acid to be transported to the ribosome [16]. The widest diversity of important sequence
motifs for protein coding-involved RNAs can be found in mRNA. Here, sequence motifs
that facilitate binding with proteins and various noncoding RNAs confer instructions for
how an RNA is to be spliced, sub-cellularly localized, translated, and eventually degraded.
Among the most obvious examples are the start and stop codon signals in the coding
region (marking the translation start and stop sites in the mRNA, respectively), and the
AAUAAA polyadenylation signal found in the 3’ end of mRNAs (promotes binding of RNA
polyadenylation machinery to the 3’ end of the RNA, adding a 3’ polyA sequence to confer
stability) [16].
Modifying RNAs such as snoRNA and snRNA use conserved sequence content that
allows them to precisely access target regions of RNAs for chemical modification or splicing.
Given that snoRNAs form snoRNPs that chemically modify specific locations in target
RNAs, their ability to strongly bind sites near the modification site in a sequence-dependent
manner is very important. The classification of snoRNAs has led to the identification of
two different groups of snoRNAs (C/D box and H/ACA box) through the identification of
highly conserved sequence elements (RUGAUGA/CUGA and ANANNA/ACA, respectively).
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These motifs direct the binding of snoRNPs to their targets [65]. In snRNAs, the Sm site, a
conserved sequence motif consisting of AUUUGUGG, is responsible for the recruitment of
SM proteins for the formation of the snRNP complex [148]. Additionally, eukaryotic splicing
is heavily influenced by basepairing between snRNA (as members of the spliceosome) and
pre-mRNA [149].
Regulatory RNAs (both small and large) are both reliant on conserved sequence content
for the primary purpose of preserving binding platforms with other biomolecules. Small RNAs
such as miRNA and piRNA are both heavily reliant on strong sequence complementarity
with their targets for efficient binding. Each miRNA has a network of target transcripts it
recognizes through (often imperfect) antisense basepairing, such that alteration of miRNA
sequence content (particularly the seed region) has been shown to abolish target preference
[77]. In a similar but more divergent manner, piRNA display strong sequence complementarity
to retrotransposons and foreign RNA, indicative that they serve the purpose of targeting
transcripts of foreign origin [80]. While lncRNAs do not contain the same conserved sequence
content for the purpose of target binding affinity, and our understanding of their full function
in the genome is still limited, there are examples of conserved sequence motifs found within
these longer transcripts that are highly functional. In the human genome there have been
481 so-called UltraConserved Regions (UCRs) that consist of spans of over 200 nucleotides
with perfect sequence complementarity between humans, mice and rats [150]. Given that the
double stranded nature of these regions in the genome makes for 962 possible transcribed
regions that could overlap these UCRs, it was found that 890 of these regions could be
classified as transcriptionally active, and that of these only around 41% clearly map to
mature mRNA regions [151]. Several lncRNAs are found antisense to particular genes which
they have been found to regulate the activity of, and examples where it has been shown
that such regulation involves direct binding of target transcripts by lncRNA exist [96].
1.8.2 Examples of higher-order structure contributing to function across mul-
tiple classes of RNA
While transcript sequence content (specifically , the presence of conserved primary
sequence motifs) are very important determinants of an RNA’s function, higher order
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structure that occurs as a result of the conferred sequence content is also key. Like functional
sequence content, numerous examples across multiple functional classes of RNA in eukaryotes
exist.
RNAs involved in the production of protein use structure to both bring together
components of translational machinery and to regulate the fate of protein-coding transcripts.
Of all RNA structures, the ”cloverleaf” structure ubiquitously formed by tRNAs is perhaps
the most studied and well known. Such a structure serves the purpose of both facilitating the
proper interaction with the ribosome and the consistent presentation of the triplet anti-codon
sequence. This structure is important enough that cells have entire pathways (of which
of snoRNA is an important member) for the purpose of inducing chemical modifications
that are thought to further stabilize the structure [65]. As previously mentioned, such
modifications are also frequent in rRNA. Like tRNAs, these transcripts are highly structured
(in fact they have the most conserved structures for RNAs across species). Such highly
ordered structure serves the purpose of providing a platform for the full assembly of the
ribosome. As for mRNA, while it is typically understood to be unstructured, the truth is
that there are many structural elements currently known to reside in mRNAs that have
functional significance. like other RNAs, mRNA is often targeted for binding by proteins or
noncoding RNAs. The binding affinity of these biomolecules for target mRNA is known to
be dependent on the accessibility of the target site in the RNA’s folded structure [152, 153].
As detailed in Figure 1.7, there are multiple regulatory events that occur during an mRNA’s
lifetime that are dependent on these interactions. Examples of some of the more well-known
structural motifs that are targeted by these proteins and regulatory RNAs are Selenocysteine
Insert Sequence elements, Internal Ribosome Entry Sites (allows for alternate translation
initiation for certain mRNAs) and Iron Responsive Elements (a structural element which
will be further brought into focus in chapters 2 and 3) [154–156].
Modifying RNAs typically utilize structure to form full RNP complexes in order to carry
out their function. Both snoRNAs and snRNAs contain conserved structure that primarily
serves this particular purpose. Both C/D box and H/ACA box group snoRNAs contain
particular conserved secondary structure motifs that contribute to their function. The C
and D box sequence motifs alluded to previously in C/D box snoRNA are brought in close
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Figure 1.8: A range of events that mRNA is subject to that are dependent on binding affinity with protein and
other RNAs. The binding affinity is highly influenced by RNA structure.
proximity via basepairings between the 5’ end 3’ end of the sequence that are necessary for
proper transcript localization in the nucleolus [157]. While the H/ACA box snoRNA has
a more intricate conserved structure, here its primary purpose seems to be in optimizing
the accessibility of the H and ACA sequence motifs previously mentioned in the secondary
structure, as both are located in separate loop regions in the otherwise highly basepaired
transcript [158]. This allows for efficient snoRNA basepairing with its target transcript in
order for target pseudouridinylation to occur. The snRNAs also have several functional
structural elements that allow them to carry out their function. There are several different
snRNAs (with different ones making up the major and minor spliceosome) and several (U1
and U2 for example) are known to have conserved stemloops that are involved in acting as a
scaffold for RNP assembly [159].
Regulatory RNAs have evolved structure for different purposes, with smaller regulatory
RNA having conserved structure for their correct processing and larger regulatory RNAs
having structure for this as well as other purposes (such as interacting with other biomolecules
in the cell). Smaller regulatory RNAs such as miRNA can often be processed from a
significantly longer precursor transcript. In order to be loaded into the RISC complex, the
precursor transcript is processed via a protein known as DGCR8, which targets stemloop
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structures within the miRNA precursor transcript [160]. These stemloop regions are processed
and loaded onto RNAi machinery. Longer regulatory RNAs have been found to frequently
utilize structure for a variety of purposes, including formation of RNPs and the basepairing
of other transcripts with single stranded regions. In spite of often poor sequence content
lncRNAs have shown evidence of being enriched for structure conservation [161]. Several
lncRNAs, such as MALAT1, contain regions of highly conserved structure; the level of
knowledge per transcript on what function these structures have varies [162].
1.9 RNA and disease
Given that RNA is such a functional biomolecule in the cell, it comes as no surprise that
there are many complex and rare genetic diseases where the disregulation of RNA, or its
aberrant function, contributes to onset or pathogenesis of the disease. We now review these
known examples, covering first many of the examples where disruption of conserved sequence
content is the causative agent. We then cover examples (some known, some hypothesized)
where RNA structure disruption is the causative agent.
1.9.1 Many known examples of RNA sequence dysregulation being tied to
disease
Given the many processes that have been outlined previously that are dependent on
RNA functionality, it should come as no surprise that there exist genetic diseases and
forms of cancer where disruption of transcript functionality is observed. Many of the more
deletarious mutations alter the blueprints for protein production found in mRNA, whereas
other mutations act through alternate means to disrupt gene regulation.
Many diseases that act through RNA dysregulation act to alter the the resultant protein
product made from a transcript. Perhaps the most obvious example of RNA transcript
disruption leading to disease is when an alteration of codon content in the coding sequence
leads some change in the resultant protein that is translated. Multiple diseases are tied to
the alteration of the coding region, which as mentioned before, is itself highly conserved
sequence content. Within these coding regions have been found multiple examples of
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sequence variation that are synonymous (do not change the sequence of the coding region),
but have been reported to be functional disease associated mutations. Regions that are
particularly sensitive to synonymous variants in the coding region are those that are involved
in splicing. Study of natural synonymous human genetic variation has shown that there is
a depletion of their overlap with exon splicing enhancer regions [163]. Plenty of examples
exist of synonymous point mutations in exons, as well as point mutations inside intronic
regions in pre-mRNA, that alter splicing. Such mutations have been found in disease-relevant
genes in patients with colorectal cancer, Phenyketonuria, Dementia, Frazier Syndrome and
multiple sclerosis [164, 165]. Disease states that are particularly well known to be associated
with splicing defects are Duchene Muscular Dystrophy (caused by missplicing of the DMD
transcript) and Spinal Muscular Atrophy (cause by the misplicing of the SMN1 gene during
transcription, which leads to propagated aberrant splicing) [97]. Additionally, examples
exist of mutations in small nuclear RNA that alter splicing. While examples of mutations in
snRNAs are few and far between (likely due to their strong deletarious effect), induction of
mutations in mouse U2 snRNA has been shown to lead to severe ataxia and neurogeneration
[63]. Additionally, mutations in the minor spliceosome snRNA U4atac have been found in
patients with microcephalic osteodysplastic primordial dwarfism type I (MOPD I) [62].
There are many additional examples of disease associated mutations that act through
the alteration of different mechanisms of gene regulation. SnoRNA transcripts, which are
typically involved in transcript modification as well as additional roles still being discovered,
have had several diseases tied to their disregulation. The most well-known is Pradar-Willi
syndrome (tied to the deletion of a cluster containing several snoRNAs) [166]. In miRNA,
mutations can alter both transcript maturation and sequence preference in target binding. In
changing target preference, mutations in miRNA are particularly deletarious when they are
found in the seed region. Several known examples of disease-associated miRNA mutations
exist, including the first disease-associated SNP found in an miRNA (which is associated with
hearing loss) [167]. Disregulation of miRNA is strongly tied to various forms of cancer as well,
with multiple miRNAs found to be differentially expressed in different cancers, and mutations
that alter miRNA/target binding affinity, such as in the case of a SNP altering KRAS/let-7
binding [168–170]. The prospect of mutations in lncRNAs is particularly intriguing due to
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their variety of functionalities, as well as the network level regulatory influence that a subset
of these RNAs can exert. In spite of this, only a few functional mutations in lncRNAs have
been found. A well-known example is the lncRNA TERC (RNA component of the telomere
extending telomerase RNP), where mutations are found in individuals wtih Dyskeratosis
Congenita, a premature aging disease [171]. SNPs within the gene for the lncRNA ANRIL
that are associated with atherosclerotic vascular disease have additionally been found to
be functional [172]. Finally, many ties have been made between lncRNA and cancer. A
particular lncRNA, MALAT1, has drawn attention for being frequently mutated in colorectal
and breast cancers [173].
1.9.2 Examples exist of disease-associated mutations in RNA predicted to
change structure
While most work into the mechanisms through which these disease-associated mutations
act has focused on looking for the disruption of conserved sequence content, there do exist
examples of mutations where it was found that the mutations may have an effect on higher-
order structure. Examples can be found in a RNA classes involved in protein production, as
well as classes that are regulatory in nature.
There are several classic examples that are required discussion when covering rare
mutations in patients that are though to act through the disruption of RNA structure. One
of the classic examples is the repeat expansion found in patients with myotonic dystrophy.
The repeat region, consisting normally of 5-38 CUG repeats in the the 3’UTR of DMPK
mRNA, is expanded in myotonic dystrophy to above 50 repeats. Normally, the repeats
form a stem region with multiple interior bulges, which has been shown to bind the RNA
binding proteins CUGBP1 and MBNL1 [174]. When the repeat is expanded this structure
motif grows in size, and thus recruits these proteins to the point where they are drawn away
from subcellular locations where they presence is required, leading to pathogenesis of the
disease [174]. In at least one patient, The Selenocystein elements in SEPN1 mRNA that
were previously described have also been found to be mutated in particular patients with
spinal muscular atrophy, and has been shown to abolish the binding of the protein SBP2 and
this element that usually occurs [175]. Another well known example of a disease associated
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with mutations in functional RNA structure is hyperferritinemia cataract syndrome. These
elements, found in UTRs of various mRNAs whose protein products are involved in iron
metabolism, are particularly sensitive to mutations that occur within these structured
regions, as the proper formation of the IRE stemloop is important to the completion of its
function (recruitment and binding of the Iron Regulatory Protein) [156, 176–178]. These
mutations are analyzed in-depth in further chapters, and high resolution chemical mapping
displaying the structure change that a subset of these mutations bring about is provided
[124, 179].
There are also likely examples where functional RNA structure change occurs in spite
of assumptions that the functional effect of mutations is through an alternate mechanism.
A good example involves mutations in the PTEN gene found in individuals with Cowden
Syndrome, characterized by tumor-like growths in epidermal regions and a significantly
increased cancer susceptibility. A subset of these mutations are found in the 5’ end of the
gene, where their functional effect was throught to be the alteration of promoter activity
[180]. However, an analysis of 5 mutations detected in Cowden Syndrome patients within
the promoter region in question showed that they did not fall into known transcription
factor binding sites, and that PTEN mRNA levels remained constant in sequences with the
mutations. However, it was shown that translation efficiency was significantly altered in 3
out of 5 mutations. RNA secondary structure prediction work done showed that a change
in predicted MFE structure between wildtype and mutant sequences in the PTEN 5’UTR
[181]. Examples of other mutations (often in the 5’UTR region) whose predicted functional
mechanism is through the alteration of transcriptional activity, but have been predicted to
significantly change RNA secondary structure, have been identified in our work described in
further chapters [124].
1.10 Hypotheses
As we proceeded with the research described in this dissertation, we operated on several
separate hypotheses. The first is that there are a subset of mutations in noncoding portions
of the human transcriptome that significantly alter RNA structure. The second is that there
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is detectable preservation of RNA structure in a subset of available genetic variation data in
human populations. The third is that consistent with given examples of structure change
having an effect on protein or small RNA binding affinity, there is an enrichment of SNPs
that have been identified as associated with functionality near protein binding sites in a way
that suggests a structural component to their effect.
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CHAPTER 2
Disease-associated mutations that disrupt the RNA structural ensemble1
2.1 Overview
Genome-wide association studies (GWAS) often identify disease-associated mutations
in intergenic and non-coding regions of the genome. Given the high percentage of the
human genome that is transcribed, we postulate that for some observed associations the
disease phenotype is caused by a structural rearrangement in a regulatory region of the
RNA transcript. To identify such mutations we have performed a genome wide analysis
of all known disease-associated Single Nucleotide Polymorphisms (SNPs) from the Human
Gene Mutation Database (HGMD) that map to the untranslated regions (UTRs) of a gene.
Rather than using minimum free energy approaches (e.g. mFold), we use a partition function
calculation that takes into consideration the ensemble of possible RNA conformations
for a given sequence. We identified in the human genome disease-associated SNPs that
significantly alter the global conformation of the UTR to which they map. For six disease-
states (Hyperferritinemia Cataract Syndrome, β-Thalassemia, Cartilage-Hair Hypoplasia,
Retinoblastoma, Chronic Obstructive Pulmonary Disease (COPD), and Hypertension) we
identified multiple SNPs in UTRs that alter the mRNA structural ensemble of the associated
genes. Using a Boltzmann sampling procedure for sub-optimal RNA structures, we are
able to characterize and visualize the nature of the conformational changes induced by
the disease-associated mutations in the structural ensemble. We observe in several cases
(specifically the 5’ UTRs of FTL and RB1) SNP induced conformational changes analogous
to those observed in bacterial regulatory Riboswitches when specific ligands bind. We
propose that the UTR and SNP combinations we identify constitute a âĂĲRiboSNitch,âĂİ
1This chapter previously appeared as an article in the PLOS Genetics Journal. The original citation is as
follows: Halvorsen, M.; Martin, J. S.; Broadaway, S. & Laederach, A. Disease-associated mutations that alter
the RNA structural ensemble PLoS Genet, 2010, 6, e1001074
that is a regulatory RNA in which a specific SNP has a structural consequence that results
in a disease phenotype. Our SNPfold algorithm can help identify RiboSNitches by leveraging
GWAS data and an analysis of the mRNA structural ensemble.
2.2 Introduction
Genome Wide Association Studies (GWAS) pinpoint mutations associated to a disease
state with single nucleotide precision [182–185]. In some cases, the molecular cause of the
disease is evident from the mutation data alone. For example, if the mutation results in a
premature stop codon, the production of a truncated protein is the cause for the disease
[186]. In a majority of cases, however, it is difficult to identify the molecular cause of the
disease from the GWAS data alone [184, 187–192]. This is especially true when associations
are identified in non-coding and intergenic regions of the genome [191, 192]. Since a majority
of the human genome is non-coding and intergenic, it is not surprising that many GWAS
studies are finding disease associations in such regions [193–195]. In this study we aim to
evaluate the role of mutation induced structural changes in regulatory RNAs of the human
genome and their consequence on the disease state.
The central role of RNA as a major regulator of genetic networks in the cell is now
well established [196]. Furthermore, it is estimated that up to 95% of the human genome is
transcribed, suggesting that a majority of mutations are transferred to the transcriptome
[182]. This study focuses on the potential structural consequences of disease-associated
mutations on the RNA transcriptome, in particular single nucleotide polymorphisms (SNPs)
in the 5’ and 3’ UTRs of genes. UTRs are the regulatory elements of genes, acting as
controllers of translation and RNA decay, as well as targets for RNA interference (RNAi)
[197–199]. Since UTRs are readily transcribed, play a central role in post-transcriptional
regulation, and are integral to the mature mRNA, they present an ideal starting point for
studying the potential structure/function relationships of disease-associated mutations on
the transcriptome.
Unlike highly structured RNAs such as self splicing introns [200], Riboswitches [201],
and the Ribosome [202], the UTRs of mRNAs are not generally evolved to adopt single,
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well-defined structures. Instead they adopt an ensemble of conformations best described
by a partition function, which is defined as the probabilities of all possible base-pairs
[117, 203, 204]. Most mutations in an RNA only have local effects on the structural ensemble.
A small subset of mutations, however, have a large and global effect [203]. If a disease-
associated mutation belongs to the latter, it can suggest a role for RNA structure in the
molecular mechanism of the disease. We make several assumptions in this study, which will
be borne out by the data presented below. These assumptions are:
1.) Certain human disease states are caused by mutation induced conformational changes
in transcribed, regulatory RNA molecules. If a disease-associated mutation causes a large
change in the ensemble of RNA structure, this suggests RNA conformational change as a
potential molecular cause of the disease.
2.) Large regulatory RNAs generally adopt multiple conformations and it is critical
to consider how mutations affect this ensemble rather than just the minimum free energy
structure [205].
3.) A majority (> 95%) of mutations result in only small, local changes in the structure
of an RNA.
4.) The same phenotype (disease) can be caused by different mutations with varying
degrees of effect on overall RNA ensemble structure. A global analysis of the structural
consequences of all disease-associated mutations on a regulatory RNA can pinpoint the
regulatory region of the RNA.
In this study we investigate known disease associated SNPs that map to non-coding
UTR regions of the human genome with respect to their effect on the ensemble RNA
structure. We identify disease states in which the associated SNPs significantly alter the
RNA structural ensemble of the UTR. This analysis provides insight into the potential
molecular causes of several genetic disorders including Hyperferritinemia-cataract syndrome
[206], β-Thalassemia [207, 208], and Chronic Obstructive Pulmonary Disease (COPD)
[209, 210]. More importantly, our analysis reveals the extent to which SNPs affect RNA
structure, and the nature of those effects in disease-states.
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2.3 Results
2.3.1 Ensemble RNA structural analysis
We first consider the C33G SNP in the 5’ UTR of the HBB (β-globin) gene, which is
associated with β-Thalassemia [211, 212] to illustrate the basic premise of our methodology.
The SNP is not located near any transcription, translation start or stop sites (Figure 2.1A).
A recent study demonstrated that the C33G mutation (replacing C33 with a G) has a
negligible effect on mRNA transcriptional levels [213]. A possible cause for the disease state
is therefore a conformational change in the RNA structure. In Figure 2.1B, we show the
result of a partition function calculation for the wild-type (non-diseased) âĂĲCâĂİ allele of
the UTR. Unlike traditional Minimum Free Energy calculations (MFE) that predict a single
low energy structure of the RNA, the partition function computes the probability of pairing
for all possible base-pairs including potential pseudoknots [117, 203, 204]. The partition
function therefore is a representation of the RNA structural ensemble, i.e. all possible RNA
structures [203]. Since whole UTRs are generally not evolved to adopt a single well defined
structure, the partition function illustrated in Figure 2.1B is a more accurate representation
of the RNA’s structural ensemble than the single structure obtained by traditional MFE
computations such as mFold [117]. We choose to highlight the HBB 5’ UTR and the C33G
SNP associated with β-Thalassemia [211, 212] because of the difference in the partition
functions illustrated in Figures 2.1B and 2.1C. The partition function calculation using
the mutant sequence (replacing C33 with a G) is dramatically altered by this single SNP,
suggesting a significant change in the overall structural ensemble of the UTR RNA. In Figure
2.1D, we compute the base accessibility (i.e. the probability of the base being paired) by
summing the base-pair probabilities down the columns of the partition function. When we
compare the base-pairing probabilities for the wild type (C33 non-diseased allele, black line)
with the disease-associated mutation (G33, red line), we see that specific bases show large
changes in nucleotide accessibility while others remain unaffected by this mutation.
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Figure 2.1: Partition function analysis of the C33G SNP in the 5’ UTR of HBB associated with β-Thalassemia
[208]. A) Schematic representation of the HBB gene, showing the 5’ UTR and the start of the first exon (black).
The C33G SNP position is indicated in green. B) Partition function heat map for the wild-type (non-diseased) 5’
UTR RNA illustrating base-pair probabilities. The rectangle to the right of the heat map is a legend, with zero
probability being black and a probability of one colored white. C) Partition function heat map for the HBB 5’ UTR
RNA with the diseased G allele at position 33. The appearance of alternative structures is apparent when compared
to the non-diseased C allele above. D) Nucleotide base-pair probability (or accessibility) of the HBB 5’ UTR for the
wild-type (non-diseased, black) and mutant (disease-associated) RNA (red). The base-pair probability is computed
by summing the rows (or columns) of the partition function. We compute the Pearson correlation coefficient between
the wild-type (black) and disease-associated mutation (red) lines to quantify the change in the structural ensemble
caused by mutation. In this case, we compute a Pearson correlation coefficient of 0.797 for the C33G mutation.
2.3.2 Evaluating the significance of a change in the RNA structural ensemble
For the purposes of this study, we are particularly interested in identifying disease-
associated SNPs like C33G in the HBB 5’ UTR that have a significant effect on the RNA
structural ensemble as defined by the partition function calculation. We quantify the overall
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structural effect of a mutation on an RNA by computing the Pearson correlation coefficient
between the wild-type and diseased base-pair probabilities (black and red lines, Figure 2.1D).
For the C33G mutant we determine a WT/mutation correlation coefficient of 0.797 (Table
2.1). This simple calculation allows us to quantitatively describe the overall rearrangement
in the structural ensemble of the RNA caused by the disease-associated mutation.
The Pearson correlation coefficient as computed above provides a quantitative measure
of the overall change in the partition function caused by a mutation. However, based on this
single calculation, it is difficult to determine the significance of the structural change. We
compute Pearson correlation coefficients for all 150 possible single nucleotide mutations (the
HBB 5’ UTR is 50 nucleotides in length) and illustrate their values as a heat map in Figure
2.2A. This result illustrates that a majority of mutations in the HBB 5’ UTR only have
small effects (Pearson correlation coefficient > 0.95) on the structural ensemble. To better
illustrate this point, we plot in Figure 2.2B a histogram of Pearson correlation coefficients
for all single nucleotide mutations of HBB.
The distribution of Pearson correlation coefficients is dependent on both the sequence
and its length. This is illustrated in Figure 2.2C where we plot the distribution of Pearson
correlation coefficients for the 1599 mutations in the 5’ UTR of SERPINA1 (serpin peptidase
inhibitor, clade A (α-1 antiproteinase, antitrypsin), member 1, which is 533 nucleotides in
length), where the C116U SNP is associated with COPD [214]. The two distributions are
clearly different and these results suggest a straightforward approach for comparing the
extent of conformational change caused by a SNP in an RNA. The C33G mutation in the
HBB 5’ UTR has the sixth lowest correlation coefficient out of the 150 possible mutations
and we therefore compute a p-value of 6/150=0.04 for this SNP(Table 2.1). Similarly, the
C116U mutation in the 5’ UTR of SERPINA1 results in a Pearson correlation coefficient
of 0.664 and this yields a p-value of 21/1599= 0.013. This simple calculation allows us to
compare the effects on SNPs on different UTRs and thus rank order the disease-associated
SNPs in the Human genome with respect to the significance of the structural rearrangement
they induce.
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Figure 2.2: Comprehensive single mutation analysis of the HBB 5’ UTR to determine the significance of the
observed rearrangement in the structural ensemble caused by mutation. A) Heat map diagram illustrating the Pearson
correlation coefficients for all possible mutations in the HBB 5’ UTR. The heatmap color scheme is identical to that
used in Figures 2.1B and 2.1C. The four rows on the diagram each indicate a different nucleotide (A, C, G or U)
while each column represents a position in the UTR. The wild-type sequence is indicated with black boxes. Only
a few mutations (e.g. C33A, C10A) including the C33G result in small (< 0.8) Pearson correlation coefficients. B)
Histogram of Pearson correlation coefficient values for all 150 possible mutations in the HBB 5’ UTR. A majority of
mutations (< 95%) have correlation coefficients greater than 0.9. We use these calculations to estimate a p-value for
the significance of the observed structural change in the ensemble. C) Similar histogram for all mutations in the 5’
UTR of the SERPINA1 gene where C116U is associated with Chronic Obstructive Pulmonary Disease (COPD) [214].
The distribution of Pearson correlation coefficient values gets steeper with longer RNAs (the 5’ UTR of SERPINA1
is 533 nucleotides long)
2.3.3 Genomic scan of all known disease associated SNPs in HGMD
We analyzed a total of 514 disease-associated SNPS in 350 UTRs and non-coding
RNAs from the HGMD (Human Gene Mutation Database) [215, 216]. HGMD is a curated
database that records the results of published GWAS and other disease association studies
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[215]. This database is unique in that it provides flanking sequence for a majority of its
entries, allowing us to automatically validate the location of SNPs within UTRs using the
latest human genome annotations [217, 218]. Of the 350 RNAs we analyzed, 206 were 5’
UTRs, 132 were 3’ UTRs and 12 were non-coding RNAs. The SNPs we analyzed map
only to the untranslated regions of mature mRNA and are at least 10 nt away from any
transcription or translation start or stop sites. Furthermore, the HGMD annotation stores
SNPs associated with alternative splicing in a separate table, which we did not include in our
analysis. Our data therefore represents a comprehensive subset of known disease-associated
mutations within mRNA UTRs that are not expected to directly affect splicing, translation
or transcription through sequence variation. We chose to perform our analysis on this
particular subset of disease-associated SNPs to maximize our chances of finding disease
states where RNA structural rearrangements are likely to be causative in the association.
We map in supplementary Figure 2.S5 all SNPs in strong LD (Linkage Disequilibrium, R2
> 0.9) for common variants identified in Table 2.1.
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Disease/phenotype Gene HGMD
Acc.
UTR UTR
len.
mut. Corr.
Coeff
P-val ref. Motifs1 RBP2
Binding
dbSNP3
ID
Alteration of plasma
zymogen TAFI concen-
tration
CPB2 CR080756 3 427
453
T310A
T336A
0.64
0.826
0.001
0.094
[219] uORF
MBE
PAS
- rs1087
Chronic obstructive
pulmonary disease
SERPINA1CR061339 5 533
554
551
C116T 0.664
0.784
0.777
0.013
0.033
0.04
[214] uORFs - rs8004738*
Retinoblastoma RB1 CR961736
CR086248
5 166 G17C
G18T
0.679
0.766
0.014
0.098
[220]
[221]
IRES ELAVL1 -
-
Hyperferritinemia
Cataract Syndrome
FTL CR011064
CR061336
CR061334
CR031001
5 199 C14G
A56T
T22G
C10T
0.673
0.713
0.766
0.792
0.02
0.042
0.065
0.072
[176]
[156]
[156]
[177]
IRE - -
-
-
-
Cartilage-Hair Hy-
poplasia
RMRP CR063415
CR054274
CR054268
nc-
RNA
265 T252G
G40A
G182T
0.738
0.762
0.801
0.029
0.047
0.083
[73] - - -
-
-
b-Thalassemia HBB CR900265
CR984119
CR014260
CR880076
3 132 A11G
C47G
T110G
A113G
0.794
0.799
0.815
0.841
0.033
0.038
0.045
0.071
[207]
[211]
[222]
[223]
PAS - rs63751128
-
-
rs33985472
CR961734 5 50 C33G 0.797 0.04 [208] - - rs34135787
HBD CR075247 5 195 G66A 0.771 0.07 [224] uORF
MBE
- -
Hypertension AGT CR971935
CR973338
5 508 G465A
A51C
0.694
0.765
0.051
0.089
[225]
[226]
uORFs ELAVL1
PABPC1
rs5051*
rs5050*
Table 2.1: Disease states and phenotypes in which two or more associated SNPs were found to alter the structural ensemble of the RNA. 1 Structural and sequence motifs
identified in mRNA UTRs using UTRScan[227]. 2 RNA Binding Protein as determined by RIP-chip [228]. 3 dbSNP reference IDs for common variants. A star (*) indicates
LD data is available and reported in Supplementary Figure 2.S5
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Our results are presented in Table 2.1 and in the supplementary Table 2.S1. We report
on all the disease-associated SNPs that alter RNA structure with a p-value < 0.1. We
therefore report the top 10 percent of disease-associated SNPs in regulatory non-coding RNA
that alter their RNA structural ensemble within the human genome. The disease-states
reported in Table 2.1 are particularly interesting to this study, as they potentially offer
mechanistic insight into how RNA structural rearrangement can affect gene regulation and
lead to disease. We begin our analysis of SNP induced RNA conformational change by
considering the four SNPs associated with Hyperferritinemia Cataract Syndrome listed in
Table 2.1.
2.3.4 Hyperferritinemia Cataract Syndrome
We identify four SNPs in the 5’ UTR of the FTL (ferritin light chain) gene that
significantly affect the RNA structural ensemble (Table 2.1) and that are associated with
Hyperferritinemia Cataract Syndrome. The FTL gene encodes the Ferritin light chain
protein, and deregulation of this gene leads to the disease phenotype [178]. Recent studies
on the regulation of FTL have revealed an Iron Response Element (IRE) in the 5’ UTR
to which a regulatory Iron Response Protein (IRP) binds [178, 206]. The IRE is an RNA
hairpin and mutations in the 5’ UTR disrupt the structure of the IRE and thus alter the
binding affinity of the IRP, leading to aberrant FTL regulation [206]. This type of regulatory
system is precisely what we aim to identify with our genomic analysis.
One limitation of the partition function representation (Figure 2.1B, for example) is in
the visualization and interpretation of the structural ensemble change induced by mutation.
UTRs generally do not adopt single well-defined structures and classic representations
of RNA structure (commonly referred to as âĂĲairport terminal diagramsâĂİ) cannot
accurately be used to visualize overall changes in the ensemble. An alternative visualization
of the structural ensemble is illustrated in Figure 2.3A for the wild-type (non-diseased)
FTL 5’ UTR. We carried out a Boltzmann sampling of RNA structures using the sFold
procedure [229, 230] and generated an ensemble of 5000 alternative RNA structures from
the wild-type and mutant sequences. We then perform principal component analysis (PCA)
on the full ensemble of structures. The ensemble of structures that belong to a particular
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Figure 2.3: Structural analysis using Boltzmann sampling and principal component analysis of FTL 5’ UTR and four
Hyperferritinemia cataract syndrome associated mutations [178]. A.) Boltzmann sampling and principal component
decomposition of 5000 alternative structures of the FTL 5’ non-diseased UTR. Each cross in the diagram represents
one of the 5000 structures projected onto the first two principal components [229]. We use linear (or arc) diagrams to
illustrate representative structures in the principal component space. In this case, three main clusters are observed,
with the right, middle quadrant (red representative structure) being most highly populated for the WT sequence.
Structures within this highly populated cluster all contain an IRE element (indicated in the figure), which has been
shown to be critical in regulating FTL [178]. B.) Effect of the U22G mutation on the RNA structural ensemble
involves populating both of the alternative RNA conformations. C.) A similar redistribution occurs with the A56U
mutation. D.) Only the top, left hand cluster is populated with the disease-associated C10U mutation. E.) The C14G
populated the lower, left hand quadrant, which also does not form the regulatory IRE.
sequence (wild-type or a specific mutant) were then projected onto the first two principle
components as shown in Figure 2.3. This allows us to visualize the structural heterogeneity
in the ensemble of structures for a sequence, keeping in mind that two points that are close
together in our projection diagram indicate the two corresponding structures are similar in
structural space.
For the FTL wild-type sequence we find that a majority of our sampled structures are
grouped in a single cluster in the right center quadrant of the PCA graph. Representative
structures for the three main structural clusters identified for FTL are illustrated in the
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Figure 2.3A insets as linear diagrams. We clearly see the formation of the IRE in the
representative structure (red), indicating that a majority (97%) of wild-type RNAs adopt
this structure. It is when we perform the same Boltzmann sampling procedure for the
four diseased SNP sequences that we are able to visualize the nature of the structural
ensemble change caused by these disease-associated mutations. In Figures 2.3B-2.3E we
project Boltzmann sampled structures onto the same principle components as those used in
Figure 2.3A for the four Hyperferritinemia Cataract Syndrome associated SNP sequences.
This analysis immediately reveals the nature of the structural change that putatively is
the cause of the disease phenotype. The U22G and A56U mutations result in all three
structural clusters populated (Figures 2.3B and 2.3C) while the C10U and C14G mutations
selectively populate one of the mutant clusters (Figures 2.3D and 2.3E). In all cases, we
find that the disease-associated mutations populate alternative conformations where the
IRE is not formed. For FTL, the non-diseased UTR adopts a compact structural ensemble
where the IRE is formed, while the diseased-associated SNPs shift the ensemble to include a
significant number of structures where the IRE is disrupted in favor of long-range base pairs.
In Table 2.2, we compute the relative population of the three clusters for the wild type and
mutant sequences and find that all four disease-associated mutations significantly reduce
the percentage of structures containing an IRE. Nonetheless, we see that no single mutation
completely abolishes the cluster with the IRE, suggesting a shift in the relative populations
of each conformation.
Red Cluster1 Green Cluster2 Blue Cluster3
Wild-Type 98% 1.60% 0.40%
U22G 12% 83% 5%
A56U 17% 18% 64%
C10U 36% 0% 64%
C14G 25% 75% 0%
1 Middle-right quadrant in Figure 3, red structure containing IRE.
2 Lower-left quadrant in Figure 3, green structure.
3 Upper-left quadrant in Figure 3, blue structure.
Table 2.2: Relative population of the three structural clusters for the FTL 5’ UTR.
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2.3.5 One phenotype, multiple genotypes
The four SNPs we identify in the 5’ UTR of FTL as having a large effect on its
structural ensemble are a subset of the 30 SNPs associated with Hyperferritinemia Cataract
Syndrome reported in HGMD. Since HGMD is based on existing published literature, one
can assume that these 30 SNPs represent only a subset of all mutations that can cause
the Hyperferritinemia phenotype. A majority (28) of the known SNPs associated with
Hyperferritinemia Cataract Syndrome occur in the 5’ UTR of FTL, suggesting that the
UTR is central in the regulation of the gene. The four mutations we identify using our
partition function calculation and correlation analysis (which we will now refer to as the
SNPFold algorithm) identify SNPs that have a major effect on the RNA structural ensemble.
By design, SNPFold identifies the SNPs that alter the global structural ensemble of the
RNA, and will not identify SNPs that have only local structural effects on the RNA. It is
clear, however, that a global effect on the RNA structural ensemble is not a prerequisite for
disease association. Clearly, multiple molecular mechanisms can cause the same phenotype;
in the case of Hyperferritnaemia Cataract Syndrome any mutation that either directly or
indirectly affects the IRE and its ability to bind the corresponding Iron Response Protein
(IRP) can result in the phenotype.
In the supplement (Figure 2.S2) we illustrate a natural extension of the SNPFold
algorithm for analyzing multiple disease-associated SNPs. We average the change in base-pair
probability for each nucleotide and for all Hyperferritinemia Cataract Syndrome associated
SNPs. This global analysis of the effects of SNPs on the RNA structure clearly identifies the
IRE in the 5’ UTR, which is where on average, the largest changes in base-pair probability
are observed. As more associated genotypic information becomes available, it is likely that
it will be possible to use this data to identify other RNA structural elements within the
transcriptome.
2.4 Discussion
Our analysis of the effects of disease-associated human genetic variation on mRNA
and regulatory non-coding RNAs reveals the extent to which specific SNPs affect the RNA
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structural ensemble. The SNPfold algorithm we propose is unique in that it takes into
account the effects of mutation on the ensemble of possible RNA structures, and not just a
single minimum free energy structure. UTRs are not evolved to adopt a single, well-defined
structure (unlike catalytic RNAs, for example [231]) but will rather adopt a large ensemble
of structures[232]. We find that a majority of mutations have small, local effects on the
structural ensemble (Figure 2.2), while certain specific mutations can profoundly alter it. In
Supplementary Figure 2.S3, we compare the performance of MFE (mFold) algorithms to
the partition function approach we used and show that our approach is far less sensitive to
mutation. We identified those disease-associated mutations in human UTRs that have a
large effect on the RNA structural ensemble and report them here.
We identified a broad range of disease phenotypes that are associated with SNPs that
alter the RNA structural ensemble. For all the disease states presented in Table 2.1, the
mRNA is either hypothesized or has been shown to play a causal role in the association. In
certain cases, assays have already been carried out to show that the SNP causes a change
in translation efficiency [178, 206], and/or mRNA stability [219, 233]. We also identified
the mRNAs in which RIP-chip [228] experiments measured an interaction with an RNA
binding protein (Table 2.1). We find that several RNA binding proteins including ELAVL1
(embryonic lethal, abnormal vision, Drosophila)-like 1), PABPC1 (Polyadenylate-binding
protein 1), and IGFBP2 (insulin-like growth factor binding protein 2) are found to co-IP
with our mRNAs of interest (Table 2.1 and Supplementary Table 2.S1). This suggests that
the SNP induced structural changes could affect protein binding for the mRNAs identified
in Table 2.1. Furthermore, our analysis of pre-mRNAs (Supplementary Table 2.S2) suggests
that the conformational changes induced by SNPs are most significant in the mature mRNA.
Finally, analysis of eQTL (expression Quantitative Trace Locus, supplementary Table 2.S3)
data reveals that for all but two of the common SNPs we identified in our RNA structural
analysis, there is no measured effect on transcriptional levels [234].
To ascertain the relationship between our predicted changes in base-pairing probability
and RNA functional elements we performed additional analyses reported in the supplement
(Figure 2.S4). We find that predicted changes in base-pairing probability overlap significantly
with known RNA functional elements including IREs, IRES (Internal Ribosome Entry Sites),
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uORFs (upstream Open Reading Frames), PAS’s (Polyadenylation Sites), TOPs (Terminal
Oligopyrimidine tracts), MBEs (Musashi Binding Elements), K-Boxes and GY-Boxes. The
IRES is an alternate translation initiation site that allows the ribosome to bind the mRNA
in a 5’ cap independent manner [235]. uORFs are found upstream of the normal ORF
and lower the translation of the main ORF, and in some cases lead to the production of
a short regulatory transcript [236, 237]. A PAS is a variable AU-rich sequence that is
essential for the recruitment of the polyadenylation machinery needed to add the polyA tail
to a given RNA [238]. TOP elements tag the mRNA for growth associated translational
repression [239]. MBEs recruit and bind the Musashi protein, an evolutionarily conserved
RNA-binding protein known to have the ability to regulate mRNA translation [240]. K-Boxes
and GY-Boxes are conserved negative regulators, acting as binding platforms for the 5’ seed
regions of miRNAs [241, 242]. We therefore observe SNP induced changes in base-pairing
probability in a majority of the RNA functional elements in our UTRs of interest. For each
of these elements, accessibility is key to function, and the base-pairing probability changes
we predict affect accessibility.
We performed a complete analysis of the structural changes caused by disease associated
mutations in the 5’ UTR of FTL, because it is already established that an IRE is present in
the UTR and is responsible for regulating FTL [178, 206]. Our structural analysis of the
FTL 5’ UTR (Figure 2.3) begins to reveal the molecular complexity of disease caused by
mRNA structural rearrangement. We see in Figure 2.3 that no single SNP has the exact
same effect on the structural ensemble. Nonetheless, the structural changes observed are
limited in the case of this phenotype to three major structural clusters. Mutations shift the
equilibrium between the different structural clusters. However, all structures sampled when
projected in principal component space fall into these same clusters. A different behavior is
observed in the 5’ UTR of RB1 (retinoblastoma 1), where the two disease-associated SNPs
we identified also significantly repartition the structural ensemble (Figure 2.S1). In this case,
the disease-associated SNPs have the opposite effect to that observed in the FTL 5’ UTR.
For the RB1 5’ UTR, the Retinoblastoma associated SNPs collapse the structural ensemble
from three clusters to one.
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Structural rearrangement of a UTR as a post-transcriptional regulatory mechanism is
common in bacterial Riboswitches [197, 201]. In this case, the binding of a small molecule,
in general a metabolite, changes the secondary structure of the RNA so as to promote or
inhibit Ribosomal binding and gene translation [197]. It is therefore not surprising that
certain specific mutations can have profound structural consequences on a human UTR. The
UTRs and their associated SNPs we report here are in fact a type of âĂĲRiboSNitch,âĂİ
that is a molecular switch that is activated by SNP. Unlike the Riboswitch, however, a
RiboSNitch results in a permanent change in regulation and thus leads to the disease
phenotype. RiboSNitches represent a novel therapeutic target, since small molecules can
repartition the RNA structural ensemble.
The U310A and U336A mutations in the 5’ UTR of CPB2 are particularly noteworthy.
CPB2 codes for the Thrombin-Activable Fibrinolysis Inhibitor (TAFI) [219]. An activated
form of TAFI is known to slow down Fibrinolysis [233]. Mutations that alter the expression
level of this protein are associated with various thrombotic disorders, including ischemic
stroke [243]. Results from mRNA decay assays show the presence of these SNPs result in
an mRNA with an altered stability [219]. Our results suggest that the associated SNPs
significantly alter the RNA conformational ensemble of the TAFI 5’ UTR and that this
could affect RNA decay. Therefore, conformational change is also a likely determinant of
mRNA stability which indirectly controls protein expression.
Low-cost whole genome sequencing, SNP microarrays specifically focused on non-coding
regions of the genome, and greater phenotypic information available through electronic
medical records will necessarily yield new phenotypic associations in the non-coding regions of
the genome. The SNPfold algorithm provides a novel approach to gain structural insight into
the structural consequences of mutations on a transcript. We therefore developed a web server
(http://cloud.wadsworth.org/snpfold) that reproduces the computational functionality
we describe in this manuscript. In particular our web server allows the simultaneous analysis
of multiple SNPs. This computational tool will provide the GWAS community with a
simple way to quantitatively evaluate the effects of SNPs (and other mutations) on the RNA
structural ensemble.
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2.5 Materials and Methods
2.5.1 Identification of a set of disease associated SNPs in UTRs
The Human Genetic Mutations Database (http://www.hgmd.cf.ac.uk/) was utilized
[215, 216] as a primary source of genotype/phenotype associations in our study. The
professional version of the database, obtainable through a yearly subscription fee, contains
the ”prom” table. The 2009.1 version of HGMD that we utilized contains 1459 entries in
the prom table. Each entry contains DNA sequences that flank the disease associated SNP.
These flanking sequences were mapped to the human reference genome, in order to determine
the genomic coordinates of the corresponding SNPs [217]. 1385 mutations from this table
were successfully mapped to some specific coordinate within a specified chromosome.
Once the coordinates of the SNPs in the table were obtained, the ’refgene’ table from
the hg18 build of the Human genome [218] was used to identify SNPs that map on a UTR of
a gene. For a given gene transcript, the corresponding chromosome and strand are provided,
as well as coordinates of the transcription and translation start/stop sites, and the exon
start/stop sites. SNPs whose coordinates map between the transcription start/translation
stop sites or the translation stop/transcription stop sites were classified as mapping onto
a UTR region. SNPs that either mapped onto intronic regions of UTRs (not between an
exon start and stop coordinate) or were less than 10 nucleotides away from either end of the
UTR were excluded from our analysis.
2.5.2 Obtaining Sequences of UTR regions
The gene coordinates in ’refgene’ were used to extract UTR sequences for a given disease
associated UTR SNP in ’prom’. For this, full sequences for each chromosome in the human
reference genome were required. We used UCSC genome build hg18 [217]. If the gene was on
the ’minus’ strand, we used the reverse complement of the extracted sequence, as the human
reference genome consists entirely of sequence from the ’plus’ strand. Using the mapped
coordinates for each UTR SNP, two different UTR sequences were produced: the wild type
sequence, and the sequence containing the disease-associated SNP. It should also be noted
that the UTR sequences produced were from the mature transcripts, and are fully spliced.
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2.5.3 SNPfold Algorithm
The SNPfold algorithm that was developed utilizes the RNA partition function calcula-
tions implemented in RNAfold [244, 245]. The algorithm requires an input of two different
RNA strands that are identical in length. For the analysis of any RNA SNP, the wild type
RNA sequence and the RNA sequence containing the disease associated SNP of interest was
obtained as previously described. The sum of the columns of each partition function was
used to compute the Pearson Correlation coefficient for each WT/SNP pair.
To normalize for sequence length, we computed a non-parametric p-value for a given
correlation coefficient. This value represents the likelihood of a random mutation in the
RNA of interest producing the same or lower correlation coefficient. For a sequence of length
n all possible 3n mutations are computed and the mutation of interest ranked compared
to all the other possible mutations. The non-parametric p-value was then estimated as the
rank of the mutation of interest divided by 3n.
2.5.4 Principal Component Analysis of the structural ensemble
The structures for the Principal Component analysis were generated using the statistical
sampling algorithm in the sFold software [229]. The structures were then parameterized into
a vector of ones and zeros (with one representing the base being paired). A sample of 1000
structures from each mutant and WT sequence was randomly selected and used to generate
the basis vectors of the principle component analysis. The two first basis vectors representing
the variances in the data were used to project the 5000 structures from each sequence onto
the same principle components. The resultant data took the form of a 2D scatterplot. The
linear structure diagrams for the wild type were generated using the VARNA software [48].
2.5.5 Scanning UTRs for RNA regulatory motifs
A search for known RNA regulatory motifs was carried out in every UTR reported
in Table 2.1 and 2.S1. The UTRscan algorithm (which searches a user-submitted RNA
sequence for known UTR motifs listed in the UTRsite database) was utilized [246, 247]. In
76
3’ UTRs, an additional search for miRNA binding sites was conducted using RegRNA which
predicts splicing sites and miRNA binding sites in mRNA sequences [227].
2.5.6 Detection of RBP binding to transcripts of interest
RIP-Chip Data obtained from Scott Tenenbaum (UAlbany) was analyzed in the con-
text of the mRNAs reported in Table 2.1 and 2.S1[228]. The data included analyses of
RNA transcript coprecipitation with three different RNA-binding proteins (Elavl1, Pabpc1,
and Igfbp2) in two different cell lines (Gm12878 and K562). p-values (-log10) above 1.3
were deemed statistically significant for RNA binding, and are reported in Table 2.1 and
Supplementary Table 2.S1.
2.5.7 LD and eQTL analysis of SNPs
We searched dbSNP to identify common variants (SNPs) with accession IDs (rs numbers)
from Table 2.1 and 2.S1. For the mRNAs in which we identified common variants, LD data
from HapMap was downloaded [248] and reported above a significant (R2 > 0.9) threshold.
eQTL data from [249] was queried using the common dbSNP IDs.
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2.6 Supplementary Material
Figure 2.S1: Principal component decomposition of Boltzmann sampling of the RB1 5’ UTR where mutations are
found to be associated with Retinoblastoma [221]. A) Wild-type structural sampling showing four distinct clusters;
representative structures for each cluster are presented as blue arc diagrams. The three upper clusters are most
populated, with 98% of the structures. B) Effects of the disease-associated G17C mutation on the RNA structural
ensemble. The mutation causes a radical shift towards an alternative structure with far fewer long-range interactions.
C) Effects of G18U on the structural ensemble resulting in a complete shift in structures as well.
Figure 2.S2: Average change in base-pair probability due to mutation for the 30 known Hyperferritinaemia Cataract
Syndrome associated SNPs. SNP locations are indicated as vertical green lines, and the average change is plotted in
red. This graph clearly identifies the largest average changes in nucleotides 20-50, which make up an Iron Response
Element in the 5’ UTR of the FTL mRNA.
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Figure 2.S3: Comparison of WT/SNP correlation coefficient distributions for all possible mutations in nine selected
UTRs in which we have identified a putative RiboSNitch (see Table 2.1). The black line is using our novel partition
function calculation, while the red line is using a standard minimum free energy (MFE) approach (like mFold). The
partition function calculation is far less sensitive to mutations and produces a continuously decreasing distribution,
allowing us to accurately estimate the significance of a conformational change and will thus lead to fewer false-positives.
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Disease Gene HGMD
Acc.
UTR UTR
len.
mut. Corr.
Coeff
P-val pmid ref. Motifs1 RBP2
Binding
dbSNP3 ID
Loss of protection
against HIV infection
CCR5 CR084787 5 357 G310A 0.665 0.005 18094161 [250] uORF
MBE
- -
Hirschprung Disease RET CR033995 5 190 G154C 0.617 0.018 14633923 [251] - ELAVL1
PABPC1
-
Change in Detoxifica-
tion ability
GSTM4 CR040571 5 314 C30G 0.406 0.018 15128050 [252] - PABPC1
IGFBP2
rs1010167*
Epith. ovarian cancer,
serous type, prot., as-
soc.
XRCC3 CR057423 5 380 A65G 0.601 0.022 15924337 [253] IRES
uORF
- rs1799794*
Allergy, assoc. with RNASE3 CR067512 3 179 G16C 0.789 0.024 16434694 [254] PAS - rs2233860
Alzheimer disease, as-
sociation with
BDNF CR014434 5 346 C301T 0.851 0.035 11244490 [255] IRES
uORF
ELAVL1
PABPC1
rs56164415
Increased triglyceride
levels, association with
ABCA1 CR025352 5 313 C35G 0.566 0.036 11940086 [256] - ELAVL1
PABPC1
-
Glaucoma, primary
congenital
CYP1B1 CR032431 5 402 C118T 0.675 0.037 12598442 [257] uORF - -
Reduced promoter ac-
tivity, association with
AGRP CR073538 5 300 G79A 0.585 0.052 17180153 [258] - ELAVL1 rs34018897
Myocardial infarction,
assoc. with
THPO CR014438 3 528 G35A 0.867 0.053 11257273 [259] IRES
KBOX
uORF
- rs6141*
Parkinson disease, au-
tosomal recessive
PARK2 CR024270 5 134 G114T 0.504 0.067 11971093 [260] - ELAVL1 -
Hypercholesterolaemia LDLR CR973644 5 168 C23A 0.745 0.083 9259195 [261] uORF - -
Increased LDL choles-
terol, association with
PPARD CR035869 5 309 C223T 0.804 0.085 12615676 [262] uORF ELAVL1 rs2016520*
Cowden’s disease PTEN CR032089 5 1032 G268A 0.867 0.087 12844284 [180] uORF
GYBOX
TOP
- -
Eosinophilic oesophagi-
tis, association with
CCL26 CR066323 3 169 T13G 0.679 0.097 16453027 [263] IRES
PAS
ELAVL1
PABPC1
rs2302009*
Alleviation of zellweger
syndrome
PEX1 CR053503 5 96 C44G 0.818 0.097 16088892 [264] IRES ELAVL1 rs12386703*
.
Table 2.S1: Disease states and phenotypes in which one associated SNP was found to alter the structural ensemble of the RNA.
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Table 2.S2: A) Lengths of pre- and mature mRNAs where we have identified a RiboSNitch. B) SNPFold analysis
of RiboSNitch in pre and mature mRNA UTRs revealing that a majority of the RiboSNitches identified affect the
mature mRNA only. The * indicates an approximate p-value computed from a distribution of random sequences, due
to the computational limitations of calculating the p-value for the longer (> 2000) pre-mRNAs.
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Disease Gene HGMD Acc. # UTR Length SNP 
dbSNP  
Ref. ID eQTL 
Alteration of plasma zymogen 
TAFI concentration CPB2 CR080756 3 
427 
453 
T310A 
T336A rs1087 - 
Chronic obstructive 
pulmonary disease SERPINA1 CR061339 5 
533 
554 
551 
C116T rs8004738 - 
-Thalassemia HBB 
CR900265 
CR880076 
CR961734 
3 
 
5 
132 
 
50 
A111G 
A113G 
C33G 
rs63751128 
rs33985472 
rs34135787 
- 
- 
- 
Hypertension AGT 
CR971935 
CR973338 
 
5 508 
G465A 
A451C 
 
rs5051 
rs5050 
 
- 
Acts in cis w/ AGT, score=5.903 
Change in Detoxification 
ability GSTM4 CR040571 5 314 C30G rs1010167 
Acts in cis w/ GSTM4, score 
=6.0734 
Epith. ovarian cancer, serous 
type, prot., assoc. XRCC3 CR057423 5 380 A65G rs1799794 - 
Allergy, assoc. with RNASE3 CR067512 3 179 G16C rs2233860 - 
Alzheimer disease, 
association with BDNF CR014434 5 346 C301T rs56164415 - 
Reduced promoter activity, 
association with AGRP CR073538 5 300 G79A rs34018897 - 
Myocardial infarction, 
association with THPO CR014438 3 528 G35A rs6141 - 
Increased LDL cholesterol, 
association with PPARD CR035869 5 309 C223T rs2016520 - 
Eosinophilic oesophagitis, 
association with CCL26 CR066323 3 169 T13G rs2302009 - 
Alleviation of zellweger 
syndrome PEX1 CR053503 5 96 C44G rs12386703 - 
Table 2.S3: eQTL data for common variant SNPs identified as potential RiboSNitches. A minority of the SNPs we
identified affect transcriptional levels. The SNP rs5050 is listed to as a cis eQTL according to [249], while the SNP
rs1010167 is listed as a cis eQTL via [234].
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Figure 2.S4: Schematic representations (heat maps) of the change in base-pairing probability upon disease-associated
SNP mutations in their respective UTRs. Red indicates high differences in base-pairing probability between the wild-
type and disease genotype. Motifs detected using the UTRscan program are indicated with green boxes. miRNA
binding targets in 3’ UTRs detected with RegRNA are indicated via blue boxes. Gene names, 5’ or 3’ UTR and UTR
length are indicated under each diagram, and the corresponding SNP is indicated to the left of each heatmap.
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Figure 2.S5: pre-mRNA gene maps of SNPs that are in high LD (R2 > 0.9) with our predicted RiboSNitch SNPs.
Exonic regions are indicated as thick lines, introns as thin horizontal lines. Vertical black lines indicate the postions
of high LD SNPs. SNPs that cause missense mutations in the coding region of the listed gene are colored in pink, and
have an associated rs number listed above their respective positon. A) rs1087 (in CPB2 3’ UTR, 427 nt), B) rs1087
(in CPB 3’ UTR, 453 nt), C) rs8004738 (in SERPINA1 5’ UTR, 533 nt), D) rs8004738 (in SERPINA1 5’ UTR, 551
nt), E) rs8004738 (in SERPINA1 5’ UTR, 551 nt), F ) rs5051 (in AGT 5’ UTR, 508 nt), G) rs5050 (in AGT 5’ UTR,
508 nt), H) rs1010167 (in GSTM4 5’ TR, 314 nt), I) rs1799794 (in XRCC3 5’ UTR, 380 nt), J) rs6141 (in THPO 3’
UTR, 528 nt), K) rs2016520 (in PPARD 5’ UTR, 309 nt), L) rs2302009 (in CCL26 3’ UTR, 169 nt), M) rs12386703
(in PEX1 5’ UTR, 96 nt)
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CHAPTER 3
Structural effect of linkage disequilibrium on the transcriptome1
3.1 Overview
A majority of SNPs (single nucleotide polymorphisms) map to noncoding and intergenic
regions of the genome. Noncoding SNPs are often identified in genome-wide association
studies (GWAS) as strongly associated with human disease. Two such disease-associated
SNPs in the 5’ UTR of the human FTL (Ferritin Light Chain) gene are predicted to alter
the ensemble of structures adopted by the mRNA. High-accuracy single nucleotide resolution
chemical mapping reveals that these SNPs result in substantial changes in the structural
ensemble in agreement with the computational prediction. Furthermore six rescue mutations
are correctly predicted to restore the mRNA to its wild-type ensemble. Our data confirm
that the FTL 5’ UTR is a ”RiboSNitch,” an RNA that changes structure if a particular
disease-associated SNP is present. The structural change observed is analogous to that of a
bacterial Riboswitch in that it likely regulates translation. These data further suggest that
specific pairs of SNPs in high linkage disequilibrium (LD) will form RNA structure-stabilizing
haplotypes (SSHs). We identified 484 SNP pairs that form SSHs in UTRs of the human
genome, and in eight of the 10 SSH-containing transcripts, SNP pairs stabilize RNA protein
binding sites. The ubiquitous nature of SSHs in the transcriptome suggests that certain
haplotypes are conserved to avoid RiboSNitch formation.
1This chapter previously appeared as an article in the RNA Journal. The original citation is as follows:
Martin, J. S.; Halvorsen, M.; Davis-Neulander, L.; Ritz, J.; Gopinath, C.; Beauregard, A. & Laederach, A.
Structural effects of linkage disequilibrium on the transcriptome. RNA, Department of Biology, University of
North Carolina, Chapel Hill, North Carolina 27599, USA., 2012, 18, 77-87
3.2 Introduction
Non-coding but nonetheless transcribed regions of the human genome often play impor-
tant regulatory functions in the cell [124, 139, 198, 265, 266]. In particular, the 5’ and 3’
UTRs (untranslated regions) of genes are central components of the regulatory machinery
[124, 219, 241, 246, 267]. In bacteria, Riboswitches in 5’ UTRs will bind small molecules
(often metabolite precursors) that alter their conformation to regulate protein expression
levels [197, 201, 268–270]. Riboswitches exist because certain RNA sequences will adopt
multiple, near isoenergetic conformations; small molecule binding stabilizes one conformation
over the other [197, 265, 269–271]. Analogously, we expect that specific mutations will
significantly alter the RNA conformational ensemble [124]. If the RNA plays a regulatory
role in the cell, the consequences of these structural changes can be a contributor to human
disease [181, 272].
A RiboSNitch is a functional RNA regulatory element (generally in the 5’ or 3’ UTR of
a gene or a non-coding RNA) where one or more Single Nucleotide Polymorphism (SNPs) or
mutations cause a large conformational rearrangement in the RNA structural ensemble [124].
Of particular interest are RiboSNitches where the SNP or mutation is associated with a
human disease [189, 194, 214, 267, 273, 274]. Using the SNPfold algorithm [124], we predicted
that two SNPs in the 5’ UTR of the human FTL (Ferritin Light Chain) gene associated
with hyperferritinemia cataract syndrome (a rare but dominant hereditary disorder resulting
in early onset cataracts) alter the mRNA structural ensemble [124, 156, 178, 206]. Our
data reveal the ensemble of conformations adopted by mRNA are exquisitely sensitive to
specific mutations despite being described as ”unstructured.” Furthermore, these structural
changes can be rescued with multiple secondary compensating mutations. This raises the
possibility that certain SNPs in high Linkage Disequilibrium (LD) stabilize critical regions
in transcripts. A comprehensive analysis of common human genetic variation reveals that
such ”structure stabilizing haplotypes” are ubiquitous in mRNA and in a majority of cases
stabilize RNA binding protein (RBP) sites.
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3.3 Results
3.3.1 Disease-associated SNPs repartition the RNA conformational ensemble
Certain non-coding RNAs (for example the Ribosome and self splicing introns) have
evolved to fold into unique three-dimensional structures with highly specific function [196,
275–279]. However, many regions in the transcriptome are under selective pressure that
will not necessarily favor a single conformation [124, 198, 265, 266, 280, 281]. Instead
they adopt an ensemble of conformations that cannot be described by a single structure
[117, 203, 204, 282, 283]. This is the case for a majority of human mRNA transcripts,
including the 5’ UTR of the human FTL gene.
To visualize the conformational diversity of the FTL 5’ UTR, we performed Boltzmann
sampling of suboptimal secondary structures and projected these onto a principal component
decomposition of the ensemble [229, 230]. Unlike traditional minimum free energy methods
for predicting RNA structure (e.g. mFold), Boltzmann sampling allows us to visualize
the conformational ensemble of an mRNA [124]. Each dot in Figure 3.1A represents one
suboptimal RNA structure, and the distance between them is correlated to the difference in
structure. What is apparent from Figure 3.1 is that the human FTL 5’ UTR is predicted to
adopt three major conformations. The WT sequence (Figure 3.1A) adopts primarily one
conformation (Red), while two disease-associated mutations (U22G and A56U, Figures 3.1B
and 3.1C, respectively) favor the alternative blue and green conformations. The FTL 5’ UTR
includes an Iron Response Element (IRE) which is indicated in light purple (Figure 3.1A).
Only for the wild-type (WT) sequence does a majority of structures adopt a conformation
where the IRE is in the correct hairpin conformation. These calculations suggest a putative
mechanism for the disease association. The Iron Responsive Element-Binding Protein
(IREBP) binds to the IRE and represses translation [178]. When the disease-associated SNP
shifts the equilibrium away from the WT conformation (Figure 3.1A), FTL translation is
enhanced leading to the hyperferritinemia phenotype [206].
A particularly important feature of computing RNA ensembles such as those illustrated
in Figure 3.1 is that they also predict the probability of base pairing for each nucleotide
[117, 203, 204]. The frequency of formation for a base pair in the ensemble is proportional
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Figure 3.1: A principal compenent decomposition of Boltzman sampled suboptimal structures for wildtype and
Hyperferritinemia Cataract syndrome mutant FTL 5’ UTRs. A) Projection of 10,000 Boltzman sampled suboptimal
structures of the human FTL 5’ UTR onto a principal component decomposition of the structural space [229]. The
projection allows us to visualize the conformational ensemble of the non-coding RNA. We identify three distinct
conformations illustrated by the representative secondary structures (blue, green and red conformations). The FTL 5’
UTR includes an IRE (Iron Responsive Element, shaded in light purple), which is a regulatory motif known to repress
translation when bound by the Iron Responsive Element Binding Protein (IREBP) [156]. In the two alternative
conformations (blue and green), the IRE does not adopt a functional hairpin conformation. BandC) visualizations of
the structural ensemble for the U22G and A56U single nucleotide polymorphism-containing FTL 5’ UTRs, respectively,
identified in patients suffering from hyperferritinemia cataract syndrome [156, 176, 177, 206]. Both SNPs repartition
the ensemble favoring the blue and green conformations. We propose that the FTL 5’ UTR is a RiboSNitch, which
much like a bacterial Riboswitch [201, 284, 285] undergoes an important structural rearrangement that controls
translation. On the secondary structure diagrams the two hyperferritinemia cataract syndrome SNPs (U22G and
A56U) are indicated with arrows while SNPfold predicted structure-stabilizing mutations for U22G are indicated in
purple.
to the probability of that base pair [229, 230]. Figure 3.2A schematically represents the
FTL 5’ UTR, and Figure 3.2B is a heatmap of the predicted difference between the WT
and U22G base-pair probabilities. We immediately observe another important aspect of
this system. Even though the disease-associated mutation is not in the IRE, the largest
predicted changes in base-pair probability are within the functional element.
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Figure 3.2: Results of SHAPE experiments conducted on FTL 5’ UTR sequence variants. A) Schematic of the human
FTL 5’ UTR and Exon 1, the IRE is indicated in green. B) SNPfold prediction of the changes in the probability of a
base being paired caused by the U22G hyperferritinemia associated SNP [156, 176, 177, 206] as a heatmap, with red
indicating the disease-allele results in higher base-pair probability and blue indicating a lower probability. C) Raw
capillary traces of SHAPE (Selective 2’-Hydroxyl Acylation and Primer Extension) analysis of the WT (black), U22G
(cyan, disease-associated) and G4A (purple, not disease-associated) FTL 5’ UTRs. D) Quantification, averaging and
scaling of multiple repeats for WT (black) and U22G (cyan) SHAPE data. The thickness of the line indicates one
standard deviation over six repeats of the experiment. The heatmap below the data is orthologous to the predictions
made in B) since changes in SHAPE reactivity correlate with changes in base-pair probability [286–288]. E) Scaled and
averaged repeats for G4A construct indicating the control mutation has no effect on base-pair probability as predicted.
These experiments validate the SNPfold prediction and indicate that the FTL 5’ UTR is indeed a RiboSNitch.
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3.3.2 Structure Mapping confirms the presence of a RiboSNitch in the FTL 5’
UTR
Changes in base-pair probability are experimentally assayed using chemical structure
mapping probing [144, 232]. We transcribed the human FTL 5’ UTR and performed Selective
2’-hydroxyl acylation analyzed by primer extension (SHAPE) chemical mapping experiments
[271, 286, 289]. These experiments probe RNA structure with single nucleotide resolution and
report the flexibility of the backbone, which is directly correlated with base-pair probability
[142]. Figure 3.2C illustrates raw capillary (+) SHAPE traces for the WT, U22G, and a
control G4A mutation (which is not predicted to affect the RNA structural ensemble, and is
also not disease-associated). From these raw traces alone, we visually discern the effect of the
U22G mutation on the structure of the FTL 5’ UTR. As predicted by Boltzmann sampling,
the IRE nucleotides (C33-A49) have higher SHAPE reactivity for the U22G construct,
indicative of a significant decrease in base-pairing. The full extent of the disease-associated
SNP’s effect on the RNA ensemble is observed when the peak areas are integrated, scaled
and averaged over multiple repeats (Figure 3.2D) [144]. Analogous experiments on the
A56U construct reveal a similar effect, consistent with the ensemble calculation prediction
(Supplementary Figure 3.S1). Furthermore the control SNP G4A has only minimal effect on
the RNA structure, as predicted (Figure 3.2E).
3.3.3 RiboSNitch rescue through double mutation
To further validate our ensemble model for the FTL 5’ UTR (Figure 3.1) we performed
a comprehensive SNPfold analysis to identify secondary mutations that restore the ensemble
to wild type partitioning. These mutations are reported in Supplementary Table 1. We
experimentally validated the top three mutations for both constructs. The SHAPE data
for the U22G-G17C double mutant shows that this mutation restores IRE structure to
WT (Figure 3.3A). This prediction is particularly interesting as it does not simply restore
the U22-A58 base-pair (Figure 3.1, red conformation) through isosteric replacement of a
canonical Watson-Crick pair [290]. Instead it further destabilizes the first stem in the blue
and green conformations favoring the wild-type structure.
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Figure 3.3: SHAPE analyses of compensatory mutations in the mutated FTL 5’ UTR selected to restore structure.
A) SHAPE chemical mapping data scaled and averaged over 6 repeats for the WT (black), U22G (Cyan) and U22G-
G17C (green) FTL 5’ UTRs. The heatmap below the data shows that the U22G-G17C haplotype restores base-pair
probability to near WT conformation, as predicted by SNPfold. B) SHAPE data heatmaps indicating experimentally
determined SNP induced changes in probability of a base being paired for hyperferritinemia (U22G and A56U) and
non-diseased genotypes. We made orthologous predictions using SNPfold and report the True Positive, False Positive,
and True Negative, and False Negative (TP, FP, TN and FN, respectively) rates when comparing SNPfold predictions
to SHAPE chemical data. C) Receiver Operator Curve (ROC) analysis of the SNPfold algorithm for predicting
changes in IRE base-pairing probability (solid line, AUC = 0.86) and identifying RiboSNitches (dashed line, AUC =
0.97), and using traditional minimum free energy (e.g. mFold) calculations (long dashes, AUC = 0.62). ROC analysis
includes SHAPE data collected on the additional 10 FTL 5’ UTR mutants reported in Supplementary Figure 3.1C.
We systematically collected SHAPE data on the WT, single and double mutants predicted
to affect the IRE structure to evaluate the performance of the SNPfold algorithm. Figure
3.3B illustrates a subset of these data (the additional data are summarized in Supplementary
Figure 3.1C). The SHAPE data were used to calculate the True positive, False positive, True
negative, and False negative rates of our SNPfold predictions for each base. We compared
traditional minimum free energy predictions to our SNPfold algorithm using a Receiver
Operator Curve (ROC) analysis [291]. The SNPfold algorithm preforms better with an
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area under the curve of 0.86 (long dashes, Figure 3.3C) compared to that of the minimum
free energy predictions (long dashes, Figure 3.3C) with an area under the curve of 0.62.
Furthermore, we evaluated SNPfold for identifying SNPs that cause a SHAPE reactivity
change in more than 8 nucleotides in the IRE of FTL. The performance of SNPfold for
RiboSNitch detection is high (Figure 3.3C, short dashes, area under the curve 0.97).
3.3.4 Structure Stabilizing Haplotypes
Our results on the FTL 5’ UTR reveal that specific SNPs can have profound effects
on the structural ensemble of non-coding regions of RNA and that the SNPfold algorithm
accurately predicts these (Figure 3.3C). It is important to realize that a majority of SNPs
have little or no effect on the ensemble partitioning of RNA. An analysis of all possible FTL
5’ UTR mutations previously showed that the U22G and A56U SNPs are in the top 5% in
terms of their predicted structural effect [124]. Our experimental results predict that an
individual with the U22G-G17C (Figure 3.3A) haplotype will not have the hyperferritinemia
phenotype since this double mutation stabilizes the IRE in the FTL 5’ UTR. The U22G
and A56U mutations are extremely rare, as is hyperferritinemia cataract syndrome. We
performed a comprehensive search of HapMap haplotypes and did not find any individuals
with the U22G or A56U SNPs [182, 234].
We nonetheless expect to find pairs of SNPs in high linkage disequilibrium (LD) that
stabilize mRNA structure. We call these pairs of SNPs ”structure stabilizing haplotypes”, or
SSHs. Our experimental results demonstrate that the SNPfold algorithm is highly predictive
of SSHs (area under the curve 0.97, Figure 3.3C), having correctly identified six pairs in
the FTL 5’ UTR. We comprehensively analyzed LD SNP pairs in the human genome that
map to 5’ and 3’ UTRs to identify potential SSHs. A complete list of the 484 SSH pairs
we identified in human UTRs are provided in the supplement (Supplementary Table 2). In
Table 1, we report UTRs where more than four SSH pairs were found. These are particularly
noteworthy, since observing multiple SSH pairs in the same UTR is unlikely by chance (< 1
in 100,000).
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Gene Name Full Name UTR SSHs Representative
SSH SNP Pairs
LOD
Score
Function RBP
Sites
RPA1
(NM 002945)
replication protein
A1
3 12 C380G/G417A
G417A/ T463C
17.89
17.47
Bind ssDNA during replication [292]. IGF2BP
HLA-DOA
(NM 002119)
HLA class II histo-
compatibility antigen
3 12 G534A/C214A 25.74
6.85
Member of MHC class II, highly con-
served [293]
AGO
PUM2
TNRC6
KIAA1609
(NM 020947)
TLD domain-
containing protein
KIAA1609
3 6 C2194G/C2131T
A2259G/T2034G
25.77
2.7
An orthologue for the EAK-7 protein
in C. Elegans, which controls Develop-
ment by inhibiting DAF-16/FoxO activ-
ity [294]
IGF2BP
miR124
L3MBTL4
(NM 173464)
Lethal (3) malignant
brain tumor-like pro-
tein 4A
3 5 T665C/A74G
T665C/C103T
26.23
26.23
Chromatin formatter, deregualtion as-
sociated with breast cancer [295]
IGF2BP
ADAMTS14
(NM 139155)
Disintegrin and met-
alloproteinase with
thrombospondin mo-
tifs 14
3 5 C700G/A1580G
G546A/G1185A
16.34
3.4
An amino-procollagen peptidase, muta-
tions associated with Multiple Sclorosis
[296, 297].
-
EP400
(NM 015409)
E1A binding protein
p400
3 5 T73C/C193T
G57A/C193T
4.28
4.28
Destabilizes Nucleosomes during Dou-
ble Strand breaks as part of repair [298]
IGF2BP
PUM2
B3GALTL
(NM 194318)
β-1,3-glucosyl
transferase-like
3 4 A1801G/G1836A
G1836A/G2082T
21.99
18.42
Post-translational modification protein
[299]
IGF2BP
PUM2
SPTBN1
(NM 178313)
Spectrin β-chain,
brain 1
3 4 T1310C/G1913A
G852A/T1926C
23.13
11.21
Interacts with calmodulin in a calcium-
dependent manner [300].
IGF2BP
APOL4
(NM 030643)
Apolipoprotein L4 5 4 C327T/C323A
C323A/A250G
12.38
11.43
Involved in Lipid metaobolism. Only
present in primates [301].
-
QDPR
(NM 000320)
quinoid dihydropteri-
dine reductase
3 4 C510T/A468C
C408T/A403G
21.66
5.58
Regenerates tetrahydro-biopterin
(needed for phenylalanine. metabolism).
Mutations associated with tetrahydro-
biopterin deficiency [302]
IGF2BP
Table 3.1: Structure stabilizing haplotypes in the human genome where more than four SNP pairs stabilize RNA structure. PAR-CLIP sites stabilized by the haplotype are
indicated in the RBP Sites column.
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Figure 3.4A illustrates the subset of LD SNP pairs that are predicted structure-stabilizing
haplotypes in the 3’ UTR of RPA1 [292] (Replication Protein A1). In Figure 3.4B we plot
the mean change in base-pair probability caused by all individual SNPs in the haplotype.
This allows us to visualize the regions in the RNA that are stabilized by the SSH and we
observe that these coincide with experimentally determined IGF2BP binding sites [303, 304].
We performed a similar analysis on the SSHs reported in Table 1, and find that in eight of
the 10 UTRs, the predicted regions of the UTR that are stabilized coincide with RBP or
miRNA binding sites determined by Photoactivatable-Ribonucleoside-Enhanced Crosslinking
and Immunoprecipitation (PAR-CLIP [303, 304]).
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Figure 3.4: Structure stabilizing haplotype identified in the 3’ UTR of the RPA1 (replication protein A1) using
SNPfold analysis. A) Schematic representation of RPA1 3’ UTR including the coding sequence (CDS) and all currently
known LD SNPs in the region, indicated as an inverted triangle. The LOD scores of the SNPs are indicated in variable
shades of gray and the subset of SNP pairs that stabilize structure are indicated in blue. B) Mean change in base-
pair probability based on a SNPfold analysis of the effects of individual SNPs that together stabilize structure. Red
translucent bars indicate experimentally determined IGF2BP (Insulin-like growth factor binding protein) binding sites
[303, 305] on the 3’ UTR using the PAR-CLIP approach. The structure stabilizing haplotype (indicated with a series
of blue triangles) stabilizes a majority of IGF2BP binding sites, suggesting an important structural role for this region
in the RPA1 3’ UTR. We report in Table 1 an additional 10 structure stabilizing haplotypes, 8 of which stabilize
known RNA binding protein sites.
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3.4 Discussion
The SHAPE data we collected validate the presence of a disease-associated RiboSNitch
in the FTL 5’ UTR as computationally predicted by SNPfold. Our results illustrate the
extent to which specific disease-associated SNPs can impact mRNA transcript ensemble
partitioning. The two hyperferritinemia-associated SNPs (U22G and A56U) cause similar
large rearrangements in the ensemble partitioning of the RNA. The rearrangements favor
alternative conformations where the IRE does not adopt a hairpin conformation, a pre-
requisite for IREBP binding [306]. We find that the performance of the SNPfold algorithm is
better than traditional minimum free energy approaches at identifying SNPs that alter mRNA
structure (Figure 3.3C) most likely because it takes into account the structural heterogeneity
of the transcript[117, 203]. Most importantly, our results indicate that transcripts, which are
generally thought of as ”unstructured,” are nonetheless highly sensitive to specific mutations.
The SNP induced structural change in the FTL 5’ UTR is analogous in magnitude to
that observed upon ligand binding in bacterial Riboswitches [201]. Furthermore, the effects
on FTL protein expression are likely posttranscriptional, explaining the hyperferritinemia
phenotype. Indeed, IREBP binding represses translation, such that if the IRE is indirectly
disrupted by SNP induced ensemble repartitioning, excess protein will be translated. More
importantly, secondary compensating mutations exist that restore WT partitioning, and
the SNPfold algorithm correctly predicted six of them for both diseased alleles (Figure
3.3B). Interestingly, these compensating mutations are not necessarily standard isosteric
replacements of canonical base-pairs (e.g. U22G-A58C), but also include more complex
structural mechanisms (e.g. U22G-G17C, Figure 3.3A).
These results suggest that certain SNP pairs are conserved in the human population
because they stabilize specific ensembles of conformations in mRNAs. Of particular interest
are genes where multiple SNP pairs stabilize structure (Table 3.1, Figure 3.4). Combined
with PAR-CLIP data that identify transcriptome wide RBP binding sites, an intriguing
interplay between population genetics, RBP binding and mRNA structure is revealed. We
have thus far found eight transcript UTRs where multiple SSHs stabilize RBP and/or miRNA
binding sites (Table 3.1). This likely represents only a subset of the genes where SNPs
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stabilize RNA structure, since we have limited human genetic variation data and PAR-CLIP
data for four RBPs and one miRNA. Furthermore, to maintain computational tractability,
we analyzed only SNP pairs in LD that map to the same UTR.
To identify pairs of SNPs in high linkage that stabilize RNA structure (i.e. structure
stabilizing haplotypes) we defined a new metric, the Structure Recovery Ratio (SRR,
Equation 1 below). Conceptually, the SRR measures the extent to which a pair of SNPs
restores structure relative to the SNP that has the largest effect on that structure. Because
it is a ratio, the numerical value of the SRR is not dependent on length of the RNA. We
show this empirically in Supplementary Figure 3.S2A, where there is no correlation between
the SRR and length. We empirically chose an SRR cutoff value of two based on an analysis
of the number of SSHs as a function of this threshold (Supplementary Figure 3.S2B). The
mRNAs we identify in Table 3.1 are particularly interesting as four or more SSHs were
found in either the 5’ or 3’ UTRs. We therefore expect that RNA structure likely plays an
important regulatory role in these gene’s regulation.
Co-variation is common in large structured RNAs such as the Ribozyme, tRNAs, and
even bacterial Riboswitches [307–310]. In fact, co-variation models are often used to identify
structured RNAs in genomic data [139]. Traditionally, programs such as CMfinder [140, 185]
or FOLDALIGN [311] are used to predict structure. These techniques require significant
co-variation, however, to constrain a structure and make an accurate prediction. Linkage
data does not provide sufficient information to determine a structure in this way, which is why
we chose to combine our structural predictions with PAR-CLIP data (Figure 3.4) to make
biological predictions. Our data suggest that certain haplotypes in the human population are
conserved because they stabilize specific ensemble partitioning of functional mRNA regions.
We conclude that RiboSNitches are likely ubiquitous in the human genome, and that specific
haplotypes are conserved because they preserve mRNA ensemble partitioning. We expect
that structure-stabilizing haplotypes in mRNA play an important regulatory role, and that
our strategy of combining common genetic variation data with SNPfold analysis and PAR-
CLIP data can pinpoint important new regulatory regions in the transcriptome. It is also
likely that SNP induced structure change affects mRNA stability. As more eQTL (expression
Quantitative Trait Loci) data become available, it will be possible to correlate structural
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change and mRNA stability, greatly expanding our understanding of post-transcriptional
regulatory mechanisms [312].
3.5 Methods
3.5.1 Computational Methods
The SNPfold algorithm was used to predict how RNA structure is modified by single
nucleotide polymorphisms (SNPs) [124]. The FTL SNPs were originally selected for their
disease association. Secondary correcting mutations were predicted by identifying the SNP
pair containing the primary mutant that resulted in the highest correlation coefficient to the
WT base-pair probability plot as computed by the partition function [117, 313]. The control
SNPs were selected because SNPfold calculations showed they had the highest Pearson
correlation coefficient (CC) in relation to the WT base-pairing. Rescue SNPs were identified
by using SNPfold to calculate the CCs of the disease associated SNP and a secondary SNP
pair to the WT base-pairing and selecting those pairs with the highest CC.
From the hg18 genome assemble and hg18 âĂŸrefgene’ datafile, as downloaded from the
UCSC dbSNP, 44,186 SNPs were identified. These SNPs satisfied the conditions that they
were located in the untranslated region of genes and mapped to fully assembled chromosomes.
Of these SNPs, 15,491 are located on the same spliced UTR and have R2 values greater than
0.8. The R2 values were extracted from Linkage Disequilibrium (LD) flatfiles (available at
the Hapmap webpage, http://hapmap.ncbi.nlm.nih.gov/downloads/ld_data/2009-04_
rel27/) corresponding to the CEU population of Hapmap (release #27, Phase II and III).
The Structure Recovery Ratio (SRR) is defined as:
SRR = 1− CCmin1− CCboth
where CCboth is the correlation coefficient of the pairing probability of the RNA with both
SNPs present and CCmin is the correlation coefficient of the pairing probability to WT for
the SNP in LD that has the largest effect on RNA structure (smallest CC). In both cases
the correlation coefficients are computed with respect to the pairing probability of WT.
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3.5.2 Principal Component analysis
Principal components were calculated (as described previously [124]) from a total of
10000 Boltzmann sampled structures generated equally from the five sequences: WT, C10U,
C14G, U22G and A56U. The projection of the binary representation of these 10000 structures
onto the first two principal components revealed three distinct clusters as identified by the
k-means clustering algorithm. The centroid structure of each cluster was drawn using R2R.
For a given SNP of interest, we project 10000 structures, generated just from that sequence,
onto the first two principal components with the projections colored according to which
cluster they belong to.
3.5.3 SHAPE experiments
The WT FTL 5’ UTR sequence
(GCAGTTCGGCGGTCCCGCGGGTCTGTCTCTTGCTTCAACAGTGTTTG
GACGGAACAGATCCGGGGACTCTCTTCCAGCCTCCGACCGCCCTCCG
ATTTCCTCTCCGCTTGCAACCTCCGGGACCATCTTCTCGGCCATCTCC
TGCTTCTGGGACCTGCCAGCACCGTTTTTGTGGTTAGCTCCTTCTTGC
CAACC)
was inserted between the SgfI and MluI sites of the pCMV6-AC non-tagged precision shuttle
vector (Origene). The modified plasmid was transformed into E. coli DH5α electro-competent
cells and grown up over night at 37řC. The resulting plasmids were extracted using the
Qiagen Miniprep Kit. A T7 promoter (TAATACGACTCACTATAGG) was introduced to
the 5’ end of the FTL 5’ UTR during PCR amplification. Overlap PCR was used to create
mutants by introducing a point mutation on oligonucleotides used during the first round of
amplification with a second round of amplification used to join the PCR fragments. The
resulting PCR product was transcribed into RNA using MegaScript followed by MegaClear
according to Ambion’s protocol.
Selective 2’-Hydroxyl Acylation and Primer Extension (SHAPE) experiments were
performed in the following way: A total of 10 pmol RNA was suspended in 12 µl of 0.5X
TE buffer and then heated to 95řC for 2 min. Immediately after, the mixture was placed on
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ice for 2 minutes. With gentle pipetting, 6 µl of folding mix was added (3.3X folding mix;
333 mM HEPES, pH 8.0, 20 mM MgCl2, 333mM NaCl) to the mixture and then incubated
at 37řC for 20 min. Following incubation, the mixture was split equally to obtain a negative
control. The negative control was treated with 1 µl of dimethyl sulfoxide (DMSO) while the
experimental mixture was treated with 1 µl of DMSO containing 65mM N-methylisatoic
anhydride (NMIA). Both mixtures were incubated for 45 min. at 37řC, or roughly five
half-lives of NMIA hydrolysis. RNA incubated at -80řC for 30 min. following the addition
of: 90 µl of water, 4 µl of 5 M NaCl, 4 µl of 5 mg/ml glycogen, 2 µl of 100 mM EDTA pH
8.0, and 350 µl of 100% ethanol. RNA was precipitated by centrifugation at 14,000 rpm at
4řC for 30 min. The RNA was rinsed with 70% ethanol after the removal of the supernatant.
After being spun down and dried by speed-vac for 10 min., the RNA was suspended in 10 µl
of 0.5X TE. The resulting mixtures had 1 µl of 5 µM of Cy5-labeled primer solution added
and mixed by pipetting. The primers were annealed to the RNA by incubation at 65řC
for 5 min then 35řC for 5 min and finally placed on ice for 1 min. The solutions with the
annealed primers had 7 µl of the reverse transcriptase buffer mix which contained: 250 mM
KCl, 167 mM Tris-HCl, pH 8.3, 1.67 mM each dNTP, 17 mM DTT, 10 mM MgCl2 and 40
U of Invitrogen’s RNaseOUT. The reverse transcriptase buffer mix was also added to the
sequencing ladder reactions and for the reactions lacking NMIA, 1âĂŞ2 µl of one ddNTP
(5mM) was also added. The samples were heated at 52řC for 11 mins with 1 µl of Superscript
III (Invitrogen) added after the first minute and mixed by pipetting. The resulting cDNA
was cleaned up with the addition of 2 µl of 2 M NaOH and incubated at 95řC for 5 min.
Following the incubation, the samples were treated with a solution containing: 2 µl of 2
M HCl, 3 µl of 3M Na-acetate, 1 µl of 100 mM MgCl2 and 90 µl of 100% ethanol. The
mixture was then centrifuged at 14,000 rpm at 4řC for 30 min. and rinsed with 70% ethanol.
The resulting cDNA pellets were dried, suspended in 40 µl of Sample Loading Solution
(Beckman) and subjected to capillary electrophoresis on a Beckman CEQ 8000.
Taking advantage of the data independent Beckman ladders and using custom writ-
ten Matlab software (available at http://ribosnitch.bio.unc.edu/The_Laederach_Lab/
Software.html), the data from the CEQ was aligned. The ShapeFinder [314] software
package was used to analyze the aligned SHAPE data. The reproducibility was determined
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by calculating the product of the mean SHAPE value for each nucleotide and multiplying
it by the square root of the number of sets used divided by the standard deviation of that
nucleotide. Our data was normalized using outlier analysis as previously reported resulting
in the majority of the reactivities being between 0 and 1.5. SHAPE experiments were carried
out under standard RNA folding conditions (10 mM MgCl2 and 100 mM KCl) as described
in separate publications on the technique [271]. CAFA analysis of the SHAPE capillary
traces was performed with CAFA and Shapefinder as previously described [144, 314]. The
SHAPE data were normalized using standard outlier analysis [314]. Receiver operator curve
analysis is based on threshholding the SHAPE data [291], a Welch’s t-test was used to
determine significance over a minimum of 3 repeats per experiment. Raw SHAPE data
was made available using the SNRNASM standard [143] and the data are available at
http://snrnasm.bio.unc.edu.
3.5.4 Heatmap graphs
With the exception of the G4A mutant having only three data sets, a minimum of
four data sets per mutant were used to preform statistical tests. The Shapiro-Wilkes test
comparing the dataset to the normal distribution with the same mean and standard deviation
was performed individually for each position to confirm the appropriateness of using a Welch’s
t-test. The Welch’s t-test for mean difference was performed at each nucleotide with the
null hypothesis being that that the mutant and WT datasets were equal. The degree of
mean difference for positions with p-values less than 0.001 are color-coded red when the
mutant has the higher value and blue when the WT has a higher value with the depth of
the color indicating the degree of difference in 0.15 steps and a maximum value of 0.6. Even
in our most extreme cases, less than 8% of the positions were non-normal with a p-value
less then 0.05. All statistical tests were performed using version 2.8.1 of R (R development
Core Team).
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Supplementary Figure 1
Figure 3.S1: SHAPE analyses of multiple mutations and sequence variants in the FTL 5’ UTR. A) Heatmap
illustrating the SNPfold predicted changes in base-pairing probability for the A56U hyperferritinemia associated SNP.
Blue indicates a decrease in base-pairing probability relative to WT, red indicates an increase. B) SHAPE chemical
mapping data for WT (black) and A56U (green) FTL 5’ UTR indicating a SNP induced conformational rearrangement.
C) Heatmaps of SHAPE data for additional FTL 5’ UTRs compared to WT data. TP, FP, FN and TN rates when
the SHAPE data are compared to SNPfold predictions are reported for these data. The data presented here were
combined with the data in Figure 3.3B for the ROC analysis reported on Figure 3.3C.
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Correcting Mutation Correlation Coefficient
A58C 1
G17C 0.914
A58U 0.875
G19U 0.845
G32C 0.831
G32U 0.828
G52U 0.828
C29G 0.824
G52C 0.821
U30G 0.814
G63C 0.802
U34G 0.799
C27G 0.788
U31A 0.784
C33A 0.783
U59C 0.783
U34C 0.783
U13C 0.781
G20C 0.779
C145U 0.777
Table 3.S1: SNPfold predicted secondary mutations to correct the U22G hyperferritinemia associated SNP. We
experimentally validated the top three correcting mutations listed (A58C,G17C and A58U).
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Correcting Mutation Correlation Coefficient
U24A 0.999
G63C 0.94
U59C 0.934
G17C 0.928
G32C 0.911
G52A 0.901
G63U 0.899
G48U 0.897
U30G 0.897
G48C 0.895
C15A 0.891
U35C 0.888
G52U 0.886
G17U 0.882
C15G 0.881
C15U 0.878
G48A 0.875
G51U 0.871
G32U 0.87
C16A 0.866
Table 3.S2: SNPfold predicted secondary mutations to correct the A56U hyperferritinemia associated SNP. We
experimentally validated the top three correcting mutations listed (U24A,G63C and U59C).
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Figure 3.S2: The distribution and thresholding of structure recovery ratios in order to call structure stabilizing
haplotypes. A) Scatter plot the Structure Recovery Ratio (SRR) as a function of the mRNA length. There is no
correlation between the two with SRRs distributed across all measured lengths. The green shaded area shows all
points with an SRR above 2. The threshold of 2 represents a doubling of the CC difference between the lowest SNP
of a pair and the SNP pair. B) The plot of the number of SSHs as a function of the SRR threshold used. The number
of SSHs follows a power law as shown.
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Table 3.S3: Structure-stabilizing haplotypes in human genome from with a structure recovery ratio greater than 2.
The LOD scores as determined by the HapMap project.
Chr RefSeq ID UTR UTR
len.
dbSNP
ID 1
SNP
1
dbSNP
ID 2
SNP
2
SSR LOD
Score
11 NM 003139 3 977 rs1049666 T235C rs1049665 A179G 32567.1115.91
18 NM 015285 3 2598 rs3745033 C14T rs1657396 T1969C 637.51 2.19
8 NM 001026213 3 2016 rs7003319 A1042G rs5017238 C1020T 109.97 27.09
3 NM 152785 3 2614 rs1492490 T1179C rs1492488 A956G 81 5.83
11 NM 006597 5 78 rs1136141 C68T rs2276077 G28A 43.97 0.12
22 NM 152868 3 467 rs2269608 G279A rs196058 C278T 40.6 0.1
1 NM 181644 3 2457 rs3818970 T384C rs4951014 A2204G 35.21 6.54
5 NM 012188 3 1114 rs6555887 G440A rs6555888 A535G 32.29 6.94
6 NM 001004349 5 415 rs9391806 C24T rs2516711 A26G 32.16 0.2
11 NM 023930 3 878 rs7931417 A510G rs7942125 G500A 32.03 12.77
10 NM 018324 3 623 rs11259458 T472C rs4748140 C491G 31.49 2.19
14 NM 153648 3 2624 rs4900131 C176T rs12888354 G200A 31.06 3.49
12 NM 015409 3 2787 rs12309945 G1036A rs7484529 G1153A 27.88 1.61
1 NM 000299 3 2948 rs1105331 A683G rs17425876 G1884A 22.64 1.19
14 NM 020553 3 1541 rs12587724 C416T rs17757618 T580C 22.55 3.3
7 NM 001100600 3 1407 rs372454 A852G rs10951714 A150G 20.19 4.51
16 NM 001100873 3 574 rs12927239 C188T rs9926366 C147T 20.08 0.38
10 NM 001083913 3 2933 rs284856 A1241T rs14849 C2764T 18.16 0
16 NM 170776 3 917 rs1141417 A866G rs1141418 T876C 17.23 18.49
13 NM 194318 3 2606 rs876540 A1644T rs912603 G1836A 14.31 0.65
6 NM 014068 5 274 rs3131003 G76A rs3094197 A79G 13.78 5.16
22 NM 173793 3 893 rs712979 T750C rs756649 A392G 13.55 16.69
6 NM 002119 3 2655 rs3130602 G2408A rs376892 C1728T 13.45 1.54
15 NM 001128628 3 1393 rs2242120 A390T rs2242119 C528A 13.14 0.37
X NM 014235 3 1822 rs7051615 C711T rs7057286 G91A 13.04 15.02
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1 NM 001103169 3 2763 rs3010886 C400T rs3010887 A454G 12.9 24.53
2 NM 176825 3 1451 rs3731680 A300G rs11689841 G652A 12.84 0.77
17 NM 002945 3 2379 rs3744766 C480G rs1131636 C720T 12.84 9.21
7 NM 032350 3 619 rs8591 C462T rs8145 C410T 12.71 1.91
2 NM 016510 3 1058 rs1054640 A810G rs3816347 A1001G 12.41 0.23
17 NM 002945 3 2379 rs12727 G596C rs17734 C675T 12.21 7.11
1 NM 004481 3 2742 rs16851328 G926A rs3088075 T2190C 11.88 0.16
10 NM 139155 3 1586 rs16927931 G129A rs3740434 A1580G 11.82 2.87
2 NM 178313 3 2222 rs2971877 G1913A rs10528 T1926C 11.52 1.02
5 NM 001447 3 1473 rs165345 G1069A rs165344 T1037C 11.13 17.9
10 NM 139155 3 1586 rs3740438 C1042T rs3740437 G1185A 10.76 1.21
16 NM 002386 5 1380 rs3212357 T318C rs3212363 A1155T 10.3 15.35
9 NM 018201 3 2553 rs7862546 C25G rs3829901 C2057T 10.08 0.01
22 NM 016426 3 2219 rs6008729 C1401G rs9615348 C1962G 9.94 14.91
18 NM 173464 3 1514 rs3745091 A1136G rs1940622 C1038T 9.93 0.22
7 NM 001039966 3 959 rs3808353 G480A rs3808354 G679T 9.84 0.84
7 NM 133463 3 2557 rs4719644 G1749A rs4719645 A1859G 9.76 15.7
1 NM 017761 3 1564 rs3211051 A37G rs3211053 T109C 9.47 17.87
4 NM 153365 3 2803 rs13634 A1722G rs9946 A1710G 9.45 1.42
22 NM 173793 3 893 rs9606020 G739A rs756649 A392G 9.09 0.3
4 NM 207405 3 2257 rs3733190 C750T rs6828777 A734C 9.03 0.62
12 NM 015409 3 2787 rs12317704 T73C rs7484529 G1153A 8.9 1.84
21 NM 003343 3 2337 rs235355 G1454T rs1060564 T118C 8.89 0.54
22 NM 030643 5 423 rs132736 A250G rs6000181 T227A 8.78 4.14
1 NM 020710 3 868 rs8379 T762G rs17411356 T617C 8.42 3.14
16 NM 004204 3 1073 rs710924 T318C rs710925 G319A 8.39 28.51
7 NM 001080529 3 1789 rs4722959 A60T rs10231810 C924T 8.38 23.46
17 NM 002945 3 2379 rs12727 G596C rs1131636 C720T 8.22 7.11
13 NM 145061 3 1555 rs11620227 T653C rs12872592 T534C 8 0.17
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15 NM 207444 3 1493 rs1495186 G710A rs12916379 A774G 7.82 1
6 NM 001264 3 932 rs3094220 T815C rs3094219 C516T 7.79 5.53
6 NM 004155 3 2893 rs13196459 T1326G rs9392442 T781C 7.6 0.63
17 NM 015654 3 1177 rs12797 C870T rs12937268 G445A 7.44 0.33
17 NM 002945 3 2379 rs1051315 G668T rs1131636 C720T 7.42 2.2
X NM 000686 3 1600 rs5193 G199T rs5194 A205G 7.39 5.5
4 NM 001130088 3 1021 rs16841552 G32A rs17180256 C10T 7.12 0.55
17 NM 002945 3 2379 rs3744767 T463C rs1131636 C720T 6.97 8.76
18 NM 052947 3 573 rs1129928 T259C rs3744867 T7C 6.92 7.48
3 NM 024616 3 1551 rs729641 C547T rs340162 C1456T 6.88 0.37
10 NM 017987 3 2250 rs3781567 G347A rs3781568 G239T 6.82 13.61
16 NM 002163 3 1323 rs1568391 G416T rs6638 A1156T 6.74 24.17
7 NM 001080529 3 1789 rs4722959 A60T rs12532093 G1280A 6.67 9.39
1 NM 001103169 3 2763 rs3010886 C400T rs17038468 A2150G 6.67 9.2
17 NM 001030006 3 2718 rs226426 A458G rs17638867 C1795T 6.65 2.43
16 NM 005752 3 1260 rs2072665 T750C rs7188702 A935T 6.61 25.66
6 NM 002119 3 2655 rs3130602 G2408A rs9276977 C774T 6.59 0.31
2 NM 030923 3 727 rs610624 A525G rs2289469 C245T 6.55 2.03
10 NM 207372 3 2479 rs11186419 C1246A rs7081754 T1703C 6.31 0.28
2 NM 148962 3 409 rs2278585 C54A rs12617777 G38T 6.29 12.45
11 NM 015368 3 1102 rs1046805 G416A rs13655 G443C 6.26 2.37
16 NM 170776 3 917 rs1064327 G806A rs1141418 T876C 6.24 14.71
7 NM 020144 3 2159 rs11972290 G1841A rs11972309 G1798C 6.23 12.04
9 NM 001018116 3 1440 rs10989164 A1046C rs10989165 C1104G 6.23 8.67
2 NM 022449 5 630 rs2292872 G203A rs2292871 T47C 6.21 2.08
11 NM 024662 3 718 rs1983642 C86G rs8187 G414A 6.18 0.22
12 NM 000415 3 1056 rs5486 A740G rs1056007 G778T 6.16 4.22
6 NM 183050 3 2466 rs7758761 A1778G rs15062 G2271A 6.13 22.74
6 NM 002119 3 2655 rs9276977 C774T rs3129303 G737A 6.06 2.01
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10 NM 152309 3 2265 rs7448 G2121A rs7074516 G410A 6.05 9.74
14 NM 145231 3 118 rs9026 A87T rs1555616 G62T 5.98 2.77
18 NM 052947 3 573 rs1129928 T259C rs10867 G229C 5.97 2.15
5 NM 176816 3 2037 rs12651858 A1089G rs4421064 A128G 5.94 1.38
1 NM 001007239 3 960 rs1045456 C668T rs12140193 T684G 5.91 1.42
17 NM 002945 3 2379 rs3744767 T463C rs17734 C675T 5.9 8.76
1 NM 031459 3 1689 rs17163112 C897G rs10494394 A1025G 5.9 0.05
13 NM 005073 3 922 rs1289389 G688A rs4646234 A598G 5.77 0.52
2 NM 012092 3 1976 rs10932036 A859T rs4675379 G1773C 5.66 0.63
17 NM 015654 3 1177 rs12937268 G445A rs880827 A428G 5.6 0.55
19 NM 002034 3 775 rs8101625 T539G rs778982 G27A 5.58 2.65
16 NM 016256 3 634 rs1045693 C253T rs887855 C139G 5.56 0.61
21 NM 003343 3 2337 rs8103 T2062A rs1060564 T118C 5.56 4.99
8 NM 001908 3 2600 rs9009 T628A rs709821 C40G 5.53 19.82
21 NM 006948 3 2501 rs11088017 C1171T rs2822639 T762C 5.5 1.13
13 NM 194318 3 2606 rs17703938 G1693C rs912603 G1836A 5.5 0.75
5 NM 006598 3 1986 rs3810853 C557T rs3810854 G115A 5.49 0.33
3 NM 024616 3 1551 rs11824 T1073C rs340162 C1456T 5.47 0.37
9 NM 001244 3 1087 rs3181374 T1024C rs3181370 A459G 5.47 17.63
3 NM 173653 3 1479 rs3796228 A833G rs3796227 C804G 5.45 0.08
9 NM 001039395 3 2495 rs17814462 C1930A rs3739642 A7G 5.43 0.15
15 NM 001018004 3 742 rs1050255 C260T rs7178040 G727T 5.34 18.34
1 NM 005857 3 1515 rs10489431 C723T rs10489432 A890G 5.31 10.17
12 NM 015409 3 2787 rs11246914 G57A rs7484529 G1153A 5.31 1.84
1 NM 007365 3 2283 rs2235927 C764T rs2076598 C18T 5.18 11.93
11 NM 139075 3 2651 rs2253658 C1383G rs1005858 C1495T 5.17 9.96
13 NM 145061 3 1555 rs12872592 T534C rs9506624 C344T 5.14 1.47
1 NM 014424 5 827 rs1056207 C459T rs945419 G428A 5.14 2.97
1 NM 001077195 3 2521 rs644749 A635G rs646193 T284C 5.11 0.49
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3 NM 001080513 3 1300 rs6774653 T233C rs11713634 C216T 5.06 3.97
7 NM 002612 3 2144 rs6931 A2051T rs16868830 A295C 5.03 4.19
8 NM 024699 3 972 rs2955015 T927G rs6415649 A340G 4.97 0.85
2 NM 203372 3 1747 rs16864237 C884T rs1046108 G885A 4.95 1.03
5 NM 005927 5 476 rs478020 A363G rs689715 T381A 4.94 27.22
6 NM 002119 3 2655 rs3130602 G2408A rs417812 G534A 4.88 0.82
9 NM 001077365 3 700 rs3739495 T41C rs10793885 T278C 4.83 10.17
6 NM 002119 3 2655 rs417812 G534A rs2581 C214A 4.82 25.74
12 NM 006390 3 1872 rs7325 A1392G rs8414 G1302A 4.81 25.01
6 NM 080723 3 1583 rs3829810 G498A rs1053047 A1309G 4.79 6.48
4 NM 000671 3 1438 rs6827292 A574G rs1803037 G417A 4.75 0.16
6 NM 007028 3 639 rs2240071 G381C rs1110446 G376A 4.74 21.89
6 NM 032730 3 968 rs9320182 G584A rs7357031 C583A 4.74 0.33
15 NM 005545 3 726 rs3888004 G280A rs3848161 A611C 4.73 14.54
1 NM 012137 3 2967 rs3813600 C969T rs233113 A836T 4.73 2.42
6 NM 183050 3 2466 rs7758761 A1778G rs10864 C2282T 4.71 22.74
15 NM 152455 3 2901 rs935901 C2015G rs10518812 T334G 4.7 0.93
1 NM 001012329 3 2442 rs1220394 C1270T rs7539650 C1055T 4.67 0.12
5 NM 173362 5 1389 rs10054161 A578G rs17790731 C944T 4.65 0.07
12 NM 000617 3 2331 rs149411 T1876C rs224446 G390A 4.64 6.85
9 NM 003389 5 266 rs2275709 A224T rs2275710 G125A 4.62 3.16
3 NM 052859 3 1109 rs7645611 C622G rs2564921 A334G 4.61 3.88
6 NM 000322 3 1700 rs405043 C1375T rs405059 C1357T 4.61 20.72
10 NM 173575 3 518 rs2818413 G396T rs1046577 A365G 4.61 0.19
16 NM 002080 3 1040 rs11861897 T860A rs6993 T708C 4.59 0.49
6 NM 183050 3 2466 rs926733 G121A rs1042367 C1142G 4.57 22.74
21 NM 003343 3 2337 rs760431 T1641G rs235355 G1454T 4.57 0.91
14 NM 001001872 3 646 rs2256270 T165C rs17807721 C105T 4.51 2.54
12 NM 007035 3 852 rs10859100 C792T rs11105951 T759C 4.45 3.64
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3 NM 024871 3 1474 rs8391 A1180G rs2582091 G50A 4.44 26.66
14 NM 001008396 3 1266 rs1354 C1216T rs7146775 C451T 4.39 5.28
3 NM 004393 3 2416 rs1050088 T250C rs4625 A1508G 4.38 7.29
11 NM 005472 3 2411 rs7789 A1977C rs12277342 C463T 4.37 0.31
12 NM 031474 3 1859 rs2334868 T874C rs3814250 G324A 4.36 0.28
5 NM 022824 3 1972 rs12188414 G462A rs1865015 C445T 4.33 1.42
7 NM 139316 3 1114 rs2072505 T380C rs6960550 A354C 4.31 0.34
14 NM 015163 3 2028 rs12879906 C1379T rs1049371 T1339C 4.31 0.2
10 NM 003873 3 2585 rs10080 C1896T rs2506140 T1465C 4.28 6.62
6 NM 014722 3 2088 rs1803005 C1741A rs9358799 G7A 4.24 9.04
15 NM 006091 3 1831 rs17279860 A646T rs1128848 G1269C 4.24 18.32
10 NM 024834 3 2014 rs6881 A1584C rs10550 A1212G 4.23 3.37
4 NM 000320 3 731 rs1049601 C408T rs1049600 A403G 4.13 5.58
12 NM 007035 3 852 rs11105951 T759C rs10859101 G678T 4.13 4.01
11 NM 024806 3 277 rs7107502 G61A rs1057704 T121C 4.13 27.69
6 NM 014068 5 274 rs3094197 A79G rs3815087 G181A 4.11 2.53
5 NM 001447 3 1473 rs165344 T1037C rs165343 A676G 4.11 17.32
17 NM 002945 3 2379 rs3744766 C480G rs17734 C675T 4.09 9.21
4 NM 025205 3 739 rs555 A237G rs7684560 C474T 4.08 0.11
17 NM 001114091 3 2990 rs11079757 C2451T rs1713494 A2111G 4.07 2.98
12 NM 006390 3 1872 rs8414 G1302A rs2278558 G51A 4.06 6.36
1 NM 015053 3 2346 rs3737880 G1157C rs3737879 C1261T 4.05 18.79
1 NM 001010984 3 2637 rs203742 T641C rs2749717 G2001T 4.02 6.56
4 NM 021069 3 2183 rs10009018 T1760C rs10031753 G1372A 3.99 16.99
4 NM 020803 3 2457 rs6840470 A2145G rs3204865 C1825T 3.99 0.92
14 NM 020431 3 2769 rs384491 C400A rs11847091 G903T 3.97 3.74
1 NM 181339 5 406 rs1150258 T302C rs3093431 A306G 3.97 0.47
9 NM 130459 3 1692 rs534652 C828T rs538066 A538G 3.97 0.75
22 NM 001104595 3 1550 rs4823462 C1102T rs6007600 T1195C 3.93 0.44
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9 NM 014279 3 1006 rs11103684 G46A rs16781 G862A 3.92 0.93
12 NM 181709 3 1497 rs10846654 G387A rs12551 T1247C 3.88 19.3
15 NM 139057 3 2964 rs2573650 C510T rs2581346 A429C 3.87 0
5 NM 005546 3 2421 rs3892245 C941A rs27988 A997G 3.86 0.52
3 NM 004391 3 2119 rs12494055 A1958G rs3732860 A1791G 3.83 28.08
10 NM 024701 3 1835 rs1132305 C1782T rs12414278 G362C 3.81 1.04
16 NM 020947 3 2410 rs16973913 A2259G rs390892 T2034G 3.81 1.7
18 NM 173464 3 1514 rs3745091 A1136G rs3737351 C103T 3.8 0.21
21 NM 175857 3 332 rs2833101 C259T rs1892667 A242C 3.75 27.36
8 NM 177924 3 1118 rs3810 A926C rs417661 T124A 3.74 2.14
13 NM 180989 3 2521 rs2298057 A1498T rs7984105 A2244G 3.74 4.7
1 NM 005814 3 1489 rs11736 A1309C rs3753914 T870C 3.71 10.5
1 NM 170782 5 150 rs1061122 G49A rs4845397 A35G 3.7 17.04
1 NM 001103169 3 2763 rs3010888 C1669T rs17038468 A2150G 3.68 9.2
5 NM 001099287 3 1762 rs10476052 C566A rs11739062 G1733T 3.66 10.48
17 NM 024591 3 980 rs8076478 C456T rs13507 T815C 3.65 0.17
5 NM 001099287 3 1762 rs3734029 T782C rs3822692 A910T 3.63 7.83
17 NM 002945 3 2379 rs3744769 C380G rs17734 C675T 3.62 8.43
14 NM 172314 3 523 rs3811178 G155A rs11465521 G265T 3.61 0.24
16 NM 032206 3 996 rs3751705 T18C rs27193 C965T 3.59 0.12
2 NM 178313 3 2222 rs17046097 G852A rs10528 T1926C 3.55 11.21
3 NM 022776 5 290 rs1055419 C103T rs7625936 C31T 3.53 0.83
11 NM 006108 3 2422 rs11369 A863G rs1043237 A1820T 3.53 25.08
4 NM 006005 3 797 rs1046317 T47C rs3200 C683T 3.52 11.75
10 NM 139155 3 1586 rs16927931 G129A rs3740437 G1185A 3.51 0.47
10 NM 001128925 3 746 rs2860840 C31T rs1042192 G83A 3.47 3.02
9 NM 203453 3 1995 rs1485202 C1486T rs2295963 A1589G 3.47 1.31
1 NM 002596 3 1411 rs6674683 C667T rs3820377 T675C 3.46 0.21
4 NM 207330 3 891 rs10805163 C190T rs10938519 G395A 3.46 0.18
115
4 NM 173660 3 981 rs11733064 C55G rs10937930 C882T 3.44 10.55
6 NM 002119 3 2655 rs1044429 G1973A rs2581 C214A 3.42 3.09
6 NM 002031 3 884 rs580396 A396G rs12208531 C53T 3.42 17.44
7 NM 017549 3 1544 rs2722279 C1131A rs1047785 C1188T 3.41 2.87
10 NM 006504 3 2994 rs11813708 C800A rs12768414 G2610A 3.4 0.21
18 NM 173464 3 1514 rs719153 T665C rs3737351 C103T 3.4 26.23
6 NM 002031 3 884 rs580396 A396G rs1338507 A146G 3.38 0.43
1 NM 001004341 3 605 rs1055106 G468A rs1176536 C77T 3.36 25.62
7 NM 018697 3 2422 rs3823584 G710A rs815990 C1632T 3.36 0.21
2 NM 152834 3 1607 rs17729501 A962G rs17042334 G895A 3.36 0.39
9 NM 014279 3 1006 rs11103684 G46A rs2298249 C623T 3.36 0.52
22 NM 030643 5 423 rs80587 G259C rs6000181 T227A 3.35 4.56
17 NM 002945 3 2379 rs3744769 C380G rs3744768 G417A 3.33 17.89
2 NM 014011 3 2647 rs10221923 A487G rs17823065 T793C 3.33 0.45
22 NM 030643 5 423 rs132734 C327T rs132735 C323A 3.31 12.38
7 NM 002612 3 2144 rs11768781 T1000G rs16868830 A295C 3.31 4.06
15 NM 014967 3 1543 rs11293 G1216A rs3512 G1240C 3.31 23.52
13 NM 005845 3 1746 rs9516519 A1372C rs3742106 T38G 3.28 1.82
6 NM 198392 3 2391 rs4896011 A469T rs6932322 G873A 3.28 9.1
12 NM 153364 3 650 rs11109970 A346G rs11613157 A469G 3.27 20.71
2 NM 018000 3 2272 rs4258792 G2084T rs6435927 G1434T 3.27 1.72
4 NM 024590 3 1990 rs4452507 T825G rs17620564 T114G 3.26 0
1 NM 014424 3 1552 rs1048245 A721C rs1739839 C550T 3.26 1.32
21 NM 001001692 5 2197 rs2836723 T1469C rs2836725 G1324T 3.24 24.34
16 NM 020947 3 2410 rs16973913 A2259G rs4993376 T163C 3.24 0.02
18 NM 173464 3 1514 rs3745091 A1136G rs3737352 A74G 3.23 0.21
3 NM 033013 5 1839 rs1523130 T177C rs1523127 C1709A 3.22 26.24
2 NM 020161 3 1304 rs2176189 G638T rs2176188 A558C 3.22 0.83
2 NM 018269 3 1044 rs3349 A536T rs1130165 G336A 3.21 14.73
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6 NM 002119 3 2655 rs376892 C1728T rs3129303 G737A 3.2 2.27
2 NM 006773 3 1653 rs1863041 C340T rs10094 C413T 3.19 1.47
4 NM 153365 3 2803 rs9946 A1710G rs10516299 G1445A 3.19 4.82
1 NM 012231 3 1945 rs2697966 C486T rs2697962 T1362C 3.19 7.88
4 NM 173660 3 981 rs11733064 C55G rs2858030 T249C 3.18 5.62
1 NM 181703 3 1938 rs11240121 G1396A rs1043806 C971T 3.18 1.64
6 NM 021635 3 1998 rs9402958 G1693T rs9402959 C1648T 3.18 7.33
12 NM 001024668 3 993 rs3190077 A152C rs15756 G423T 3.17 11.92
2 NM 018000 3 2272 rs4258792 G2084T rs8911 T1860C 3.16 1.72
2 NM 022460 3 1183 rs1047169 G970A rs1047163 T935C 3.16 0.76
1 NM 006699 3 2741 rs1290558 A262G rs964530 T1727A 3.15 5.84
10 NM 139155 3 1586 rs3740440 C700G rs3740434 A1580G 3.15 16.34
9 NM 016525 3 991 rs1049557 G413C rs1049567 T597C 3.14 2.49
10 NM 033100 3 2744 rs3814212 A4G rs12356218 G907A 3.13 5.29
6 NM 003447 5 1084 rs203876 T102C rs203877 T400C 3.13 25.03
1 NM 017761 3 1564 rs3211053 T109C rs1043880 G690C 3.12 22.1
2 NM 178313 3 2222 rs2971879 T1310C rs2971877 G1913A 3.12 23.13
12 NM 013267 3 535 rs1043011 C231A rs2638315 C215G 3.11 19.31
8 NM 001026213 3 2016 rs4736312 T1852G rs7003319 A1042G 3.09 27.09
12 NM 000020 3 2468 rs810052 C949T rs706819 T1246C 3.08 0.31
22 NM 138415 3 1924 rs762979 T901A rs762980 C857T 3.08 18.09
22 NM 014310 3 1966 rs736212 G186C rs6518958 A1255G 3.07 22.73
2 NM 020868 3 2015 rs272008 C1710T rs3768692 T1922C 3.06 2.76
6 NM 007109 3 1498 rs1419881 G99A rs1841 A266G 3.06 2.67
19 NM 032584 3 913 rs984871 T661C rs1650972 G64A 3.04 8.09
4 NM 000320 3 731 rs1031327 C510T rs1049601 C408T 3.04 0.37
4 NM 152618 3 918 rs4833843 G248A rs309386 C811G 3.04 4.82
19 NM 173548 3 541 rs3764533 A43G rs3764531 G154C 3.04 20
1 NM 004481 3 2742 rs16851339 T1628A rs1043909 C2167T 3.03 1.83
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8 NM 012173 3 1071 rs8049 G189C rs1050909 G564T 3.03 8.44
4 NM 145244 3 1807 rs2903209 T1542A rs3819184 C1417G 3.01 2.92
12 NM 002284 3 578 rs2280949 A94G rs1137015 C312T 3 0.88
6 NM 182966 3 608 rs3798733 G79C rs3798734 G57A 2.99 22.74
11 NM 058166 3 1616 rs7120093 A1028G rs11038346 T1473A 2.99 0.59
8 NM 178857 3 545 rs12542071 C244T rs12542104 C98T 2.95 7.59
6 NM 002119 3 2655 rs1044429 G1973A rs3129303 G737A 2.94 0.39
20 NM 006466 5 118 rs1474974 C47A rs4264617 C66G 2.93 4.93
6 NM 002127 3 383 rs1063320 C233G rs1610696 C287G 2.91 11.15
1 NM 153812 3 2396 rs3747994 C47T rs14057 G1543A 2.9 6.51
15 NM 001040657 3 1687 rs12439819 C508T rs260089 C70T 2.9 0.76
3 NM 021101 3 2573 rs1364722 G2009A rs17500920 A1173T 2.89 4.84
16 NM 020947 3 2410 rs8053390 C2194G rs4993376 T163C 2.88 0.23
13 NM 145061 3 1555 rs3087725 C1155T rs9506624 C344T 2.87 0.46
9 NM 001039395 3 2495 rs2771 T2432C rs17814462 C1930A 2.87 0.32
1 NM 006802 3 1206 rs9686 T908A rs1050257 C270T 2.86 10.97
17 NM 003954 3 1515 rs1047841 G1372A rs3744410 C90A 2.86 0.23
16 NM 153688 3 1900 rs7205215 T909C rs17673793 A981G 2.86 0.18
3 NM 130835 3 2926 rs1056366 A1343G rs10419 A2873T 2.85 2.52
16 NM 199355 3 1828 rs3087939 G813A rs889706 A262G 2.85 0
3 NM 001024660 3 1719 rs4234221 C12T rs1162 A1368G 2.85 5.79
1 NM 020526 3 1853 rs209698 A579G rs209697 A1142G 2.85 3.24
2 NM 080657 3 2290 rs4669114 A548G rs6431838 G765C 2.85 5.56
22 NM 005297 3 886 rs9611386 A601G rs3087592 C733T 2.84 0.2
22 NM 001104595 3 1550 rs2064068 C199T rs4823462 C1102T 2.83 0.82
19 NM 145295 3 1270 rs4804612 T493C rs7531 A1001G 2.83 26.31
16 NM 002163 3 1323 rs1044873 C783T rs6638 A1156T 2.83 16.18
14 NM 001008396 3 1266 rs1354 C1216T rs7147147 C264A 2.83 5.28
7 NM 133468 3 2599 rs11972404 A704G rs17169667 C1067T 2.79 1.08
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2 NM 000393 3 2155 rs1131518 T392C rs7586 G298A 2.79 0.24
19 NM 000527 3 2513 rs3826810 G141A rs2738466 A773G 2.79 0.24
17 NM 006460 3 1831 rs1801921 G552C rs8070447 A1662C 2.78 0.05
16 NM 005752 3 1260 rs1922608 A401G rs7188702 A935T 2.78 7.14
15 NM 018602 3 1736 rs6996 A685T rs3743083 C817T 2.77 1.2
2 NM 138801 3 820 rs3731838 G220A rs3112178 G260A 2.77 11.6
14 NM 052978 3 1933 rs10483607 T1396C rs17123377 C446T 2.77 0.02
10 NM 001083913 3 2933 rs17115073 C768T rs284858 T848C 2.77 0
14 NM 014169 5 411 rs2295319 C349T rs2295318 T61C 2.76 9.31
18 NM 173464 3 1514 rs719153 T665C rs3737352 A74G 2.76 26.23
6 NM 002119 3 2655 rs3129304 G872A rs9276976 G821A 2.74 1.69
11 NM 016412 3 1427 rs3741208 A1307G rs3741206 T1397C 2.73 22.47
12 NM 001423 3 2083 rs8885 C1571T rs3191064 A1949G 2.73 2.65
18 NM 014268 3 1482 rs3786313 C26T rs3810021 C745T 2.73 14.55
2 NM 001080437 3 2592 rs16843245 C1658T rs3815292 A1711G 2.73 11.88
6 NM 001007466 5 1357 rs4433000 C584T rs9456286 A624G 2.71 1.04
16 NM 020947 3 2410 rs8053390 C2194G rs8053541 C2131T 2.71 25.77
2 NM 002254 3 2392 rs12105137 G704A rs6731972 A641G 2.71 0.11
22 NM 013385 3 1830 rs5750409 G743A rs2284051 G1017T 2.71 24.34
6 NM 021572 3 1301 rs1047153 G318A rs2235882 G269A 2.7 2.51
2 NM 022436 3 644 rs4148195 C622T rs2278357 G416A 2.7 19.36
13 NM 005845 3 1746 rs9516520 A971G rs3742106 T38G 2.69 1.82
13 NM 003576 3 2972 rs9517312 C1572T rs3742134 G1257A 2.69 21.13
4 NM 024743 3 1354 rs3088249 C1193T rs3749514 T172C 2.69 1.06
6 NM 002119 3 2655 rs3130602 G2408A rs1044429 G1973A 2.68 0.15
22 NM 031444 3 2566 rs9704 T2004C rs1004134 A519T 2.68 16.99
6 NM 020056 3 883 rs1744 A696T rs2395253 G822A 2.68 0.02
13 NM 007106 3 2850 rs10492458 G1920A rs1058650 A807G 2.66 0.45
12 NM 000617 3 2331 rs224446 G390A rs2285230 A358G 2.65 1.6
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7 NM 004760 3 2537 rs699509 G184T rs1044217 C344T 2.65 7.1
13 NM 194318 3 2606 rs912604 A1801G rs912603 G1836A 2.65 21.99
3 NM 024871 3 1474 rs1061594 G974A rs2582091 G50A 2.65 25.15
3 NM 024871 3 1474 rs3732582 C1075G rs2582091 G50A 2.65 2.04
11 NM 032021 3 1237 rs1047624 C304G rs17654386 T385A 2.63 12.74
20 NM 172005 3 982 rs6032449 C242T rs170800 T382C 2.63 0.44
4 NM 003948 3 2708 rs7684530 C2266G rs6829402 T1215C 2.62 2.1
8 NM 005218 5 150 rs11362 G131A rs1799946 G99A 2.62 8.45
10 NM 145869 5 483 rs6585454 T422C rs12779955 A259G 2.61 11.28
12 NM 181709 3 1497 rs904647 G316A rs10846654 G387A 2.6 21.27
8 NM 001908 3 2600 rs9009 T628A rs3947 C259T 2.6 20.63
1 NM 052896 3 2615 rs2641957 T1206A rs1690549 A873G 2.59 9.29
7 NM 020144 3 2159 rs11972309 G1798C rs17135241 T160C 2.59 10.51
1 NM 001103170 5 233 rs3000860 A101C rs3000859 A227T 2.59 8.07
5 NM 001001669 3 2773 rs2279132 G1833A rs1056189 A2664G 2.58 0.58
2 NM 003387 3 2973 rs7739 C2846T rs2358888 T2450A 2.58 7.33
4 NM 001263 3 2654 rs1372971 A1500G rs1120 G2535A 2.58 7.1
1 NM 005814 3 1489 rs12461 T1190C rs3753914 T870C 2.57 11.57
4 NM 000320 3 731 rs699460 A468C rs1049600 A403G 2.56 0.37
12 NM 015409 3 2787 rs11246914 G57A rs12313437 C193T 2.55 4.28
5 NM 014402 3 1262 rs17166297 A723G rs254284 A1193G 2.54 4.86
14 NM 022073 3 1676 rs1750708 T1495C rs1680709 C211T 2.53 3.81
10 NM 139155 3 1586 rs2587469 G546A rs3740437 G1185A 2.53 3.4
1 NM 000702 3 2262 rs12077973 A621G rs2070704 A1026G 2.52 0.24
1 NM 002053 3 1051 rs7911 T918C rs2296882 A865T 2.52 5.23
2 NM 002254 3 2392 rs1061449 C1273T rs6738270 C1258A 2.51 0.37
15 NM 024666 3 1792 rs12476 A1433G rs10518716 C336G 2.51 18.95
9 NM 032843 3 1550 rs3802347 C431T rs11792889 T3C 2.51 1.93
8 NM 024295 3 2099 rs11691 G179A rs7159 A59G 2.49 0.29
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12 NM 015409 3 2787 rs12317704 T73C rs12313437 C193T 2.49 4.28
3 NM 015141 3 2798 rs3749278 T1828C rs3087806 T2348C 2.49 18.9
9 NM 005772 3 789 rs10072 T689C rs1053889 G705A 2.49 9.52
7 NM 001039966 3 959 rs10235056 G256A rs3808354 G679T 2.49 0.65
2 NM 020161 3 1304 rs2138404 A943G rs2176189 G638T 2.48 0.98
9 NM 006444 3 2104 rs483377 A703G rs10991117 C826T 2.48 0.13
1 NM 001079874 3 2171 rs8458 C2097T rs8676 C2088T 2.47 26.38
2 NM 172070 3 2286 rs17635525 T211C rs1343 G306A 2.47 2.3
1 NM 001012329 3 2442 rs946273 T2261C rs1220394 C1270T 2.47 0.58
1 NM 001040033 3 741 rs12030938 G41A rs1936939 G738C 2.46 8.24
6 NM 031949 3 1010 rs2981978 A266G rs12197891 A929G 2.45 1.15
1 NM 004481 3 2742 rs1043909 C2167T rs11620 T2204C 2.44 7.09
5 NM 024028 3 998 rs353255 G511A rs353254 A519G 2.44 28.16
4 NM 000671 3 1438 rs1061187 C715T rs6827292 A574G 2.44 0.22
8 NM 024295 3 2099 rs1059588 A787G rs7812 G125A 2.44 0.23
11 NM 030774 3 1578 rs7111883 C1066T rs12575268 A186T 2.43 1.78
16 NM 020947 3 2410 rs4993376 T163C rs899250 A56C 2.43 0.44
16 NM 020927 3 2409 rs10514435 G1956C rs9711 A2290T 2.42 4.03
10 NM 001083913 3 2933 rs284856 A1241T rs6892 A2782G 2.42 4.61
17 NM 024619 3 810 rs1046889 C464T rs1046896 C486T 2.41 2.34
7 NM 003014 3 1546 rs2598116 T733G rs1052981 C580T 2.41 0.85
4 NM 014421 3 2152 rs10488898 C1618T rs3914885 T1165G 2.41 0.2
6 NM 002119 3 2655 rs9276977 C774T rs408036 A347G 2.4 6.85
10 NM 033100 3 2744 rs12356218 G907A rs1059342 A2643T 2.39 15.65
5 NM 152547 3 1653 rs10434810 C282A rs1053110 T1398C 2.39 21.53
9 NM 001497 3 2813 rs7019896 C256A rs7019909 G130A 2.39 0.09
1 NM 022371 3 776 rs1046385 A522G rs1128952 C772T 2.38 3.13
9 NM 018201 3 2553 rs7862546 C25G rs11999937 C1410T 2.36 0.01
5 NM 153223 3 1634 rs1047484 A1546C rs13436337 C983G 2.36 19.54
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4 NM 001977 3 1779 rs1448816 A289G rs1042279 C419A 2.35 0.06
2 NM 024293 3 2846 rs7017 C799T rs2385394 C1939T 2.34 27.69
22 NM 198440 3 2557 rs5760062 G657C rs1128127 C115T 2.34 0.24
17 NM 015654 3 1177 rs12797 C870T rs3744208 T298C 2.34 16.81
7 NM 007356 3 488 rs1614188 T275G rs1616041 G38A 2.33 8.67
11 NM 016229 3 279 rs1128643 A210C rs11758 C112G 2.33 2.23
1 NM 015053 3 2346 rs3820151 A1016G rs3737880 G1157C 2.32 18.07
20 NM 001029871 3 1904 rs486344 T1839C rs486347 T1834C 2.31 4.67
11 NM 033036 3 1742 rs2576 G1511A rs3814744 G215A 2.31 6.67
18 NM 021624 3 2395 rs1421126 C212T rs4800573 G2144A 2.31 3.58
20 NM 003245 3 498 rs214831 A136G rs214832 T438C 2.3 21.71
6 NM 019111 3 407 rs7197 T163C rs1041885 T392A 2.3 2.32
6 NM 014069 5 324 rs1265094 T235C rs3094663 A41G 2.3 10.07
2 NM 178313 3 2222 rs17046097 G852A rs2971879 T1310C 2.29 1.5
10 NM 033100 3 2744 rs3814212 A4G rs6585845 T869G 2.29 16.9
X NM 175569 3 1547 rs3672 A1220G rs3671 G1247A 2.29 0.47
11 NM 152433 3 1752 rs1940792 A986T rs1940791 G858A 2.28 6.99
7 NM 012129 3 2543 rs9731 G2220A rs17863096 A2375G 2.26 0.2
7 NM 176814 5 712 rs1057454 T169G rs2269729 T105A 2.26 25.9
11 NM 001127489 3 2230 rs11999 T2102G rs869789 C1634T 2.26 1.1
8 NM 006158 3 1854 rs17052849 A378G rs1059111 A235T 2.26 0.12
11 NM 058166 3 1616 rs7120209 A1117G rs7104648 C1175T 2.25 0.53
21 NM 018964 3 1080 rs398717 A694G rs1046783 A748G 2.25 11.55
5 NM 176806 3 1024 rs2233218 C287T rs2233213 A68G 2.25 0.01
12 NM 152437 3 2492 rs1048497 G2065A rs3767 C2405T 2.24 0.56
6 NM 002119 3 2655 rs1044429 G1973A rs408036 A347G 2.24 3.2
2 NM 012092 3 1976 rs10932038 A1262G rs1559931 G1407A 2.24 10.91
8 NM 002514 3 1306 rs1057732 T1046C rs14324 C1114T 2.24 15.36
5 NM 022824 3 1972 rs12519388 G1684A rs12522548 A1597G 2.24 19.66
122
11 NM 138294 3 1115 rs568195 G599A rs1056417 G950T 2.24 2.95
1 NM 001113349 3 2708 rs3026912 G1713A rs3026907 C92A 2.24 0.23
9 NM 022486 3 711 rs2281788 G486A rs2281790 G141T 2.23 0.51
9 NM 000787 3 897 rs129882 C100T rs13306304 G390A 2.23 0.68
1 NM 012231 3 1945 rs2697966 C486T rs3820012 C508T 2.23 0.39
13 NM 030911 3 1725 rs9535193 C429T rs11616334 G935C 2.23 0.62
9 NM 022486 3 711 rs2281789 C439G rs2281790 G141T 2.23 3.59
1 NM 000299 3 2948 rs1105331 A683G rs12120834 A1942C 2.22 6.91
1 NM 017646 3 710 rs1043843 G551A rs7315 A518G 2.22 14.75
1 NM 004427 3 1242 rs5861 G946T rs11061 C796T 2.22 3.84
6 NM 000636 3 770 rs5746136 G441A rs5746134 C410T 2.22 0.14
2 NM 014011 3 2647 rs17823065 T793C rs4953419 T2589G 2.22 1.83
11 NM 001101653 3 2340 rs7933884 G2148C rs3812766 T2130C 2.21 11.46
19 NM 014518 3 2052 rs1369097 A1031T rs1062093 G483C 2.21 2.89
5 NM 015216 3 1574 rs28025 A44G rs8488 T1417C 2.21 24.04
5 NM 001044723 3 2374 rs3797534 G240C rs17150513 T499C 2.21 1.31
8 NM 001908 3 2600 rs9009 T628A rs6730 C430T 2.21 1.11
6 NM 181717 3 1151 rs9263876 C573G rs6921948 A663C 2.2 1.36
7 NM 001127454 5 595 rs876305 A550G rs754554 C527A 2.19 6.36
5 NM 022824 3 1972 rs12522548 A1597G rs12522552 A1575C 2.18 19.66
1 NM 001408 3 1707 rs12740374 G919T rs658435 C1599T 2.18 1
21 NM 006948 3 2501 rs11088017 C1171T rs12479 A669G 2.18 4.64
19 NM 198457 5 286 rs8107851 G225C rs1559239 T60C 2.18 0.41
15 NM 207444 3 1493 rs1495185 G690C rs1495186 G710A 2.18 6.74
8 NM 004331 3 2716 rs17310286 C1104T rs1042992 C1263T 2.17 16.6
17 NM 002945 3 2379 rs3744768 G417A rs1051315 G668T 2.17 0.49
9 NM 005226 3 2673 rs7853537 A850G rs1867 C2532T 2.17 1.36
15 NM 001128608 3 2419 rs4924576 C1959A rs4923914 C1969T 2.17 25.47
3 NM 139125 3 1600 rs850314 G885A rs1109452 C884T 2.16 4.93
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2 NM 173170 3 2066 rs2515404 C863T rs11675540 G935C 2.16 0.43
17 NM 002945 3 2379 rs3744768 G417A rs3744767 T463C 2.16 17.47
13 NM 194318 3 2606 rs912603 G1836A rs2056444 G2082T 2.16 18.42
5 NM 005990 3 2812 rs1139955 T2141C rs6555989 A1970G 2.15 11.85
8 NM 181723 3 2351 rs2517043 A204G rs17624989 T2233A 2.15 1.48
13 NM 024561 3 1428 rs6560982 G66T rs3355 G1275C 2.14 1.06
2 NM 024785 3 1549 rs3738954 T76C rs3738953 T41C 2.14 13.95
19 NM 144687 5 220 rs4539722 C209T rs4419163 T81A 2.13 6.45
3 NM 054110 3 2246 rs14210 T59G rs842280 G548T 2.13 0.36
4 NM 000297 3 2083 rs2728121 C256T rs10965 G1237A 2.13 1.75
6 NM 001954 3 860 rs1049628 C33T rs6933271 T757G 2.13 0.09
12 NM 001013635 3 1219 rs7486941 G141C rs7485057 T319C 2.13 7.67
15 NM 183235 3 1905 rs1061824 A1742G rs1061823 A1662T 2.12 20.86
21 NM 006948 3 2501 rs11088017 C1171T rs7275514 C816A 2.12 0.16
11 NM 001003819 3 686 rs12798155 G230A rs7106798 A286G 2.12 0.04
1 NM 003037 5 346 rs1000807 C54A rs2295613 G25A 2.12 0.09
2 NM 182500 3 1913 rs908276 T1456C rs2102714 C1576G 2.12 7.33
12 NM 000239 3 1014 rs710794 C178T rs1384 C835T 2.11 3.96
12 NM 017599 3 2117 rs1046007 A98G rs4468424 A157C 2.11 1.21
4 NM 173660 3 981 rs2699414 C722T rs10937930 C882T 2.11 1.47
11 NM 006108 3 2422 rs11238 G895T rs1043237 A1820T 2.1 26.08
3 NM 152305 3 2269 rs1938 G582C rs16829878 T1713G 2.1 0.58
22 NM 030643 5 423 rs132735 C323A rs132736 A250G 2.09 11.43
9 NM 019114 3 2580 rs10759332 T2573C rs7858727 G706T 2.09 0.8
16 NM 199355 3 1828 rs3087939 G813A rs889707 C97T 2.09 0.09
15 NM 198400 3 2973 rs11550869 C1963G rs2899593 G1374A 2.08 0.37
12 NM 018370 3 2363 rs7135515 G708T rs7885 C2194A 2.08 0.17
11 NM 014956 3 1098 rs521099 C95G rs2279013 C207T 2.07 4.69
7 NM 002612 3 2144 rs11531570 C1251T rs16868830 A295C 2.07 4.19
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16 NM 133458 3 2438 rs17689437 C1750T rs3203684 A1839G 2.07 1.79
7 NM 015283 3 2692 rs1186716 G500C rs1186717 C276A 2.06 20.17
7 NM 001127441 5 620 rs10226437 C361T rs10259901 A482T 2.06 13.74
17 NM 002945 3 2379 rs3744768 G417A rs12727 G596C 2.06 1.44
1 NM 003094 3 1220 rs2298870 C213T rs4512716 A484G 2.06 0.12
21 NM 198689 3 442 rs659638 A110G rs371248 C297G 2.06 11.02
8 NM 173539 3 977 rs763786 C522A rs3750097 C680T 2.06 22.18
4 NM 001037442 3 1959 rs1043903 A277G rs7681549 T761C 2.06 1.9
10 NM 001040177 3 529 rs1869214 T48C rs12569410 C84T 2.05 2.09
4 NM 006005 3 797 rs1046319 C91T rs3200 C683T 2.05 9.48
22 NM 001127649 3 1366 rs362057 A829G rs361807 T987C 2.05 0.6
16 NM 000303 3 1512 rs2072688 G175A rs2437722 G791C 2.05 0.19
15 NM 017672 3 1385 rs11070795 A503G rs616256 T304C 2.04 21.04
7 NM 001127441 5 620 rs1532046 T57C rs10259901 A482T 2.04 24.73
14 NM 052978 3 1933 rs12883270 G635T rs17123377 C446T 2.04 1.59
4 NM 000320 3 731 rs1031327 C510T rs699460 A468C 2.03 21.66
1 NM 018211 3 2244 rs1556561 A1315T rs2780889 A2123T 2.03 14.41
7 NM 001305 3 854 rs1127155 A300G rs1127156 C335T 2.02 19.06
19 NM 003436 3 946 rs2229379 A94G rs11669919 G565A 2.01 30.05
6 NM 019111 3 407 rs3177928 G18A rs7195 A122G 2.01 2.29
1 NM 001083965 3 972 rs6683364 A726T rs1054475 G693A 2.01 2.75
16 NM 020947 3 2410 rs422598 T220G rs4993376 T163C 2.01 0.42
4 NM 001040202 3 2599 rs3811766 A1195C rs10518209 G262A 2.01 2.43
CHAPTER 4
Sharing and archiving nucleic acid structure mapping data1
4.1 Overview
Nucleic acids are particularly amenable to structural characterization using chemical
and enzymatic probes. Each individual structure mapping experiment reveals specific
information about the structure and/or dynamics of the nucleic acid. Currently, there is no
simple approach for making these data publically available in a standardized format. We
therefore developed a standard for reporting the results of Single Nucleotide Resolution
Nucleic Acid Structure Mapping experiments, or SNRNASMs. We propose a schema
for sharing nucleic acid chemical probing data that uses generic public servers (in the
”cloud”) for storing, retrieving and searching the data. We have also developed a consistent
nomenclature (ontology) within the Ontology of Biomedical Investigations (OBI), which
provides unique identifiers (termed Persistent URLs, or PURLs) for classifying the data.
Links to standardized data sets shared using our proposed format along with a tutorial and
links to templates can be found at http://snrnasm.bio.unc.edu.
4.2 Introduction
Fields in which data standardization has allowed sharing among many researchers,
including sequence data in GenBank [315, 316] and structural data in the Protein Data
Bank [317], have benefited enormously from the ability of investigators to draw insights from
the work of thousands of people dispersed across the globe [218, 318–323]. Unfortunately,
there is currently no standard database for archiving and sharing nucleic acid structure
1This chapter previously appeared as an article in the RNA Journal. The original citation is as follows:
Rocca-Serra, P.; Bellaousov, S.; Birmingham, A.; Chen, C.; Cordero, P.; Das, R.; Davis-Neulander, L.;
Duncan, C. D.; Halvorsen, M.; Knight, R.; Leontis, N. B.; Mathews, D. H.; Ritz, J.; Stombaugh, J.; Weeks,
K. M.; Zirbel, C. L. & Laederach, A. Sharing and archiving nucleic acid structure mapping data, RNA, 2011,
17, 1204-1212
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mapping data, despite the compelling opportunities to incorporate such data in studies with
direct relevance to human health and to a wide range of scientific challenges [283, 324–332].
Chemical and enzymatic structure mapping techniques are useful in the field of nucleic acids
and are commonly used to experimentally validate and/or constrain structural predictions,
”footprint” protein binding sites, and characterize folding reactions both kinetically and
thermodynamically [117, 232, 332, 333]. Recent developments allowing the analysis of
chemical mapping reactions in a quantitative and high-throughput manner yield large
amounts of high-quality data that require automated processing and annotation [286, 314,
332, 334, 335].
A standardized approach for making such data available upon publication is needed
to facilitate sharing and wider dissemination of these results. Figure 4.1A illustrates
the unfortunately common scenario in our laboratories when structure-mapping data are
collected. A laboratory colleague carefully collects data and meticulously records this work in
a laboratory notebook. The data are then analyzed and published in a thesis and a scientific
journal as an exquisitely complex multi-colored diagram. Upon graduation, the thesis and
data are often misplaced or lost in a major lab fire [336]. As a result, the primary data are
lost and any attempt to reanalyze the data in a new context requires manually extracting
the data from the manuscript figure or from a PDF file in the manuscript’s supplement. In
this work, we seek to advocate for an alternative scenario that greatly diminishes the risk of
data loss and provides the data in a computer readable format (Figure 4.1B).
We consider here the distinct types of structure mapping data and organize them into an
ontology that reveals the relationships among various techniques. We then describe a system
that both allows diverse users to integrate their nucleic acid probing data and facilitates
the description of new techniques as they are developed. This systematization of knowledge
and data will thus facilitate comparisons among methods, meta-analyses combining many
independent lines of evidence about nucleic acid structure, and automated retrieval of nucleic
acids for which good structural data are available.
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Figure 1
Figure 4.1: Different possible scenarios for SNRNASM data. A) RNA chemical probing data is collected, recorded
in a laboratory notebook, and published in a manuscript as an elaborate, colorful figure. This allows the graduate
student who collected the data to graduate. Unfortunately, the raw data, meticulously recorded in the laboratory
notebook, becomes lost [336]. B) Proposed alternative in which the data is stored in a computer, uploaded to the
”cloud”, and made publically available upon publication of the manuscript, allowing other investigators access for new
analyses.
4.3 Approach
4.3.1 Classification of SNRNASM assays
An important first step in sharing data efficiently is accurately defining the vocabulary
used to describe an experiment. This is particularly important if one of the goals of
sharing data is to facilitate meta-analyses using automated tools. Ontologies are commonly
used to define terms and the relations between them in a precise way [319, 323, 337]. We
therefore describe Single Nucleotide Resolution Nucleic Acid Structure Mapping (SNRNASM)
experiments in terms of an ontological framework. We note that the use of the idiosyncratic
term SNRNASM is intentional. This term is unique to our approach to archiving nucleic
acid probing data and will make it readily Internet searchable.
We have added terms to the Ontology of Biomedical Investigations (OBI) for 23 types
of SNRNASM assays [338]. We chose to include terms describing SNRNASMs into OBI,
which focuses specifically on describing assays like structure mapping. We define two types
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of SNRNASMs, chemical and enzymatic mapping (Figure 4.2). These two terms have
corresponding OBI identifiers OBI:0001017 and OBI:0001014, respectively (Figure 4.2). The
lines in Figure 4.2 represent ”is a” relationships between terms. One can therefore infer from
our ontological classification that, for example, RNase T1 structure mapping is an enzymatic-
mapping assay, which is also a SNRNASM. Although this may seem obvious to those familiar
with the field of RNA structure mapping, in the larger context of integrating multiple data
sets for meta-analyses, it is essential to identify these elementary relationships explicitly. This
strategy greatly facilitates the implementation of automated data meta-analyses algorithms
[337, 339, 340].
Our ontological classification of SNRNASMs also captures the fact the chemical and
enzymatic structure mapping experiments almost always use a specific probe, which is
generally an enzyme or chemical compound. For this reason, we have defined the ’input’
of structure mapping assays as the chemical or enzyme reagent used to probe the nucleic
acid (Table 4.1, Specific Input column). Furthermore, we explicitly identify these chemicals
and enzymes in their respective ontologies, Chemical Entities of Biological Interest (CHEBI;
[341, 342] and Protein Ontology (PRO; [343, 344]. Additionally, for each entry, we have
provided alternative names (for example, NMIA structure mapping is commonly known
as SHAPE), and corresponding primary references. The SNRNASM classification is thus
integrated into the larger ontological framework being developed for genomic annotations
[341–344].
4.3.2 Accessing SNRNASM classifications
The field of nucleic acid structure mapping is continuously evolving as new chemical
and enzymatic probes are developed [142, 287, 329, 331]. It is therefore important that any
effort to classify these experimental techniques also evolve to reflect the field accurately.
All SNRNASM terms to date have been submitted to OBI, and are therefore accessible in
OWL and OBO format [340] from http://obi-ontology.org. Practically, the annotations
are easily visualized and edited in an ontology editor such as Prote´ge´ [319] (Supplementary
Figure 4.S1). New annotations from the community can be readily added and will appear in
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Assay Name Alt. Name Specific Input (Probe) Input Identifier Ref.
DMS structure mapping Dimethyl sulfate CHEBI:59050 [345, 346]
DEPC structure mapping Diethylpyrocarbonate CHEBI:59051 [345–347]
kethoxal structure mapping Kethoxal (1,1 - Dihydroxy - 3 -
ethoxy - 2 - butanone)
CHEBI:59052 [346, 348]
CMCT structure mapping 1 - cyclohexyl - (2-
morpholinoethyl)carbodiimide
metho - p - toluene sulfonate
CHEBI:59053 [346, 348]
NMIA RNA structure mapping SHAPE N-methylisatoic anhydride CHEBI:59054 [271]
Fe-BABE RNA structure map-
ping
Fe(II)-BABE (iron(S) - 1 - (p-
bromoacetamidobenzyl) ethylenedi-
aminetetraacetate)
CHEBI:59055 [349]
MPE-Fe(II) structure mapping Methidiumpropyl-EDTA.Fe(II) CHEBI:59056 [350]
ENU structure mapping Ethylnitrosourea CHEBI:23995 [346, 351]
Lead structure mapping Lead CHEBI:27889 [352]
Rhodium DNA structure map-
ping
Rhodium CHEBI:33359 [353]
Ruthenium DNA structure map-
ping
Ruthenium CHEBI:30682 [354]
Terbium RNA structure mapping Terbium CHEBI:33376 [355]
DNAse I structure mapping DNAse Footprinting DNAse I PRO:000006592 [356, 357]
RNAse CL3 structure mapping RNAse CL3 PRO:000025478 [358]
Nuclease S1 structure mapping Nuclease S1 PRO:000025471 [359]
RNAse T1 structure mapping RNAse T1 PRO:000025467 [360]
RNAse T2 structure mapping RNAse T2 PRO:000014060 [361]
RNAse U2 structure mapping RNAse U2 PRO:000025475 [362]
RNAse V1 structure mapping RNASE V1 PRO:000025477 [363]
OH-radical structure mapping OH footprinting OH-radical CHEBI:29191 [364]
Inline Probing Inline Probing No chem.
probe
[280, 365]
1M7 RNA structure mapping SHAPE 1 - methyl - 7 - nitroisatoic anhydride
(1M7)
CHEBI:60343 [331]
RNAse I RNAse I PRO:000014042 [366]
Table 4.1: SNRNASM assays currently in OBI along with their corresponding Inputs (Probes).
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Figure 4.2: Graphical representation of the different terms we added to OBI (the Ontology of Biomedical Investiga-
tions) used to describe single nucleotide resolution nucleic acid structure mapping (SNRNASM) experiments. Each
term is assigned a unique identifier (e.g. OBI:0001014) and organized by a series of hierarchical relationships. We used
’is a’ relationships in this case. For example DNAse 1 structure mapping (OBI:0001016) ’is a’ enzymatic mapping
(OBI:0001014) experiment, which ’is a’ SNRNASM (OBI:0000807). In organizing our description of structure map-
ping experiments in this way, it becomes possible to design algorithms that will automatically identify relationships
between different data sets.
new OBI releases. For example, some annotations (e.g. RNase 1) are ”in process,” and will
therefore be added to OBI after the publication of this manuscript (Figure 4.2).
To facilitate access to our SNRNASM classification we have developed a series of
spreadsheets that provide a straightforward framework for annotating a chemical or enzymatic
mapping experiment. Links to these spreadsheets can be found at http://snrnasm.bio.
unc.edu, which are hosted in the ”cloud,” currently Google Docs servers. ”Cloud” servers
131
can be any publically available computer designed to store and disseminate data. By placing
these documents in the cloud, no single lab is responsible for hosting these files on their
servers and anyone can edit an archived file if necessary. Our goal is to facilitate community
involvement in the annotation process and to enable the groups developing new structure
mapping techniques to specify the terms that best describe their techniques.
4.3.3 Data Sharing using the ISA-Tab format
The ontological framework we described above allows us to define structure-mapping
experiments precisely. From a practical perspective, by associating an OBI term with each
type of structure mapping experiment (Figure 4.2), it is possible to specify uniquely the type
of experiment that was carried out on a nucleic acid. Although this represents a significant
advantage in terms of being able to search for specific data sets, additional experimental
information is required to be able to compare data sets effectively. For example, experimental
conditions such as monovalent and divalent ion concentrations significantly affect the folding
of RNA; it is essential to specify these conditions when undertaking comparative data analysis
[232, 367–370]. Furthermore, SNRNASM data can be collected in different ways (using
direct labeling of the RNA and gel electrophoresis, or reverse transcription followed by cDNA
fragment analysis on a capillary sequencer [144, 314]. It is therefore important to capture,
at minimum, the defining characteristics of experimental details in an annotation. Defining
best practices for experimental annotation of data is a nuanced challenge [139, 323, 339].
On one hand, capturing as much detail as possible is ideal from a future analysis perspective.
However, excessive annotation requirements are burdensome for the individual trying to
share data and can significantly decrease the overall amount of data shared. We therefore
chose to require minimal annotations and developed a flexible format for sharing data that
allows the user to decide which annotations to provide. Furthermore, we use a simple
format that is easily edited in a spreadsheet program (including Excel and OpenOffice). We
base our standard on the ISA-Tab (Investigation/Study/Assay) format, which is sufficiently
extensible to allow easy SNRNASM annotation, is well-established, and widely used for
biomedical data sets [371].
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The SNRNASM ISA-Tab format is based on the concept of a multi-tabular spreadsheet.
It includes three tabs, ”Investigation,” ”Study-Assay,” and ”Data Matrix.” The Investigation
tab contains bibliographical references, authorship, dates, and protocol-related information.
In general, a single ISA-Tab file will communicate all data presented in one manuscript.
An assay is defined as a mapping experiment using one probe on one nucleic acid, and
each row in the Study-Assay tab (Supplementary Figure 4.S2) corresponds to one such
experiment. The actual data is stored in the third Data Matrix tab where each column
corresponds to one assay (Supplementary Figure 4.S2). There is therefore an implicit
one-to-one correspondence between rows in the Assays tab and the columns in the Data
Matrix tabs. This correspondence is explicitly coded in the Study-Assay tab by a column
with Assay Names that correspond to the first row of the Data-Matrix tab.
The Assays tab is where the ontological classification outlined above is used. The
Term Accession Number column corresponds to the OBI accession number specifying the
type of chemical or enzymatic mapping experiment. Furthermore, other variables (such as
monovalent and divalent salt concentration and type) are specified in additional columns
in the Assays tab. In principle, any number of experimental conditions can be specified in
this way; in practice, only those experimental variables that change (for example, MgCl2
concentration) are recorded. In this way, the most important variables in the experiment
are captured systematically.
4.3.4 Creating and sharing an ISA-Tab file
Given that an ISA-Tab file is simply a spreadsheet, specialized software is not required.
To simplify the process of creating the appropriate file, we have developed a tutorial
document, provided in the supplement of this manuscript and also at the SNRNASM
web site (http://snrnasm.bio.unc.edu/SNRNASM_Tutorial.pdf). Additionally, links to
template ISA-Tab files and example data sets are also available online. Column and row
headers are colored in green and yellow, indicating fields that require user input and or
not, respectively. In practice, most users will simply download an example ISA-Tab file
and modify it according to their needs. In most cases, data can be simply pasted into
the template to produce a new ISA-Tab file, greatly reducing the burden of data sharing.
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Alternatively, ISAcreator (http://isatab.sourceforge.net/isacreator.html) used in
combination with dedicated configurations (http://tinyurl.com/69r7au3) can provide the
necessary support for managing structure mapping data locally prior to release. It is an easy
to use tool that automatically helps create and populate ISA-Tab files as well as organize
data in the lab. Embedded, community vetted controlled vocabulary eases data reporting
while reducing annotation ambiguity. Currently being developed is the capability to save
ISA-Tab reports as Google spreadsheets directly from ISAcreator tool, thereby facilitating
sharing as advocated by this group. As mentioned above, we propose a distributed approach
to storing ISA-Tab files. Therefore we have not created a central server where such data are
to be uploaded. Instead users may choose to upload their ISA-Tab files to their own servers,
or alternatively make them publically available through a free cloud service like Google
Docs. Instructions on how to make data public are provided in the tutorial. One advantage
of making data available in the cloud is that it allows us to leverage web search engines
to find SNRNASM data (for example, googling the data). Links to the SNRNASM data
from pages that are already indexed will facilitate discovery by automated Internet crawling
engines. We therefore encourage users to link to their data from their homepages, as well
as from the primary publication. Additionally, we link to any SNRNASM data submitted
to http://snrnasm.bio.unc.edu. We have also created an automated ISA-Tab validation
tool for SNRNASM data at http://rmdb.stanford.edu/repository/tools/validate/
that will identify inconsistencies in a file.
4.4 Applications
4.4.1 Example use cases
The most likely SNRNASM use case is also the most straightforward in terms of
implementation. An investigator reads a paper in which structure-mapping data was
collected and wishes to reanalyze these data in a new context. Rather than having to extract
the data from a pdf in the supplement, the original SNRNASM data can be obtained in a
format that is easily parsed (Figure 4.1B). Alternatively, the user can search for SNRNASM
data and the names of the authors.
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As mentioned above, solution conditions (especially monovalent and divalent cation
concentration) significantly alter the three dimensional conformation of RNA [328, 368,
372, 373]. Chemical and enzymatic probes are often used to study the effects of solution
conditions on the structure of RNA [328, 350, 367, 374, 375].
To illustrate the value of sharing chemical and enzymatic mapping data, we performed
a simple meta-analysis of the effects of solution conditions on the DMS (OBI:0001015)
accessibilities of functional RNA residues. Specifically, we wanted to find DMS structure
mapping data that were collected under similar divalent solution conditions for different
RNAs. We therefore searched for SNRNASM files containing the terms OBI:0001015 and
CHEBI:6636 (MgCl2), and identified two studies where DMS chemical mapping data were
collected on RNA in the absence and in the presence of 10 mM MgCl2. In the first study, DMS
chemical mapping data were collected on sequence variants of the SRP (Signal Recognition
Particle) domain IV motif [376], while in the second study, data was collected on the P4-
P6 subdomain of the L-21 T. thermophila group I intron [232]. SNRNASM classification
therefore facilitated identification of similar data sets for meta-analysis.
Because SNRNASM data files provide easy access to the data, rapidly generating new
visualizations is greatly simplified. We used a tool to project structure mapping data on to
RNA secondary structure diagrams provided with the SAFA software [377] to visualize the
DMS data from these experiments on 2D representations of the RNA (Figure 4.3). What is
immediately apparent from our visualization of the DMS mapping data is that the addition
of 10 mM MgCl2 results in significant changes in the overall DMS reactivity for P4-P6
(Figure 4.3A) and to a lesser degree for the SRP domain IV motif (Figure 4.3B). The effects
of this structural change are visible when comparing the no-Mg2+ and Mg2+-present data
sets for the P4P6 domain (Figure 4.3A), which includes significant tertiary contact formation
upon folding [369, 378–380].
Interestingly, subtle effects in DMS reactivity are also observed upon Mg2+ addition to
the SRP domain IV hairpin (Figure 4.3B). No tertiary contacts are present in this RNA,
so one might expect the DMS reactivity to be identical in both solution conditions. This
domain was chosen for study because it is composed of a series on non-canonical base-pairs
(indicated using the Leontis-Westhof nomenclature in Figure 4.3B, [382]). The relationships
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Figure 4.3: Example meta-analysis of DMS (OBI:0001015) chemical mapping data from two separate studies on
RNA. For example, to visualize the effects of Mg2+ on the DMS reactivity of nucleic acids, we searched for OBI:0001015
(DMS) and CHEBI:6636 (MgCl2) in ISA-Tab [371] files and identified two studies where RNA was probed with DMS in
the absence and presence of Mg2++. We then downloaded the two ISA-Tab files (https://spreadsheets.google.com/
ccc?key=0As58Pw6ZT3UtdGFveExsek9tdUJNS0xXbUFmRE1ZR0E&hl=en#gid=1 and https://spreadsheets.google.com/
ccc?key=0AvCayBYdTclldEJoQ3otbWE5RGx0VzdobmVjX2Q5b3c&hl=en#gid=0) and used a tool included in the SAFA soft-
ware [381] to visualize the data on the RNA. A) Secondary structure diagram of the L-21 T. thermophila group I
intron with DMS data mapped to its secondary structure with (right) and without (left) Mg2+ present. B) Secondary
structure diagram of domain IV of SRP with and without Mg2+ present.
between 3D structure and chemical reactivity is not simple, but the availability of large
numbers of quantitative data sets like the two we analyzed here will allow us to better
analyze these relationships in a quantitative and predictive manner [196, 231, 383, 384].
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4.5 Discussion
Our objective in this work is to establish a simple, but robust standard that facilitates
sharing of single nucleotide resolution nucleic acid structure mapping (SNRNASM) data. To
achieve this objective, we: 1. Describe and classify common SNRNASM experiments using
a standardized (ontological) vocabulary. 2. Develop a standard format for reporting probing
data that is easily read by both humans and computers. 3. Provide a means by which to
make these data widely available. Our SNRNASM classification depends on several ontologies
including the Ontology of Biomedical Investigations (OBI) [339], the Chemical Entities for
Biomedical Investigations (CHEBI) [341, 342], the Protein Ontology (PRO) [343, 344], and
the RNA Ontology (RNAO) [323, 337, 385]. SNRNASM experiments are described as assays
in OBI, with the input being the nucleic acid and the chemical or enzymatic probe, while
the output is a measurement of reactivity. We have added the chemical probes that were
not already in CHEBI (Table 4.1) to uniquely identify the OBI inputs. Similarly, for the
nucleases used for enzymatic probing, we obtained unique Protein Ontology identifiers (Table
4.1). This allows us to uniquely identify each SNRNASM type and assign it an OBI identifier
(Figure 4.2). The RNA Ontology (RNAO) annotates crucial structural features of RNA
molecules extracted from atomic-resolution 3D structures, including all non-Watson-Crick
basepairs [323, 337, 385].
We sought to be as inclusive as possible and any omissions from the SNRNASM techniques
(described in Figure 4.2 and Table 4.1) are inadvertent. These are publically available and
can easily be updated by community input (available at http://bit.ly/d51yNY); thus,
expanding the SNRNASM classification is straightforward. Our criteria for including an assay
into our classification require: a primary publication, that the assay either modifies or cleaves
a nucleic acid, that the data can be interpreted structurally, and that the modification or
cleavage is localized to a specific nucleotide. The list of SNRNASM assays reported in Table
4.1 therefore represents a starting point for the classification of these experimental techniques
and will evolve as new methods are developed. We defined two broad classes of SNRNASMs,
chemical and enzymatic (Figure 2). It is likely that new categories of SNRNASM will be
required in the future. Advances in deep sequencing and other genome-wide techniques will
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lead to whole- or large-scale transcriptome analysis in a single experiment [334, 386, 387].
These experiments generate large amounts of data and will require a systematic approach
for documenting and distributing results accurately and efficiently.
This standardization effort represents the beginning of a community effort to make
SNRNASM data widely accessible, to facilitate quantitative comparative analysis, to establish
predictive relationships between nucleic acid structure and chemical or enzymatic reactivity,
and to provide the software and algorithm development communities with essential data
for training and validation. By enabling large-scale meta-analysis, it may become possible
to discover new approaches for interpreting the results of SNRNASM assays. We therefore
strongly encourage laboratories carrying out these assays to make their data available upon
publication.
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4.6 Supplementary Material
Supplem
entary Figure 1
Figure 4.S1: A screenshot from Prote´ge´ [319], a program for editing and visualizing ontologies (in this case we are
visualizing OBI, where SNRNASMs are classified). This screenshot shows that we are able to correctly infer whether
a SNRNASM is a chemical or enzymatic probing experiment from the OBI annotation.
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Supplem
entary Figure 2
Figure 4.S2: Example of an ISA-Tab file reporting the results of DMS structure probing experiments on a synthetic
RNA containing an SRP motif. The file contains the raw data in tabular format as well as meta-data describing the
experimental conditions. The ISA-Tab format is designed to make the process of sharing data as easy as possible
and can be read by any spreadsheet software. Furthermore, with the ubiquitous availability of internet-based sharing
applications, making the data available does not require a centralized curated database. By using one of our ISA-Tab
templates, it is easy to share data in a way that will allow automated computational tools to analyze the data.
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CHAPTER 5
eQTL SNPs enriched near RBP binding sites reveal the importance of the
mRNA conformational ensemble1
5.1 Overview
A central component of the cell’s post-transcriptional regulatory network is the complex
set of RNA binding protein (RBP) interactions with mRNAs and other non-coding RNAs.
Immunoprecipitation combined with cross-linking followed by next generation sequencing
provides comprehensive transcriptome-wide maps of RBP binding sites. RBP binding site
recognition is a function of both the sequence and in many cases structure of the RNA. Mu-
tations can disrupt RBP binding by changing the specific sequence recognized or by altering
the local RNA structure proximal to the binding site. We analyze eQTL SNPs (expression
Quantitative Trait Loci Single Nucleotide Polymorphisms), i.e. mutations associated with
a change in mRNA expression, overlapping or proximal to PAR-CLIP (Photoactivatable-
Ribonucleoside-Enhanced Crosslinking and Immunoprecipitation) determined sites for 13
RBPs. Our hypothesis is that eQTL SNPs that disrupt local RNA structure (forming a
”RiboSNitch”) next to RBP binding sites are more likely to be causative of the observed
mRNA expression difference. We developed a metric to measure the enrichment of eQTL
SNPs overlapping and proximal to RBP binding sites. We find that eQTLs are generally
not enriched in direct overlap with RBPs, but that for FXR1, C22ORF28, IGF2BP1-3 and
ELAVL1, statistically significant enrichment of eQTLs is found proximal to the binding
site. Analysis of the structurally significant changes induced by eQTL SNPs reveals that
proximal eQTLs affect the RNA structural ensemble in two distinct ways, involving an
important change in the Shannon entropy of the RNA structural ensemble. These findings
suggest distinct structural mechanisms by which a RiboSNitch may alter RBP binding and
1This work has been submitted to as a manuscript to the Journal Genome Biology, and is currently in
revision.
result in individual mRNA expression variation. Our results also illustrate the importance
of proximal structure in mediating RBP sensitivity and specificity.
5.2 Background
Although a central regulator of cellular processes, RNA rarely acts alone in the cell
[388–390]. A vast majority of transcribed RNAs including messenger RNAs (mRNAs)
interact with a host of exogenous molecules and proteins, and in some cases may even
resemble RNPs (Ribonucleoproteins) [391–394]. Understanding the molecular determinants
of RNA/Protein interaction specificity and sensitivity is therefore central to accurately
predicting regulatory processes in the cell [303, 389, 395, 396]. Although sequence motifs are
important determinants of RNA binding protein’s (RBPs) specificity, RNA structure (and
in particular the accessibility of the binding site) is essential to fine-tuning the interaction
[153, 397–400].
Mutations have the potential to disrupt specific RNA structural elements by destabilizing
existing base-pairs or favoring alternative conformations [179]. In certain cases, these can even
result in human disease phenotypes [124, 402]. When considering RNA/protein interactions,
two scenarios for mutations in proximity to RBP binding sites are potentially deleterious.
For an RBP interacting with RNA as illustrated in Figure 5.1A, the most direct mechanism
by which a mutation will disrupt the interaction is shown in Figure 5.1B. In this manuscript,
we are particularly interested in the scenario illustrated in Figure 5.1C; a mutation alters
the structure of the RNA and thus changes the accessibility of the binding site. In this case,
the mutation occurs in a proximal region to the binding site, indicated in Figure 1C (light
pink shading).
We distinguish two major classes of mutation induced structure change in non-coding
regions of mRNAs including 3’ UTRs. These regions are generally not evolved to adopt
a single conformation, but rather adopt multiple structures weighted by the Boltzmann
ensemble [179, 203, 229, 277, 403, 404]. If a majority of the structures are similar in structure,
the ensemble is considered low-entropy, while if they all differ significantly from each other, it
is considered high-entropy [405, 406]. As a result a mutation may alter structure by favoring
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Figure 5.1: Possible mechanisms by which a mutation (or SNP) can affect RNA/protein interactions in non-coding
regions of transcripts. A) The protein (blue oval) recognizes a specific sequence motif (green nucleotides) in a highly
accessible region of the RNA. B) If a SNP (red nucleotide) is present within the highly accessible recognition motif it
can disrupt the protein/RNA interaction. C) Alternatively, a proximal SNP can alter the structure of the transcript
and reduce the accessibility of the nucleotides for protein recognition. In this chapter we analyze direct and proximal
overlap between functional SNPs and experimentally determined RNA binding sites to characterize the structural
consequences of mutation induced RNA structure change on RBP binding. Proximal regions to RBP sites are indicated
in light pink. D) 3’ UTR of the NUP62 (nucleoprotein 62, GeneID 23636) which is 1412 nucleotides long. Two eQTL
SNPs map to the UTR (rs9523 and rs8429, indicated with red inverted triangles), and are in LD (indicated with a
large red triangle). In addition three SNPs (rs11547267, rs1044276 and rs11083988) are in LD with eQTL SNPs that
map to the NUP62 gene and are associated with changes in NUP62 mRNA levels [401]. Several SNPs overlap with
regions proximal to the RBP binding sites (indicated in light pink) for IGF2BP1-3, AGO1-4 and FMR1 (isoform 7),
indicative of enrichment as measured by the Ed metric (Equation 2). E.) Seven eQTL SNPs (four of which are in LD
with each other) map to the 3’ UTR of STK17B (3,864 nucleotides long, Serine/Threonine Kinase 17b, GeneID 9262),
however none overlap with proximal regions to the PAR-CLIP determined RBP sites. Proximal eQTL SNP overlap
is therefore depleted in this 3’ UTR as is evidenced by the negative Ed values.
an alternative low-entropy conformation or by increasing (or decreasing) the entropy of the
ensemble [407–409]. We therefore decided to characterize the structural changes induced by
eQTL SNPs proximal to RBP sites (Figure 5.1C) to determine the role of the entropy of the
Boltzmann ensemble in RBP/RNA interactions.
To investigate the role of mutation induced RNA structure change (or RiboSNitches [124,
179]) on RBP binding we require transcriptome-wide maps of both RBP sites and ”functional”
mutations. Recent high-throughput datasets obtained by cross-linking RNA and subsequent
143
immunoprecipitation of the RBP, specifically Photoactivatable-Ribonucleoside-Enhanced
Crosslinking and Immunoprecipitation (PAR-CLIP), provide the necessary transcriptome
wide coordinates for such an analysis [303, 304]. We utilized publicly available PAR-CLIP
data for 13 different RBPs [410]. eQTL SNPs (expressed Quantitative Trait Loci Single
Nucleotide Polymorphisms) are particularly relevant to this study as they are correlated with
changes (up or down) in mRNA expression [249, 312, 411]. Many eQTL SNPs affect mRNA
levels by altering transcription factor binding and thus transcriptional efficiency [412]. In
this study we are interested in those eQTLs that are not near or in linkage disequilibrium
(LD) with transcription factor binding sites. Instead we focus on those eQTL SNPs that
map to 3’ UTRs (Untranslated Regions) of genes. These regions are not only far from
transcription start sites, but are also the main binding sites of many RBPs [179, 187, 241].
The driving hypothesis of this study is that characterizing the RNA structure change that
results from eQTL SNPs near RBP sites can provide insight into the role of RNA structure
change (Figure 5.1C) in affecting RBP binding specificity and sensitivity.
5.3 Results and Discussion
5.3.1 Direct and proximal overlap visualization of SNPs and RBP sites
Our enrichment analysis focuses on the 3’ UTRs of mature mRNAs since a mutation
mapping to these regions is unlikely to affect transcription, nor change the protein sequence
of the gene. To illustrate the concept of enrichment we illustrate two 3’ UTRs in Figure
5.1 with different levels of RBP binding site and eQTL SNP proximal overlap enrichment.
The NUP62 (nucleoprotein 62, GeneID 23636) 3’ UTR illustrated in Figure 5.1D is 1412
nucleotides long and two eQTL SNPs map directly to it (rs9523 and rs8429, indicated with
red triangles in Figure 5.1D). In addition three other SNPs (rs11547267, rs1044276 and
rs11083988) are in LD with eQTL SNPs that map to the NUP62 gene and are associated
with changes in NUP62 mRNA levels [401]. We combined data from Gtex [401] and seeQTL
[413] with 1000 genomes LD data [414] (limited to CEU haplotypes) for our analysis. Based
on these data, we compute an Enrichment/Depletion score (Ed) for each RBP/SNP proximal
overlap (Figure 5.1D). The Ed score is simply the observed number of overlaps of eQTL
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SNPs minus the expected (Equation 1, methods). For all three RBPs illustrated in Figure
5.1D we observe more proximal overlap than what is expected by chance yielding a positive
Ed value.
In contrast, none of the 7 eQTL SNPs mapping to the 3’ UTR of STK17B (3,864
nucleotides long, Serine/Threonine Kinase 17b, GeneID 9262) overlap with the PAR-CLIP
determined RBP sites (Figure 5.1E). As such, the Ed scores are negative and the proximal
overlap is depleted. The 3’ UTRs illustrated in Figure 5.1 therefore differ in their relative
enrichment for PAR-CLIP eQTL SNP overlap. We aim to identify the RBPs that have
the most significant enrichment in direct and proximal overlap in their UTRs to identify
putative sites where a RiboSNitch (i.e. a region of an mRNA that changes structure if a
SNP is present) may be causing mRNA expression change [124, 179, 415]. We thus carried
analogous Ed calculations for all 3’ UTRs in the human genome and each of the 13 RBP
PAR-CLIP data sets [410].
5.3.2 Characterization of RBP binding site and eQTL SNP densities
To characterize the data in our analysis, we computed the fractional coverage of RBP
binding sites in intron, exons, 5’, 3’ UTRs and coding sequence (CDS). We considered
only PAR-CLIP binding sites with clusters scoring in the 20th percentile, i.e. only the
highest confidence sites reported [303, 304]. The coverage ratios presented in Figure 5.2
are normalized to transcript length and thus represent relative binding site density for the
different regions. This approach takes into account the fact that introns are usually much
longer than exons, for example. Figure 5.2A reveals that RBP binding sites are mostly found
in exons (which include UTRs), except for ELAVL1, QK1, and ZC3H7B, which also bind
significantly to introns. This is not surprising since these three proteins have all been shown
to play a role in RNA processing and splicing [416–419]. The analysis of RBP binding sites
in 5’, 3’ UTRs and CDS (Figure 5.2A, right panel) reveals more heterogeneity in binding
density for each RBP. Nonetheless, a large majority of RBPs target 3’ UTRs preferentially
(the fractions reported are again normalized by length). Given 3’ UTR’s established role in
regulation, this data further supports the focus on these regions for our study [419–421].
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Figure 5.2: Transcriptome coverage analysis of PAR-CLIP and eQTL SNP data sets used in this manuscript.
Fraction coverage is computed relative to genomic element lengths, and thus represents relative coverage density. A)
Relative PAR-CLIP mapping density to introns (cyan) and exons (purple) in human transcripts for the 14 data sets
used in the analysis. A majority of RBP binding maps to exons except for ELAVL1, QK1 and ZC3H7B where a
significant fraction of PAR-CLIP sites are also found in introns. Only PAR-CLIP RBP binding sites above the 80th
percentile quality score (high quality binding site as determined in the doRiNA database [410]) are considered. B)
Relative RBP binding site coverage analysis of mature transcripts for each RBP for 5’ (blue), 3’ (green), and coding
sequence (CDS, pink). Total number of sites in each data set is also reported. In a majority of RBPs, the 3’ UTR is
the major binding target, and there are significant variations in the total number of binding sites, ranging from 414
to 23,019. This study focuses on RBP binding sites in 3’ UTRs. C) Relative coverage of introns (cyan) and exons
(purple) of eQTL SNP data sets used in this analysis. 76% of eQTLs in our data set (first bar graph) map to exons;
when including LD partners (second bar graph) a greater percentage map to introns. Excluding all eQTLs that are in
LD with SNPs near (within 500nt) a transcription start site (TSS) results in equivalent SNP density in introns and
exons (third bar graph). D) Mature transcript mapping density analysis of eQTL SNP dataset indicates that when
including LD SNPs and filtering for those near a TSS, a majority of eQTLs SNPs map to 3’ UTRs. The total number
of SNPs in each data set is reported.
Unlike PAR-CLIP data, eQTL SNPs are derived from comparative analysis of gene
expression in multiple cell lines [249, 312, 411, 412]. An eQTL SNP is the result of a correlative
analysis, using natural genetic variation to power statistical association regressions [249].
One limitation of this approach is that in most cases eQTL SNPs are in LD with many others,
and as such the correlation is for the entire haplotype and not a single SNP [179, 182, 402].
Identifying the causative SNP for an eQTL remains an important challenge in the field
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[249, 312, 412]. It is therefore necessary to consider LD when identifying eQTL SNPs
proximal or directly overlapping with RBP binding sites.
LD blocks depend on the ethnicity of the population being studied; in this analysis we
only consider eQTL studies derived from the CEU population of 1000 genomes, as these
remain the most comprehensively studied ethnic group [414]. In addition, a majority of
the PAR-CLIP data was collected in HEK293 cells, which were derived from a European
individual. We consider 3’ UTR eQTL SNPs that alter mRNA levels in cis of the transcript
they map to, i.e. they are correlated with a change in expression of the mRNA containing
the UTR. For each eQTL SNP mapping to a 3’ UTR, we use the 1000 genomes LD data
to find all SNPs in LD using an R2 > 0.6 as a threshold. If any of the LD partners of the
eQTL SNP map near (within 500 nt) a transcription start site (TSS), we eliminate the entire
haplotype from our analysis. All LD SNPs mapping to the same 3’ UTR are included in the
enrichment analysis, since any of these could be causative.
Figure 5.2C summarizes mapping density for the eQTL SNPs used in the analysis.
Comparing the mapping density of eQTLs with and without LD, we see an increase in the
percentage of eQTL SNPs mapping to introns when we include all SNPs in LD. Because we
exclude eQTL SNPs in LD with other SNPs near a TSS, the fraction of eQTLs mapping
to 5’ UTRs decreases as expected (Figure 5.2D). Overall, LD analysis combined with TSS
filtering further increases the fraction of eQTL SNPs mapping to 3’ UTRs, which is also
where a majority of the PAR-CLIP data maps (Figure 5.2B). These data illustrate one of
the reasons we focus the rest of our analysis on 3’ UTRs, as these regions have the highest
data density improving the potential statistical power of the analysis.
5.3.3 Transcriptome-wide enrichment/depletion analysis
We performed an enrichment/depletion analysis analogous to the one presented in
Figures 1D and 1E for all 3’ UTRs in the human transcriptome. For each 3’ UTR with at
least one eQTL SNP and one RBP site we computed Ed and report mean values in Figure
5.3 for each RBP. We measured Ed for direct overlap (dark gray) and proximal regions
ranging from 10 to 100 nts up and downstream of the RBP site (lighter shades of gray,
respectively). To determine the significance of the enrichment (or depletion) we performed
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Figure 5.3: Transcriptome-wide analysis of direct and proximal enrichment/depletion (mean Ed) for human 3’ UTRs
in which at least one RBP binding site and mutation is present. Direct overlap Ed is plotted as dark gray an increasing
proximal regions to the RBP binding site are indicated in lighter shdes of gray (see legend). Significance tests based
on random permutation (10,000x) of mutation sites and indicated with red (enrichment) and blue (depletion) asterisks
above bar graphs. A) Mean Ed values for eQTL SNPs mapping directly to 3’ UTRs, excluding any eQTLS in LD
(CEU haplotypes) with a TSS. We observe only weak enrichment in IGF2BP1-3 and ZC3H7B RBP binding sites. B)
Mean Ed values for all eQTL SNPs mapping to 3’ UTRs including those in LD (CEU haplotypes) with any eQTLs
associated with a change in mRNA expression in cis to the gene containing the 3’ UTR. Proximal overlap enrichment is
observed for the three RBPs, AGO1-4, C22ORF28 and FXR1. C) Mean Ed values for NHGRI GWAS SNPs mapping
to 3’ UTRs including any in LD as determined in [422]. Significant proximal enrichment is observed in several RBPs,
as well as significant depletion for direct overlap for several RBPs including AGO1-4. The direct overlap depletion
is likely due to negative selection on functional sites for the common SNPs used in GWAS genotyping arrays [423].
D) Mean Ed values computed for SNVs (Single Nucleotide Variants) reported in the Human Gene Mutation Databes
(HGMD) [215, 216]. Significant direct and/or proximal overlap enrichment is observed for six RBPs as well as large
mean Ed values. Since HGMD obtains SNVs by manually curating literature, in many cases these mutations have
been experimentally determined to be causative of the phenotype, resulting in higher overlap significance.
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eQTL SNP position shuﬄing as described in the methods (10,000 fold cross validation) to
estimate a p-value. The mean enrichment or depletion values significantly different from
zero are indicated with red and blue asterisks respectively in Figure 5.3.
Figure 5.3A summarizes the analysis of eQTL SNPs only excluding those that are in
LD with SNPs near a TSS. For example, this analysis only includes the SNPs indicated
with inverted triangles in Figures 5.1D and 5.1E. For a majority of RBPs, no significant
overlap enrichment is observed, except for eQTL SNPs proximal to ELAVL1, IGF2BP1-3
and ZC3H7B. Interestingly, no direct overlap enrichment is observed for any of the RBPs.
When we include SNPs mapping to 3’ UTRs that are in LD with eQTL SNPs in cis with the
gene, a more interesting pattern of enrichment emerges (Figure 2B). Indeed, eQTL SNPs
proximal to C22ORF28, ELAVL1 FXR1 and IGF2BP1-3 binding sites are enriched. The
overall amplitudes of the mean enrichment (and depletion) is also greater, largely due to
greater number of SNPs mapping to 3’ UTRs improving signal to noise (Figure 5.2D). We
also noted a statistically significant depletion for several direct overlap Ed scores, suggesting
possible negative selection against human genetic variation near those RBP binding sites.
Given the enrichment overlap of proximal eQTL SNPs to the C22ORF28, ELAVL1, FXR1
and IGF2BP1-3, we chose to perform RNA structural analysis on these four RBP binding
sites to understand the role of structure change in RBP binding.
We also performed analyses on two related ”functional” mutation data sets to compare
our eQTL SNP enrichment results. In Figure 3C, the enrichment/depletion analysis of
the NHGRI GWAS (Genome Wide Association Studies) catalog [10] for SNPs mapping to
3’ UTRs [422] is shown. Interestingly, several RBPs are significantly (p < 0.1) depleted
for direct overlap (AGO1-4, ZC3H7B) while significant enrichment is observed proximal
to FMR1 (isoform 1 and 7). The depletion in direct overlap is likely due to the fact that
common variants are chosen for the SNP arrays used in GWAS; negative selection against
natural variation has been previously reported in functional sites in the genome [423, 424].
In Figure 5.3D the enrichment depletion analysis for SNVs (Single Nucleotide Variants)
associated with human disease from HGMD (Human Gene Mutation Database) are reported
[215, 216]. The HGMD SNVs are manually curated from the literature, and are mostly
comprised of rare variants sequenced in individuals. As a result, these data are enriched in
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”causative” mutations, and the results are striking. Indeed, significant overlap (proximal
and/or direct) is observed for 6 of the 13 RBPs. These data therefore suggest that a mutation
proximal to an RBP site is more likely to be causative. Thus, direct and proximal overlap
analysis of RBP binding sites can facilitate the discovery of causative SNPs from GWAS
and eQTL analysis, especially when combined with structural analysis.
5.3.4 Structural analysis of eQTL SNPs proximal to RBP sites
Based on the enrichment analysis illustrated in Figure 5.3B we carried out a comprehen-
sive structural investigation of the surrounding RNA regions to the C22ORF28, ELAVL1,
FXR1 and IGF2BP1-3 binding sites. We identified 15 C22ORF28, 70 ELAVL1, 12 FXR1,
and 40 IGF2BP1-3 binding sites with proximal eQTL SNPs (within 100 nucleotides up or
downstream) and report these in the supplemental tables. We performed SNPfold analysis
to identify the eQTL SNPs that have the largest effect on the RNA structural ensemble
[124, 179]. We identified 18 eQTL SNPs proximal to RBP sites that score with a SNPfold
p-value < 0.1 and report these in Table 5.1. We also report the mean change in base Shannon
entropy for each SNP (Table 5.1, last column), a larger value indicates a greater change in
the entropy of the RNA ensemble.
RBP coords rsID dist
SNPfold 
CC
SNPfold 
CC pval
Shannon 
CC pval
C22ORF28 chr15:91474268-91474292(-) rs1052532 33 0.584 0.028 0.006
ELAVL1 chr10:120442852-120442876(-) rs17662895 6 0.495 0.027 0.033
ELAVL1 chr1:161932242-161932263(+) rs2499847 61 0.697 0.028 0.035
ELAVL1 chr18:61172202-61172230(+) rs11152386 3 0.7 0.032 0.031
ELAVL1 chr1:8413238-8413282(-) rs1058791 35 0.777 0.04 0.021
ELAVL1 chr4:164449168-164449189(-) rs6816526 84 0.811 0.057 0.013
ELAVL1 chr14:75599098-75599130(-) rs13099 25 0.648 0.063 0.032
ELAVL1 chr5:96109655-96109681(+) rs1057569 46 0.79 0.08 0.034
ELAVL1 chr7:128412139-128412170(+) rs62479594 6 0.656 0.088 0.029
ELAVL1 chr4:68483799-68483849(-) rs75660867 28 0.711 0.097 0.009
FXR1 chr5:95131469-95131492(+) rs7622 69 0.732 0.097 0.026
IGF2BP1-3 chr5:95222177-95222233(-) rs11135441 44 0.679 0.017 0.023
IGF2BP1-3 chr11:76732804-76732912(+) rs7123496 37 0.746 0.033 0.007
IGF2BP1-3 chr11:61569867-61569921(-) rs174546 38 0.807 0.038 0.017
IGF2BP1-3 chr4:130033685-130033741(+) rs337263 21 0.654 0.062 0.052
IGF2BP1-3 chr5:95222547-95222644(-) rs11135442 37 0.629 0.063 0.014
IGF2BP1-3 chr19:45913104-45913136(+) rs3212985 19 0.71 0.078 0.013
IGF2BP1-3 chr9:131493147-131493239(-) rs1129169 8 0.821 0.098 0.023
Table 5.1: Putative RiboSNitches caused by eQTL SNPs proximal to RBP binding sites.
Two distinct types of SNP induced structural changes are reported in Table 5.1 with
respect to Shannon entropy change; those with a large change in Shannon entropy (> 0.01,
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e.g. rs17662895), and those with a small change (< 0.01, e.g. rs1052532). Figure 5.4A
illustrates the mapping of rs17662895, which maps to the 3’ UTR of CACUL1 (CDK2-
Associated, Cullin Domain 1, GeneID 23727) and is associated with differential expression
of the gene. The SNP maps proximally to an ELAVL1 PAR-CLIP binding site. The average
base-pairing probability of the A and G alleles are shown in black and blue (Figure 5.4B),
respectively; the correlation coefficient between these two base-pairing probabilities is 0.495
(p-value = 0.027), which is the SNPfold score reported in Table 5.1. What is particularly
interesting about this RiboSNitch is that the change in Shannon entropy of the partition
function (Table 5.1, third column) is large (0.033). If we compare the partition functions of
the A and G alleles (Figure 5.4C) we observe a far less diffuse distribution of base-pairing
probabilities in the latter, consistent with lower Shannon entropy. Effectively, the A allele
results in a far more structurally diverse ensemble of suboptimal structures, while the G
allele is highly structured.
In contrast the putative RiboSNitch caused by rs1052532 (A/G alleles, Figure 5.4D)
results in a much smaller (0.006) change in Shannon entropy of the partition function, but
still an important change in base-pairing probabilities (Figure 5.1E, SNPfold correlation
coefficient 0.584, p-value 0.028). When comparing the partition functions for both alleles
(Figure 5.4F), we observe that the SNP results in a change between two dominant structures
since; For the G allele, the RBP (nucleotides 75-125) site forms a highly probable hairpin,
which is not present in the A allele. We conclude in this case that the SNP changes the
dominant structure, whereas in CACUL1, the SNP changes the level of conformational
heterogeneity in the mRNA 3’ UTR.
Of the 18 putative RiboSNitches affecting RBP binding sites identified (Table 5.1), only
three have small changes in the Shannon entropy (< 0.1) of the ensemble. Large changes in
Shannon entropy suggest that one allele is significantly more disordered (unfolded). These
types of structural rearrangements will result in a change in the accessibility of the binding
site, but will also significantly impact the stability of the mRNA. In contrast, entropy neutral
RiboSNitches (e.g. Figure 5.4F) change the RNA from one conformation to the other. In this
case, the effect is far more specific, and will likely only affect mRNA levels if the accessibility
of the RBP binding site is altered (which is the case in Figure 5.4E). Understanding the
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Figure 5.4: Effects of eQTL SNPs proximal to RBP binding sites on 3’ UTR structural ensemble for two representa-
tive UTRs. A) 3’ UTR of the CACUL1 (CDK2-Associated, Cullin Domain 1, GeneID 23727) mRNA, which is 5146
nucleotides long. eQTL SNP rs17662895 is associated with a change in CACUL1 expression and maps proximally to
a PAR-CLIP determined ELAVL1 binding site. B) Base-pairing probability calculation for A (black) and G (blue)
alleles reveals important structural differences induced by the SNP, including the PAR-CLIP binding site. C) Parti-
tion functions computed for the A (left) and G (right) alleles, which are probabilities for all possible base-pairs, the
color scale (blue to red) indicates increasing pairing probability. The eQTL SNP illustrated here results in a large
change in Shannon entropy, the A allele has more base-pairs with intermediate pairing probabilities compared to the
G allele. As a result the G allele results in a 3’ UTR that is more likely to adopt a single structure, i.e. is more
ordered. D) 3’ UTR of the HDDC3 (HD Domain Containing 3, GeneID 374659) mRNA, which is 618 nucleotides long.
eQTL SNP rs1052532 is associated with changes in HDDC3 mRNA levels and is proximal to a C22ORF28 binding
site. E) Base-pairing probability for the A (black) and G (blue) alleles for the region proximal to the RBP site.
Significant changes in base-pairing probability are predicted in the C22ORF28 site suggesting this is also a putative
RiboSNitch. F) Partition function for the A (left) and G (right) allele. The G allele favors a high probability stem
between nucleotides 75-120 that is lower probability in the A allele partition function. Interestingly this structure
change occurs within the PAR-CLIP determined RBP binding site.
precise molecular determinants of these regulatory interactions will require further targeted
studies of these systems.
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5.4 Conclusions
Our analysis of RBP binding site overlap (direct and proximal) with eQTL SNPs (and
other sources of ”functional” mutations) reveals the importance of these interactions in
the genetics of human phenotypes. The fact that enrichment and depletion is measurable
when comparing genetic variation datasets (eQTLs, GWAS and HGMD) and PAR-CLIP
data indicates that significant functional interactions occur at many RBP binding sites.
Our analysis also begins to establish a framework with which to interpret and understand
at a molecular level the potential causal relationships of observed genetic associations.
Transcriptome-wide maps of RBP binding sites therefore represent a significant development
for the interpretation of genetic association data in a molecular context.
This analysis also reveals one of the main limitations of using natural human genetic
variation to identify regulatory networks in the cell. Indeed, LD blocks make it difficult to
identify a causative mutation without further experiments. Overlap analysis with PAR-CLIP
data has the potential to enrich association data with causative SNPs. The largest mean
overlap enrichments (and most statistically significant) observed were with the HGMD data
set (Figure 5.3D), which includes the highest percentage of experimentally verified causative
mutations [124, 215, 216]. As such, direct or proximal overlap with an RBP site of an eQTL
SNP is evidence for a causal relationship. As more high coverage individual RNA-seq data
becomes available it will be interesting to determine if allele-specific SNVs are significantly
enriched for overlap with RBP binding sites [425]. Our HGMD and GWAS enrichments
(Figures 3C and 3D) suggest that if this is the case, allele-specific determination of SNVs
will be a powerful tool for identifying post-transcriptional genetic regulatory mutations.
The structural analysis of eQTL SNP RiboSNitches (Figure 5.4) suggests an important
distinction in the type of structural change induced by a mutation. Our data reveal that
high and low entropy changing SNPs are equally functional, since we observe multiple
examples of each in regions proximal to RBP binding sites (Table 5.1). Nonetheless, a
majority of mutations significantly affect the Shannon entropy of the ensemble suggesting
changes in entropy are the most common molecular mechanism for RiboSNitch action. We
hypothesize that the downstream molecular mechanism resulting in the observed difference
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in mRNA level depends on the type of structural change caused by a SNP. Indeed, a more
disordered mRNA is more susceptible to degradation pathways in the cell, and the SNPfold
entropy calculation could be used to predict molecular mechanisms of transcript regulation.
Integration of genetic and molecular data is thus a powerful approach for dissecting the
molecular details of post-transcriptional gene regulation when combined with analyses of
the RNA structural ensemble.
5.5 Materials and Methods
5.5.1 PAR-CLIP datasets
All PAR-CLIP datasets included in the analysis were obtained from the Database of Post-
transcriptional Regulation, or DoRiNA (http://dorina.mdc-berlin.de/rbp_browser/
dorina.html). DoRiNA hosts published (and in some cases unpublished) data corre-
sponding to protein binding sites in RNA elucidated by various forms of crosslinking and
immunoprecipitation [410]. We downloaded PAR-CLIP data from publications pertaining
to human transcriptomic binding sites for 14 different RNA-binding proteins (AGO1-4,
ALKBH5, C17ORF85, C22ORF28, CAPRIN1, ELAVL1 [426], FMR1 (isoforms 1 and 7),
FXR1, FXR2, IGF2BP1-3, PUM2, QKI, and ZC3H7B). These selections were made because
the clusters in these tracks were derived via the PAR-CLIP Pipeline (PCP) in DoRiNA
[410]. The pipeline enables score percentiles representing the T2C mutation rate in each
cluster filtering. These percentiles to were used to generate track subsets corresponding to
80th percentile clusters for RBPs (highest confidence), which were used in our subsequent
analyses.
5.5.2 SNP datasets
eQTL SNPs from 10 different datasets (corresponding to data from 6 separate pub-
lications) were obtained from seeQTL (obtained 7/25/2012 http://www.bios.unc.edu/
research/genomic_software/seeQTL/) and the Genome-Tissue Expression archive, or
GTEX (obtained 7/25/2012, http://www.ncbi.nlm.nih.gov/gtex/GTEX2/gtex.cgi) [401,
413]. The eQTLs derived from hapmap LCL cell lines were taken entirely from seeQTL, and
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a significance filter cutoff of q < 0.1 was applied. The eQTLs from Brain and Liver tissue
were taken from GTEX, where a significance filter cutoff of p < 0.01 was applied. Only
cis-eQTLs (defined as less than 1 MB away from the mapped site of the relevant array probe
on the same chromosome) were analyzed. We have limited our results to CEU population
eQTLs and subsequent LD blocks (R2 > 0.6), because PAR-CLIP experiments were done in
Dutch-background HEK293 cells, which is closest in genotype to the CEU population.
The set of 3’ UTR GWAS and GWAS-LD-linked SNPs was kindly provided by Praveen
Sethupathy based on the analysis carried out in [422]. These SNPs correspond to results
from various GWAS studies. Analogous to the eQTL dataset, each LD background for
a given GWAS SNP was properly matched to the same ethnic group. The final SNP set
represents a pooling of all GWAS SNPs and LD SNP background at a cutoff of R2 > 0.6.
The Human Gene Mutation Database (HGMD) was licensed and obtained from biobase
international, and downloaded on 1/11/2013 [215, 216]. The SNVs used in enrichment
analyses were all from the ’ntsub’ table in HGMD Advanced. SNVs from the dataset were
annotated manually from publications that link them to some alternate phenotype, often
providing evidence of the SNPs’ functionality [124].
5.5.3 LD Analysis
To extract SNPs that are in LD with eQTLs in the CEU group, we used the SNP
Annotation and Proxy Search (SNAP) webserver (http://www.broadinstitute.org/mpg/
snap/ldsearch.php) [427]. We extracted all SNPs in LD (here defined as R2 > 0.6 and
distance < 500kb) with each eQTL, and kept only LD SNPs for a given eQTL where given
a specific gene region in refseq annotations that the eQTL maps to a 3’ UTR. As a final
filtration step we went through the genic LD networks that had been formed and only kept
those that where no involved SNPs that map within 500 nucleotides of the Transcription
Start Site (TSS) of the overlapping gene region to remove putative transcriptionally regulated
associations.
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5.5.4 Genome Algebra
Calculations of coverage of a given interval set in the genome, as well as in a defined set
of intervals in the genome was performed using programs derived from a simple set of C
programs. The merging of overlapping intervals to produce a set of non-overlapping intervals
in the genome was done using the ’merge’ feature in the bedtools genome algebra package
[428–430]. Sets of intronic intervals that did not overlap with any defined exonic intervals
were obtained using the ’subtract’ feature in bedrolls to get all genomic intervals from a
given bed file that do not cross any feature in a second user-defined bed file.
5.5.5 Enrichment analysis
The enrichment/depletion analysis presented in this manuscript is based on a simple
model of expected overlap. The expected number of overlaps E for a 3’ UTR of length n,
given m nucleotides covered by PAR-CLIP clusters and q SNPs is the following equation:
E = q ∗ m
n
The above equation is also applicable to regions proximal to a PAR-CLIP site; m is then the
number of nucleotides covered by flanking regions to the site. Given that the above equation
provides the expected overlap, an Enrichment (or Depletion) Ed score is easily computed
with:
Ed = x− E
where x is the number of SNPs overlapping with PAR-CLIP sites (or proximal to them). As
a result a positive Ed indicates enrichment whereas a negative value indicates depletion. Ed
values were computed for single 3’ UTRs as well as averaged for all 3’ UTRs in the transcript
where n, m, and q > 0.
To determine the significance of enrichment or depletion, SNP positions were randomly
permuted 10,000 times to obtain the background distribution of Ed. This distribution has
a mean of zero, but by determining the rank of the observed Ed value from the simulated
ones, a p-value was estimated non-parametrically. To generate a background distribution to
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compare enrichment values each region/feature combination in was permutated by assigning
new random positions to the q SNPs. This was repeated 10,000 times for each UTR where q
> 0 and m > 0. The enrichments were stored in an N * P matrix (where N is the number
of regions and P is the number of permutation tests, 10,000). Analogous analyses were
computed for direct and proximal overlap to for increasing regions proximal to RBP sites.
5.5.6 SNPfold Analysis
For PAR-CLIP clusters corresponding to an RBP, all 3’ UTR PAR-CLIP RBP binding
sites were extracted where at least one SNP that is less than 100 nucleotides from the center
of the cluster. Any RBP binding sites that were larger than 200 nucleotides in length were
not analyzed. For a given PAR-CLIP cluster site window of 200 nucleotides, the associated
human reference sequence for that region was extracted, and RNAfold 2.1.1 was used to
carry out the SNPfold algorithm to quantify the amount of predicted structure change the
SNP induces in the RNA [124, 179]. We further computed the normalized Shannon entropy
change of the partition function as previously defined [415].
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5.6 Supplementary Material
RAW OVERLAP COUNTS
total preMRNA Exon Intron 5UTR CDS 3UTR
eQTLs 31663 21160 3253 18338 227 1348 1543
eQTLs (genic LD set) 122255 122255 8513 115076 858 3029 4163
eQTLs (genic LD set, no TSS) 67858 67858 4067 64470 121 1467 2289
HGMD 81103 79971 70300 14316 1052 69260 962
3'UTR GWAS SNPs with LD SNPs 2201 2198 2191 244 0 18 2184
% OF TOTAL
preMRNA Exon Intron 5UTR CDS 3UTR
eQTLs 0.668 0.103 0.579 0.007 0.043 0.049
eQTLs (genic LD set) 1.000 0.070 0.941 0.007 0.025 0.034
eQTLs (genic LD set, no TSS) 1.000 0.060 0.950 0.002 0.022 0.034
HGMD 0.986 0.867 0.177 0.013 0.854 0.012
3'UTR GWAS SNPs with LD SNPs 0.999 0.995 0.111 0.000 0.008 0.992
% COVERAGE
preMRNA Exon Intron 5UTR CDS 3UTR
eQTLs 1.739E-05 4.616E-05 1.588E-05 4.402E-05 4.040E-05 5.876E-05
eQTLs (genic LD set) 1.004E-04 1.208E-04 9.966E-05 1.664E-04 9.078E-05 1.585E-04
eQTLs (genic LD set, no TSS) 5.575E-05 5.772E-05 5.583E-05 2.346E-05 4.397E-05 8.716E-05
HGMD 6.571E-05 9.976E-04 1.240E-05 2.040E-04 2.076E-03 3.663E-05
3'UTR GWAS SNPs with LD SNPs 1.806E-06 3.109E-05 2.113E-07 0.000E+00 5.395E-07 8.316E-05
Table 5.S1: Chart containing statistics for SNP datasets analyzed with respect to overlap counts, percent of total,
and percent coverage in each subregion of the hg19 annotated transcriptome. Region subsets analyzed often will
overlap (since some annotated regions in the genome, for example, can be both intronic and exonic when transcribed
in different transcript isoforms) and thus percentages will not add up to one. Percent coverage was calculated by
deriving the cumulative coverage in nucleotides of a set of regions of interest by the SNPs.
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% COVERAGE
preMRNA Exon Intron 5UTR CDS 3UTR
AGO1-4 0.0000129 0.0001975 0.0000026 0.0000919 0.0002138 0.0002493
ALKBH5 0.0000004 0.0000053 0.0000001 0.0000064 0.0000082 0.0000030
C17ORF85 0.0000003 0.0000047 0.0000001 0.0000081 0.0000079 0.0000012
C22ORF28 0.0000023 0.0000367 0.0000005 0.0000271 0.0000524 0.0000290
CARPIN1 0.0000016 0.0000258 0.0000003 0.0000149 0.0000288 0.0000326
ELAVL1 0.0000090 0.0000686 0.0000057 0.0000109 0.0000095 0.0001704
FMR1 (isoform 1) 0.0000189 0.0003095 0.0000022 0.0000766 0.0003626 0.0003633
FMR1 (isoform 7) 0.0000173 0.0002609 0.0000034 0.0001749 0.0003623 0.0002147
FXR1 0.0000014 0.0000226 0.0000002 0.0000035 0.0000232 0.0000311
FXR2 0.0000086 0.0001426 0.0000009 0.0000357 0.0001653 0.0001699
IGF2BP1-3 0.0000066 0.0001078 0.0000012 0.0000320 0.0001197 0.0001453
PUM2 0.0000035 0.0000501 0.0000010 0.0000023 0.0000050 0.0001269
QKI 0.0000050 0.0000143 0.0000045 0.0000045 0.0000070 0.0000269
ZC3H7B 0.0000073 0.0000759 0.0000036 0.0000390 0.0000738 0.0001072
RAW OVERLAP COUNTS
total preMRNA Exon Intron 5UTR CDS 3UTR
AGO1-4 15695 15694 13914 2991 474 7135 6547
ALKBH5 437 437 371 99 33 272 80
C17ORF85 414 414 333 116 42 263 31
C22ORF28 2855 2855 2583 548 140 1748 761
CARPIN1 1968 1968 1819 294 77 960 856
ELAVL1 10923 10922 4835 6538 56 316 4474
FMR1 (isoform 1) 23019 23018 21810 2583 395 12098 9541
FMR1 (isoform 7) 21082 21080 18384 3956 902 12088 5637
FXR1 1702 1702 1596 219 18 775 818
FXR2 10509 10509 10046 1077 184 5516 4461
IGF2BP1-3 8003 8003 7594 1367 165 3993 3817
PUM2 4320 4319 3529 1134 12 168 3333
QKI 6032 6032 1009 5196 23 232 707
ZC3H7B 8858 8858 5350 4141 201 2463 2816
% OF TOTAL
preMRNA Exon Intron 5UTR CDS 3UTR
AGO1-4 1.000 0.887 0.191 0.030 0.455 0.417
ALKBH5 1.000 0.849 0.227 0.076 0.622 0.183
C17ORF85 1.000 0.804 0.280 0.101 0.635 0.075
C22ORF28 1.000 0.905 0.192 0.049 0.612 0.267
CARPIN1 1.000 0.924 0.149 0.039 0.488 0.435
ELAVL1 1.000 0.443 0.599 0.005 0.029 0.410
FMR1 (isoform 1) 1.000 0.947 0.112 0.017 0.526 0.414
FMR1 (isoform 7) 1.000 0.872 0.188 0.043 0.573 0.267
FXR1 1.000 0.938 0.129 0.011 0.455 0.481
FXR2 1.000 0.956 0.102 0.018 0.525 0.424
IGF2BP1-3 1.000 0.949 0.171 0.021 0.499 0.477
PUM2 1.000 0.817 0.263 0.003 0.039 0.772
QKI 1.000 0.167 0.861 0.004 0.038 0.117
ZC3H7B 1.000 0.604 0.467 0.023 0.278 0.318
Table 5.S2: Charts containing overlap counts, percent of total, and percent coverage in each subregion for each
filtered PAR-CLIP dataset.
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C22ORF28
coords rsID dist
SNPfold 
CC
SNPfold CC 
pval
Shannon 
CC
Shannon 
CC pval
mean change 
in Shannon
chr15:91474268-91474292(-) rs1052532 33 0.584 0.028 0.235 0.048 0.006
chr14:24908325-24908353(+) rs3814810 42 0.852 0.131 0.584 0.052 0.031
chr17:16245892-16245916(-) rs7477 100 0.784 0.165 0.742 0.220 0.022
chr12:12629606-12629630(-) rs3088226 15 0.908 0.215 0.745 0.090 0.011
chr17:5336268-5336331(-) rs1050456 81 0.810 0.243 0.924 0.647 0.011
chr7:115897941-115897965(+) rs2896180 71 0.866 0.243 0.822 0.290 0.029
chr14:93693502-93693530(+) rs2905 81 0.954 0.318 0.747 0.161 0.025
chr14:24908325-24908353(+) rs1956904 60 0.928 0.334 0.818 0.321 0.019
chr7:115897941-115897965(+) rs2896181 58 0.931 0.421 0.934 0.606 0.003
chr17:7215197-7215224(+) rs11078672 56 0.931 0.446 0.902 0.438 0.001
chr14:75599603-75599626(-) rs3742771 21 0.976 0.552 0.968 0.734 0.001
chr19:10225706-10225738(-) rs7401 39 0.980 0.724 0.856 0.393 0.037
chr1:150937677-150937700(-) rs1546376 17 0.997 0.809 0.986 0.739 0.001
chr17:5336268-5336331(-) rs1050461 59 0.993 0.870 0.986 0.932 0.008
chr1:150938599-150938624(-) rs8444 29 0.976 0.882 0.931 0.749 0.009
chr7:6502282-6502324(-) rs6796 43 0.980 0.912 0.967 0.860 0.001
MEAN 50.313 0.903 0.456 0.822 0.455 0.013
STDEV 24.848 0.107 0.297 0.193 0.300 0.012
MEDIAN 49.500 0.931 0.378 0.879 0.415 0.010
Table 5.S3: Chart containing SNPfold analysis results for C22ORF28. The site where the PAR-CLIP cluster maps
to in hg19, the rsID of the SNP, and the distance from the SNP to the PAR-CLIP cluster are included. Correlation
coefficients (accompanied by SNPfold-estimated p-values) for baseppairing probabilities and shannon entropies in
wildtype versus mutant structural ensembles have been provided. Additionally, the mean absolute change in Shannon
entropy per nucleotide between wildtype and mutant have been included.
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Table 5.S4: Chart containing SNPfold analysis results for ELAVL1, same format as Table S3.
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ELAVL1
coords rsID dist
SNPfold 
CC
SNPfold CC 
pval
Shannon 
CC
Shannon 
CC pval
mean change 
in Shannon
chr10:120442852-120442876(-) rs17662895 6 0.495 0.027 0.279 0.005 0.033
chr1:161932242-161932263(+) rs2499847 61 0.697 0.028 0.784 0.176 0.035
chr18:61172202-61172230(+) rs11152386 3 0.700 0.032 0.745 0.123 0.031
chr1:8413238-8413282(-) rs1058791 35 0.777 0.040 0.750 0.085 0.021
chr4:164449168-164449189(-) rs6816526 84 0.811 0.057 0.706 0.093 0.013
chr14:75599098-75599130(-) rs13099 25 0.648 0.063 0.590 0.098 0.032
chr5:96109655-96109681(+) rs1057569 46 0.790 0.080 0.551 0.015 0.034
chr7:128412139-128412170(+) rs62479594 6 0.656 0.088 0.764 0.130 0.029
chr4:68483799-68483849(-) rs75660867 28 0.711 0.097 0.674 0.131 0.009
chr9:136229838-136229894(-) rs2494 6 0.771 0.113 0.559 0.093 0.058
chr5:64015387-64015425(-) rs898211 27 0.883 0.116 0.700 0.115 0.040
chr10:127524979-127524999(+) rs7320 73 0.731 0.135 0.791 0.226 0.018
chr2:20884856-20884887(-) rs9085 86 0.923 0.180 0.961 0.614 0.001
chr17:80572559-80572587(-) rs1059672 41 0.801 0.211 0.812 0.381 0.037
chr2:231268410-231268443(+) rs17273079 87 0.885 0.230 0.881 0.231 0.024
chr18:29843784-29843814(-) rs9510 14 0.695 0.233 0.619 0.186 0.004
chr2:203426099-203426125(+) rs17199242 10 0.895 0.250 0.931 0.582 0.007
chr10:18966825-18966854(+) rs10741129 53 0.850 0.278 0.655 0.078 0.034
chr5:137772209-137772239(+) rs11334 57 0.817 0.280 0.653 0.108 0.043
chr8:144682443-144682493(+) rs3210186 133 0.878 0.286 0.598 0.111 0.034
chr2:231268410-231268443(+) rs56052963 69 0.908 0.291 0.830 0.131 0.024
chr4:95588234-95588254(+) rs1509617 77 0.818 0.308 0.891 0.494 0.020
chr15:44160514-44160540(+) rs11856795 42 0.870 0.313 0.745 0.170 0.012
chr7:108214004-108214033(+) rs3763457 79 0.881 0.329 0.846 0.466 0.007
chr19:57841529-57841559(+) rs10417949 85 0.847 0.331 0.865 0.546 0.029
chr2:231268410-231268443(+) rs56303947 101 0.924 0.343 0.897 0.286 0.007
chr10:18966825-18966854(+) rs1055116 13 0.908 0.369 0.922 0.569 0.000
chr18:19446937-19446962(+) rs7449 31 0.930 0.379 0.924 0.509 0.003
chr7:128409295-128409331(+) rs1043550 71 0.886 0.379 0.880 0.396 0.010
chr4:103947054-103947086(-) rs17215211 32 0.967 0.399 0.900 0.336 0.028
chr7:106843046-106843072(-) rs7981 61 0.922 0.436 0.841 0.304 0.035
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chr4:164449168-164449189(-) rs1133505 61 0.966 0.451 0.916 0.416 0.021
chr10:119765763-119765793(-) rs11198226 58 0.959 0.453 0.957 0.526 0.004
chr4:68483799-68483849(-) rs3188451 37 0.917 0.464 0.896 0.591 0.003
chr2:54888570-54888601(+) rs2941587 74 0.938 0.493 0.862 0.547 0.021
chr1:227844073-227844144(+) rs12133625 38 0.929 0.496 0.943 0.686 0.007
chr10:116623008-116623033(+) rs36089581 26 0.883 0.589 0.931 0.795 0.014
chr10:105049109-105049134(+) rs1063461 5 0.969 0.602 0.888 0.271 0.013
chr22:31303601-31303631(+) rs8004 77 0.969 0.609 0.997 0.962 0.002
chr20:5171965-5171991(+) rs3746677 43 0.975 0.644 0.966 0.689 0.003
chr20:60757426-60757455(+) rs1056885 34 0.944 0.659 0.917 0.547 0.017
chr5:96109162-96109189(+) rs28096 55 0.964 0.669 0.948 0.797 0.028
chr10:97365757-97365807(-) rs4037 13 0.982 0.676 0.900 0.479 0.010
chr7:128412051-128412097(+) rs62479594 37 0.982 0.714 0.921 0.536 0.019
chr4:106767148-106767179(+) rs28488297 47 0.988 0.729 0.813 0.203 0.035
chr12:46581590-46581621(-) rs11183388 18 0.976 0.737 0.953 0.719 0.014
chr19:46030108-46030130(+) rs10995 24 0.973 0.739 0.933 0.612 0.013
chr9:14618582-14618610(-) rs3802481 58 0.979 0.759 0.965 0.839 0.004
chr2:54888570-54888601(+) rs2971879 38 0.989 0.812 0.963 0.820 0.011
chr22:29452955-29452979(+) rs3178915 48 0.997 0.814 0.983 0.819 0.004
chr8:22398520-22398549(+) rs7431 59 0.992 0.855 0.937 0.710 0.018
chr1:150447463-150447497(+) rs12042229 66 1.000 0.857 0.978 0.687 0.003
chr3:40576010-40576058(+) rs3924444 3 1.000 0.874 0.973 0.644 0.007
chr2:65538252-65538313(-) rs114625088 18 0.992 0.877 0.988 0.935 0.003
chr22:30423710-30423737(+) rs9983 7 0.971 0.882 0.972 0.908 0.002
chr11:94864198-94864219(+) rs679427 73 0.999 0.884 0.989 0.847 0.005
chr18:61172202-61172230(+) rs11542560 51 0.998 0.890 0.996 0.955 0.001
chr14:92527040-92527060(-) rs1134378 85 0.999 0.892 0.991 0.860 0.007
chr6:28201138-28201164(+) rs7206 1 0.984 0.895 0.975 0.882 0.003
chr8:22398465-22398489(+) rs7431 4 0.996 0.915 0.980 0.784 0.002
chr17:14111099-14111153(+) rs7214082 23 1.000 0.928 0.995 0.903 0.002
chr19:34719129-34719154(+) rs583121 72 1.000 0.930 0.985 0.880 0.006
chr16:2088370-2088398(+) rs11876 59 1.000 0.932 0.999 0.920 0.002
chr2:86732573-86732619(-) rs3201448 50 1.000 0.932 0.996 0.857 0.002
chr1:204522352-204522392(+) rs10900596 65 0.997 0.937 0.981 0.943 0.003
chr8:22398465-22398489(+) rs7430 52 0.999 0.947 0.995 0.925 0.001
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chr9:114981023-114981049(-) rs6575 57 1.000 0.967 0.999 0.935 0.004
chr9:97694509-97694535(+) rs12552838 5 1.000 0.982 1.000 0.968 0.001
chr8:61534812-61534844(+) rs629268 51 1.000 0.995 1.000 0.992 0.000
chr14:51723576-51723610(+) rs4261445 37 1.000 0.998 1.000 1.000 0.000
chr12:60174421-60174470(+) rs10506399 23 1.000 1.000 0.998 0.998 0.003
MEAN 44.986 0.908 0.538 0.872 0.538 0.015
STDDEV 28.113 0.110 0.323 0.143 0.319 0.014
MEDIAN 46.000 0.959 0.496 0.922 0.547 0.010
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FXR1
coords rsID dist
SNPfold 
CC
SNPfold CC 
pval
Shannon 
CC
Shannon 
CC pval
mean change 
in Shannon
chr5:95131469-95131492(+) rs7622 69 0.732 0.097 0.588 0.030 0.026
chr7:128413030-128413048(+) rs1868774 49 0.719 0.106 0.252 0.095 0.009
chr12:75893343-75893360(-) rs1056904 39 0.822 0.378 0.740 0.221 0.034
chr16:69730627-69730648(+) rs3826154 73 0.915 0.396 0.913 0.418 0.013
chr7:135072094-135072108(-) rs3812278 33 0.958 0.396 0.913 0.521 0.010
chr6:89322214-89322235(-) rs2610767 4 0.910 0.451 0.928 0.704 0.019
chr7:108203051-108203069(-) rs40942 2 0.943 0.594 0.969 0.724 0.004
chr6:159187286-159187306(-) rs3205303 25 0.980 0.775 0.877 0.672 0.036
chr8:8996979-8996997(-) rs330915 44 0.998 0.867 0.981 0.849 0.012
chr2:196999594-196999618(-) rs12467988 31 1.000 0.932 0.999 0.962 0.001
chr12:46577972-46577988(-) rs3742058 84 1.000 0.937 0.998 0.932 0.000
chr22:21306953-21306973(+) rs2285547 85 0.994 0.955 0.967 0.900 0.004
chr12:51139189-51139208(+) rs4768914 71 1.000 0.967 1.000 0.965 0.000
MEAN 46.846 0.921 0.604 0.856 0.615 0.013
STDEV 28.041 0.101 0.321 0.217 0.331 0.012
MEDIAN 44.000 0.958 0.594 0.928 0.704 0.010
Table 5.S5: Chart containing SNPfold analysis results for FXR1, same format as Table S3.
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Table 5.S6: Chart containing SNPfold analysis results for IGF2BP1-3, same format as Table S3.
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IGF2BP1-3
coords rsID dist
SNPfold 
CC
SNPfold CC 
pval
Shannon 
CC
Shannon 
CC pval
mean change 
in Shannon
chr5:95222177-95222233(-) rs11135441 44 0.679 0.017 0.709 0.128 0.023
chr11:76732804-76732912(+) rs7123496 37 0.746 0.033 0.823 0.097 0.007
chr11:61569867-61569921(-) rs174546 38 0.807 0.038 0.731 0.087 0.017
chr4:130033685-130033741(+) rs337263 21 0.654 0.062 0.500 0.087 0.052
chr5:95222547-95222644(-) rs11135442 37 0.629 0.063 0.115 0.003 0.014
chr19:45913104-45913136(+) rs3212985 19 0.710 0.078 0.844 0.241 0.013
chr9:131493147-131493239(-) rs1129169 8 0.821 0.098 0.722 0.158 0.023
chr12:12627712-12627846(-) rs745632 17 0.736 0.115 0.804 0.285 0.027
chr12:75893550-75893632(-) rs1056904 152 0.607 0.120 0.318 0.048 0.065
chr20:3847962-3848086(+) rs709021 4 0.739 0.128 0.859 0.406 0.017
chr3:122128723-122128814(+) rs17266816 60 0.892 0.156 0.846 0.263 0.018
chr20:3847962-3848086(+) rs79634836 3 0.792 0.178 0.778 0.266 0.040
chr13:50106832-50106925(-) rs7995684 30 0.898 0.186 0.708 0.075 0.072
chr11:94863905-94863975(+) rs677549 41 0.844 0.205 0.762 0.226 0.019
chr19:53452996-53453049(-) rs1808106 53 0.769 0.228 0.663 0.295 0.008
chr19:50410378-50410444(-) rs11083988 16 0.907 0.358 0.770 0.205 0.001
chr1:27662500-27662655(+) rs9203 11 0.849 0.449 0.925 0.795 0.012
chr1:151746390-151746496(-) rs1623480 28 0.956 0.466 0.967 0.636 0.002
chr15:23004802-23004860(-) rs3693 33 0.972 0.471 0.942 0.409 0.008
chr17:8064088-8064144(-) rs1061032 6 0.951 0.501 0.894 0.478 0.014
chr14:75519952-75519995(-) rs7303 70 0.962 0.503 0.900 0.488 0.017
chr17:74672421-74672486(-) rs10473 15 0.971 0.521 1.000 0.918 0.000
chr1:16785363-16785458(+) rs11543230 106 0.930 0.546 0.800 0.363 0.027
chr17:644987-645107(+) rs1064245 2 0.938 0.569 0.910 0.656 0.011
chr10:105048963-105049064(+) rs1063461 41 0.953 0.589 0.920 0.349 0.010
chr19:58929368-58929401(+) rs3764531 64 0.908 0.599 0.555 0.085 0.069
chr11:118405927-118405967(+) rs3741325 22 0.990 0.647 0.823 0.396 0.007
chr3:196198567-196198658(-) rs4916497 35 0.952 0.654 0.675 0.215 0.056
chr12:75893550-75893632(-) rs1056900 65 0.973 0.662 0.973 0.879 0.002
chr14:96852123-96852161(+) rs1545280 53 0.980 0.662 0.889 0.572 0.040
chr5:137682630-137682706(+) rs2269953 8 0.977 0.699 0.823 0.514 0.014
167
chr11:118895319-118895494(-) rs8301 1 0.946 0.749 0.944 0.775 0.001
chr14:24906371-24906505(+) rs3742521 10 0.979 0.765 0.890 0.611 0.020
chr14:32330308-32330380(+) rs10348 49 0.995 0.774 0.968 0.567 0.008
chr6:138657748-138657808(+) rs6932923 66 0.987 0.775 0.978 0.800 0.002
chr5:95222177-95222233(-) rs17085231 22 0.986 0.864 0.987 0.908 0.007
chr9:139323270-139323385(-) rs1128874 39 0.995 0.884 0.985 0.907 0.003
chr14:24906371-24906505(+) rs3742522 29 0.997 0.915 0.966 0.865 0.016
chr10:16554337-16554401(+) rs7915533 8 0.996 0.917 0.997 0.990 0.002
chr13:45968173-45968266(-) rs3210286 34 0.999 0.942 0.997 0.960 0.004
chr9:132898170-132898266(+) rs2240914 40 1.000 0.970 1.000 0.965 0.001
MEAN 35.450 0.973 0.735 0.904 0.665 0.015
STDEV 26.595 0.026 0.142 0.119 0.274 0.019
MEDIAN 34.500 0.979 0.724 0.955 0.715 0.007
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CHAPTER 6
Conclusion
At this point, given the amount of ground that has been covered, it is necessary (and
considerate as well) to summarize the most important details in findings from previous
chapters. Additionally, it is important to emphasize and outline the future work that needs
to be done in extending the research described. This chapter will serve the purpose of
covering in a succinct manner the work accomplished, as well as detailing the direction that
future work is headed.
6.1 A retrospective on work described
The work described, in its focus on the effect of genetic variation on RNA structure, has
been very broad, from identifying predicted large structure changers in disease-associated
mutations, to identifying compensatory genetic variation in human populations, and finally
to exploring the potential functional impact that eQTLs might have on protein/mRNA
binding affinity and folded local structure. Additionally, shortcomings to approaches utilized
often become more apparent when considered in hindsight. The key details and findings
from the previous chapters, as well as the shortcomings in their methodologies, will now be
summarized.
6.1.1 Important findings
In previous chapters, our work and methodologies for identifying rare and common
variants that significantly change RNA structure have been covered in detail. Summaries of
the previous chapters will now be summarized.
In chapter 2, we described our work in using a relatively simple algorithm (which we
call SNPfold) to identify disease associated mutations that are predicted to significantly
disrupt RNA structural ensembles of untranslated regions of RNA [124]. We utilized
partition function calculations from the popular Vienna RNA structure prediction package
to produce for wildtype and mutant RNA sequences the ensemble of possible structures in
the form of the probability of any ij basepairing probability. Collapsing these matrices down
to total basepairing probabilities per nucleotide, we then produced a Pearson correlation
coefficient between WT and mutant basepairing probabilities as the metric of global structure
change. However, this structure change alone was not enough to tell us the significance of
this mutation in changing structure, as there will likely be a distribution that correlation
coefficients of equivalent RNAs of equal length would fit. In order to provide a P-value
estimate for the RNA in question, we produced a full distribution of single mutation structure
change values for the sequence by calculating the correlation coefficient between the wildtype
and every possible point mutation in the sequence, and then found the rank of our mutation
of interest amongst all possible point mutations in the sequence. The resultant p-value tells
of the probability of selecting at random a point mutation that changes the total basepairing
probabilities per nucleotide in global structural ensemble more than the mutation of interest.
We utilized SNPfold on a set of 514 SNPs that map to 350 unique UTR and noncoding regions
in the human transcriptome, and were able to identify six disease-states (Hyperferritinemia
Cataract Syndrome, β-Thalassemia, Cartilage-Hair Hypoplasia, Retinoblastoma, Chronic
Obstructive Pulmonary Disease (COPD), and Hypertension) where there existed multiple
SNPs in UTRs that are predicted to significantly alter the structural ensemble of the
associated genes. We took the four predicted significant structure changing mutations in
the FTL 5’UTR that are associated with Hyperferritinemia Cataract Syndrome and using
combined sampled suboptimal structures from the wildtype and all four sequence mutants,
projected the structures onto the first two principal components derived from the total
structural space. We saw that the suboptimal structures for this sequence form a primary
cluster where the primary functional RNA structure in the region, the Iron Responsive
Element, forms, and alterate clusters, where the IRE does not form. The WT sequence
structures primaryly populate the IRE forming cluster, whereas the mutants populate the
non-IRE forming clusters. From here, further work to validate these predictions became
necessary.
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Chapter 3 served partly as an extension of the work described in chapter 2, as well as a
pioneering effort into predicting conserved global RNA structure through the consideration
of LD SNP pairs predicted to change structure when together less than they would when
separate. We continued our focus on disease associated mutations in the FTL 5’UTR
associated with Hyperferritinemia Cataract Syndrome by conducting SHAPE on WT and
disease associated variants of the sequence. SHAPE experiments consist of chemically
modifying folded RNA with a chemical reagent (both N-methylisotoic anhydride, or NMIA,
and 1-methyl-7-nitroisatoic anhydride, or 1M7, can be used). The modifications were done
with single-hit kinetics per RNA molecule, in a manner that is dependent on the folded
structure of the transcript structural ensemble in solution. We conducted SHAPE on two
disease associated point mutations within the FTL 5’UTR that are predicted to significantly
change the global structure of the region (U22G and A56U) in order to ascertain their
effect on the formation of the Iron Response Element. SHAPE reactivities from repeated
experiments conducted on FTL 5’UTR WT, U22G, A56U and G4A transcripts showed that
U22G and A56U both disrupt the formation of the IRE structure, whereas the negative
control G4A did not. We then hypothesized that there exist compensatory mutations that
we can induce in the U22G and A56U mutants that would restore the IRE structure close to
that of WT. Through the use of SNPfold on all double mutants containing either U22G or
A56U, we identified the double mutants for each mutation that were predicted to bring the
total basepairing probabilities closest to that of the WT sequence. While some of the double
mutants were in line with restoring the specific basepairing formed in the WT sequence
(U22G/A58C, A56U/U24A), others were predicted to act by destabilizing the alternate,
non-IRE forming conformations and shifting the equilibrium of structures back towards
those that are IRE-forming (U22G/G17C, A56U/G63C). We then attempted to find other
examples of conserved global structure across inherited SNP pairs taken from the CEU
population in HAPMAP, and identified 484 LD SNP paired in 5’ or 3’ UTRs of mRNAs
that were predicted to conserve global secondary structures. In the work we reported 11
structure stabilizing haplotypes, 9 of which stabilize RNA binding protein sites as reported
by PAR-CLIP data for IGF2BP1-3.
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In Chapter 4, we explored the issues inherent to the sharing of chemical mapping data for
RNA structure, and proposed a universal file format meant to both provide single nucleotide
resolution structure data from experimentation and to carefully describe the protocol utilized.
The group involved in this work established a schema for the storing of data corresponding
to Single Nucleotide Resolution Nucleic Acid Structure Mapping (SNRNASM). The format
of the schema is based on the concept of a multi-tabular spreadsheet, and includes three
tabs, ”Investigation,” ”Study-Assay,” and ”Data Matrix.” Hence, these files are referred to
as ”ISA-tab” documents. The Investigation tab lists the literature source of the data, as
well as the full protocol for deriving the data contained in the ISA-tab file. The Study-Assay
tab contains the details of each specific assay (using one chemical or enzymatic probe on
one nucleic acid) contained within the ISA-tab, with one assay being listed for each row.
Lastly, the Data Matrix tab contains the reactivities for each individual assay listed in
the Study-Assay tab. Using a consistent nomenclature within the Ontology of Biomedical
Investigations, we are able to provide unique identifiers (termed Persistent URLs, or PURLs)
for classifying the data, and we utilize Google ”Drive” cloud servers for the hosting of these
ISA-tab files. The URL at which these files can be found is http://snrnasm.bio.unc.edu.
In Chapter 5, we explored the possible structural and functional effects of common
functionally enriched SNPs within the human population. We collected a set of eQTL SNPs
taken from multiple studies, where the presence of a particular polymorphism is associated
with a statististically signficant change in RNA expression level, and analyzed the enrichment
of their overlap with protein binding sites corresponding to results from PAR-CLIP datasets
for 14 different RNA binding proteins. We focused our study on overlaps in 3’UTRs due
to the majority of these PAR-CLIP sites mapping to these regions of the transcriptome.
We detected enrichment of proximal overlap of eQTLs with several RNA-binding proteins,
including the less understood IGF2BP1-3 and ZC3H7B, as well as the more well understood
ELAVL1 and AGO1-4. We saw additional proximal enrichment when we utilized the full
LD set inherited alongside the eQTLs, with haplotypes filtered out if they are within
500 nucleotides of the transcription start site for the gene in question. Unsurprisingly
we observed both direct and proximal enrichment of overlap between the binding sites
and disease-associated SNPs from HGMD, particularly with known key regulators such as
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ELAVL1 and AGO1-4. We conducted a local version of SNPfold on SNPs from the LD set
that were within a 100 nucleotide radius of the center of each PAR-CLIP site for which the
corresponding protein experienced proximal enrichment of overlap, and reported several
SNPs that were predicted to cause significant structural change in the local region around
where the PAR-CLIP site is located.
6.1.2 Weaknesses of approaches
As we look back on our work that we have conducted over the years, it becomes obvious,
knowing some of the things that we know now, that there were particular shortcomings to
our approaches. Some of these issues may be more obvious to people who read and consider
our work, whereas other issues may be more subtle. We will now consider these issues in
detail.
The SNPfold algorithm, while having proven effective in identifying mutations that
change RNA structure (as evidenced by our SHAPE analyses), has particular shortcoming,
some of which were known at the time of its development and some of which were only
discovered later on. Perhaps the most significant issue is not so much one with SNPfold itself,
but rather the RNA structure prediction utilities that it is dependent on. Current RNA
structure prediction algorithms have certain limitations that limit the accuracy of SNPfold.
Many of these limitations have been discussed already (cubic runtime complexity, inability
to detect pseudoknots, limited parameter set, and no non-WC basepairing). One limitation
that has not been discussed in-depth, however, is the poor performance of many algorithms
in predicting long range interactions in RNA. It has been known for a while that the current
thermodynamic parameters, as well as the secondary structure prediction algorithms used,
provide a bias towards short-range basepairing interactions [107]. Operating under the
assumption that indeed the probability of basepairing for an RNA goes down with increasing
basepairing distance, Bernhart et al. made modifications to the MacCaskill algorithm to
allow for a scanning window folding approach with adjustable maximum basepairing span
L [204]. This local structure focused approach has been used to predict structure change
in a higher specificity, more efficient manner by later SNPfold-inspired programs such as
RNAsnp [431]. Another limitation of SNPfold is its p-value estimation. In generation of the
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underlying background distribution, SNPfold only takes into account all SNPs within the
sequence in question. RNAsnp, on the other hand, uses distributions generated from SNPs
in RNAs matched for sequence length, GC content and SNP position, and thus provides a
p-value estimate that not only is more accurate, but much faster to calculate as well [431].
The final most important limitation of SNPfold to take into account is that it involves the
folding of single sequences only, without any regard to the conservation of the sequence
in question. Additional information that a region is functional or conserved is needed to
provide evidence that structure change in a region may be functional. In the case of our
work in chapter 2, that evidence was the disease-associated status of many of the SNPs.
While SHAPE is commonly used and trusted within the RNA structure community,
there are certain limitations and caveats to its use that are worth discussing. One limitation
is that due to the fact that a primer binding site at the 3’ end of the sequence is required
for the RT step, as well as the fact that a large portion of cDNAs are full length and
indiscernible from one another, 5’ and 3’ end structural information is lost. To counter this,
5’ and 3’ end structural cassettes consisting of stable hairpins are utilized [142]. In spite of
this, however, it is possible in some cases that these linkers may ultimately alter the SHAPE
reactivities via helical stacking interactions in the tertiary structure. Another limitation
is that there is that what SHAPE reactivities are not necessarily 100% representative of
secondary structure basepairing probability. In essence, they represent the flexibility of
each nucleotide in the ensemble of structures. This roughly correlates with the secondary
structure of an RNA, but also incorporates RNA tertiary structure. It is also important
to note that these reactivities are sensitive to salt and magnesium concentrations, and
thus a SHAPE assay on a particular transcript can have different results depending on the
concentrations in question. An important limitation that we have experienced in our work
is that there are not many particular ways to determine whether a mutation significantly
changes structure or not. We are able to conduct T-tests with consideration of unequal
sample variance in order to identify nucleotides with statistically significant differential
SHAPE reactivity between wildtype and mutant, but the amount of nucleotides that should
show differential SHAPE reactivity in order to call the structure of two RNAs ”different”
remains unclear [179].
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Looking back on our work to identify Structure Stabilizing Haplotypes (SSHs), there
are many shortcomings to the analysis. One problem with our work (and one that was
out of our control) was that the SNP data that we had at our disposal was limited by
what the HAPMAP project covered on their genotyping arrays. The SNPs on these arrays
are chosen in a manner that allows them to tag portions of the genome, and thus SNPs
that are close enough together that they may conserve structure on a transcript tend to
be few and far between. Current phased haplotype data derived from the 1000 genomes
project represents a much more comprehensive collection of sequence variation inherent to
untranslated regions of mRNA in populations (containing around 3 times as many total
SNPs) [432]. It is additionally not hard to find shortcomings with our SSH algorithm.
Perhaps the biggest issue is that we look at global structure conservation for particular 5’
and 3’ UTR sequences, since as discussed previously, it becomes harder to trust structure
predictions when there are predicted long-range base pairings at play [107]. Given that
many known functional structural motifs are smaller, and that current structure prediction
methods poorly predict long range pairing, a better strategy would be to focus on the
conservation of local structure instead. Improvement of the SSH method utilized, complete
with an RSM (Root Mean Squared) calculation between structure ensembles instead of
correlation coefficients, and a consideration of large SSH values that can be generated from
small amounts of structure recovery in very structurally similar mutations, would also be
ideal. In these types of studies done across species, mutual information and covariation
models have been used to extract evidence of conserved RNA structure, but such models
depend on a level of sequence variation that simply is not present in human populations
[138, 141, 308].
The weaknesses of the analysis of overlap between PAR-CLIP data and eQTLs in human
3’UTRs are a large part due to datasets utilized. The eQTLs that we use are typically
derived from very particular cell types, and thus are only detectable when they are involved
in some way with a gene that is currently active in the cell type in question. Many of the
studies that these eQTLs are drawn from utilize SNP arrays, and thus may miss the full
suite of SNPs in a region that are associated with differential expression of a particular gene.
Newer eQTL studies (including the GEUVADIS study) utilize high-throughput sequencing
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and thus are more likely to pull out the (still unidentifiable based on eQTL status alone)
SNP that is causative of differential gene expression [433]. With respect to the PAR-CLIP
data utilized, there is a danger of particular datasets having a large amount of false positive
clusters. Due to the high binding affinity provided by the introduction of a nucleotide
analogue, there is no step in the PAR-CLIP protocol that involves any sort of background
subtraction. In spite of this, analysis of background RNA/protein crosslinking is rarely done,
so there is no knowledge of if there is any sequence bias in PAR-CLIP reads extracted. In
regards to the enrichment analysis conducted, we used a random background distribution
of SNP positions (set to the SNP density of each UTR), and a better background model
to use would have been to select SNP populations in a manner that matches them with
the eQTL set according to minor allele frequency binning and conserves complete LD sets
[434]. Lastly, though our SNPfold analyses are based on local sequence surrounding protein
binding sites, other issues with the algorithm should be taken into consideration. In revision
of the work described, a more careful consideration of the shortcomes of the data integrated,
combined with a more comprehensive job in identifying the sequence predicted structural
characteristics of both the functional SNP sites and PAR-CLIP regions, are essential.
6.2 Future directions
In discussion of the preceding work described, it is especially important to consider
where it may lead in the future. Possible directions that this work may head in will now be
described.
6.2.1 Improvements In structure and structure change prediction
In the field of improving our ability to accurately identify SNPs that change RNA
structure, there is a great deal of work to be done. Many modifications be made to our
current algorithms to improve their accuracy, and additionally, chemical mapping data can
be used to provide additional structure change data that was previously unavailable.
It has become obvious to us that the prediction of RNA structure change is heavily
limited by the limitations in accuracy on the part of available structure prediction algorithms,
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with no structure prediction method identifying structure change for particular mutations
with an accuracy greater than 64% as reported in our own published work [122]. It has
additionally become apparent, as stated before, that there is a deficiency in the ability to
accurately predict long range basepairing in RNA structure prediction algorithms [107]. In
order to deal with this problem, other researchers have done benchmarking studies with
structure prediction algorithms using different allowed maximum base pair distances, in
order to tell what span L allows for the most accurate structure predictions when compared
to determined and verified structures. An optimal span size L = 150 was identified [129].
Thus, when using SNPfold or RNAsnp to predict if significant structure change occurs in a
region for a particular SNP, it would be better to consider local structure change only, with a
maximum allowed span of this size. Additionally, penalizing long range basepairs may prove
to be an attractive option for dealing with the amount of false positive basepairings seen
in structure prediction data, and is an option currently being explored by other structure
prediction-focused research groups [130]. In regards to pseudoknot detection, while our
current structure change predictions can detect ij basepairing patterns consistent with that
of pseudoknots, we do not currently take into account their explicit detection. Such work can
be achieved either with significantly more computationally expensive but pseudoknot-aware
structure prediction algorithms, or with the use of a program such as SHAPEknots that
uses SHAPE data as a constraint to identify likely pseudoknot structures within a sequence
[133, 135, 136].
As a step to identifying true (and biologically meaningful) structure change, an ideal
strategy will likely prove to be the identification of areas of highly ordered local structural
ensembles that have some level of sequence conservation. Here, we consider the calculation
of Shannon Entropy as a useful metric for measuring the ”predictability,” so to speak, of i’s
basepairing probability distribution within an energy-weighted ensemble of structures that
a particular sequence emits [435]. The equation for the Shannon entropy of a nucleotide i
within a partition function matrix is:
Si = −
∑
j
pi,jlog(pi,j)
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Where pi,j is the probability of an ij basepair within the ensemble. This equation has been
used to identify tRNA and rRNA nucleotides which in a partition function matrix are more
likely to be correct basepairing predictions [435]. We can modify this equation to represent
the total Shannon Entropy inherent to the structural ensemble of a sequence:
S =
−∑i<j pi,jlog(pi,j)
N
Where N is the length of the sequence in question. Here, S essentially represents the
predictability of the ensemble. We would expected a low entropy value in two types of
ensembles: ordered ensembles with highly predictable basepairing, and ordered ensembles
with low or no basepairing. To place an additional weight on our value S we can calculate
the Shannon Entropy per unit energy of the ensemble. For this equation we just calculate
SZ =
S
Z
where Z represents the total free energy of the boltzmann ensemble of structures emitted
by the sequence. Using a simple sliding window approach we can calculate SZ for each
nucleotide in a sequence, given a particular sliding window size. We have produced an
example figure using the FTL 5’ UTR as an example, with a sliding window size of 60 nt
(Figure 6.1). We hypothesize that the values in this distribution with particularly low S and
SZ values will be enriched for SNPs that bring about significant functional RNA structure
change. Additionally, cross-species sequence alignment for the candidate conserved regions
with low entropy can be utilized to form covariance models [138]. These covariance models
can be used to represent ’wildtype’ RNA primary and secondary RNA structure. A SNP
falling in this region can be analyzed for the amount that it deviates from the produced
or known covariance model by measuring the ’bit score’ of the SNP-containing sequence
when it is aligned to the model using infernal’s ’cmalign’ program [436]. This method of
measuring the amount that a particular SNP disrupts conserved RNA does so in a manner
that takes both sequence and structure into account, such that it is difficult to determine
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from the bit score alone whether sequence content or higher order structure in the covariance
model is being disrupted.
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Figure 6.1: A scanning of the entropy per unit energy along the FTL 5’ UTR. A sliding window of size 60 is being
utilized. Dots that are connected by the black line represent the midpoint of a folded window, indicated in blue. The
structured region of the FTL 5’ UTR containing the IRE is highlighted in green.
6.2.2 Structural impact of common and rare variants from sequencing projects
While HGMD was, at the time, a good initial dataset for obtaining a set of noncoding
disease-associated mutations, there now exist multiple other sources of human genetic
variation that are worth analyzing the predicted structural impact of. The HGMD set, in
many ways, was a ’dirty’ dataset, in that while on one hand it contained many rare mutations
from sequencing of particular genes in individuals with rare diseases, it also contained SNPs
that were merely associated (in many cases via a GWAS) with a particular disease. These
GWAS SNPs are far less likely to be causative than the rare mutations obtained through
direct sequencing. It seems logical that SNPs in areas where structural conservation is
important will more often than not have a low minor allele frequency, or in other words
are rare variants in a population. This would be consistent with other studies reporting
the functional enrichment of SNPs with particularly low minor allele frequency [437]. SNPs
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from the 1000 genome project would be most ideal for this, though given the low coverage
used to identify SNPs, a certain portion of these SNPs genotyped in individual samples are
likely to be false positives [432]. Mining of datasets containing so-called ’private’ variants
(which are likely of the same minor allele frequency as many of the rare mutations found in
HGMD) that are found in noncoding regions will prove to be particularly, and are also likely
signfiicant overlap enrichment with highly conserved structural regions in the transcriptome.
Datasets like these are likely to become more common as large sequencing projects become
more common, and identified private alleles from results pile up [438].
With the population wide data that is now available, we can not only determine the
impact of single variants across the genome, but determine the structural variation across
whole haplotypes. With phase 1 completed, the 1000 genomes project now has phased
haplotype data (built using HAPMAP as a guide) for its genetic variation across it sample of
1092 individuals [432]. Of particular interest would be conducting a more carefully thought
out analysis of sequence covariation across human transcripts in order to determine if there is
any evidence of structural conservation. As an example, I have extracted predicted conserved
structural regions from Evofold (a collection of structure motifs in the human genome that
are conserved across species) that do not overlap CDS exons in hg19 annotations (8,714
intervals in all) [439]. Corresponding to these regions are 11,996 total SNPs (no insertions,
deletions or indels are included). In initial searches we find multiple examples of sequence
variation that preserves structure (Figure 6.1). Whether there is a true enrichment of these
structure-preserving variants remains to be seen.
6.2.3 High-throughput probing of RNA structure
Ultimately, high throughput analysis of RNA structure and RNA structure change via
transcriptome-wide chemical mapping will likely prove to be the new standard for looking
at differential RNA structure across transcriptomes. Several methods for utilization of high
throughput sequencing to look at RNA structure change have been developed in the last
couple of years [334, 386, 440, 441]. It stands to reason that such technologies can be used on
multiple individuals in order to identify RNAs where there is differential structure. The cause
of such differential structure can then be traced back to sequence variation that is inherent
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Figure 6.2: Two examples of conserved structures according to Evofold that show evidence of conservation across the
1000 genomes population. A) The structure of an element found in an exon of the FAM214B gene. Each highlighted
color represents an alternate genotype observed in the population. B) The structure of an element found in an intron
of the AGBL4 gene. Here, the alternate genotype is a double mutant where the SNPs together preserve the basepairing
between them.
between individuals. With an increasing population size, we can create true population
profiles for diversity of RNA structures across different transcripts, identifying transcripts
and transcript regions with highly variable structure and highly conserved structure that is
likely essential for proper gene regulation.
While we have covered a great deal of work in the previous chapters, it should be clear now
that our most significant findings relevant to this work likely lie ahead. The maturation of
computational techniques for predicting RNA structure and structure change, combined with
the development of high throughput technology that allow for rapid identification of sequence
variation in a population sample, as well as the fast measurement of transcriptome structural
data, it is likely that we will see an exponential jump in the amount of understanding of
how RNA structure contributes to function, as well as how its variation and disruption can
alter phenotype.
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